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Abstract 
Immunity declines during ageing, however the mechanisms involved are not known. 
In this study we show that the cutaneous delayed type hypersensitivity response 
(DTH) to recall antigens is significantly decreased in old individuals and that this 
was unrelated to CCR4, CLA or CD11a expression or physical capacity for 
migration of CD4
+ 
T cells. Instead, there was defective activation of dermal blood 
vessels of these subjects that resulted from decreased TNF-α secretion by 
macrophages after antigen-challenge in vivo. However, isolated skin macrophages 
from these subjects could be induced to secrete TNF-α after stimulation with TLR 
1/2 or TLR 4 ligands in vitro, indicating that the defect is reversible. The decreased 
conditioning of tissue microenvironments by macrophage-derived cytokines may 
therefore lead to defective immunosurveillance by memory T cells. This may be a 
predisposing factor for the development of malignancy and infection in the skin 
during ageing.  
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Chapter 1. Introduction 
1.1. The Skin Immune System 
The skin is the largest organ of the human body and its principal function is that of a 
physical barrier. It protects the organism by being impermeable to a multitude of 
harmful exogenous substances and maintains internal homeostasis by preventing 
excessive water and heat loss (Kalinin et al., 2002; Candi et al., 2005). In addition 
there is a highly specialised immune system consisting of immune cells which are 
resident, recruited or recirculating within the skin (Table 1-1) (Bos Jan D, 2004; 
Nestle and Nickoloff, 2007; Zaba et al., 2009). These cells are distributed in the 
epidermal and dermal layers of the skin and are capable of participating in both 
adaptive and innate immune responses. They are also responsible for distinguishing 
self from non self which is of fundamental importance since the skin comes into 
daily contact with exogenous substances. In particular, skin immune cells play an 
important role in the initiation and amplification of immune responses, with close 
interlinking between innate and adaptive pathways (Bos Jan D, 2004). 
Table 1-1: Cells of the Skin Immune system 
 Resident Recruited Recirculating 
Innate Keratinocytes Monocytes Natural Killer Cells 
 Endothelial cells 
-Vascular 
-Lymphatic 
Granulocytes 
-Basophilic 
-Eosinophilic 
-Neutrophilic 
Dendritic cells 
 Mast cells Mast cells ?Promonocytes 
 Tissue macrophages Epitheloid cells  
Adaptive T lymphocytes T lymphocytes T lymphocytes 
 Dendritic cells B lymphocytes  
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1.2. T cell mediated immune responses 
1.2.1. Primary T cell response 
Primary T cell responses are mediated by naïve T cells that, after leaving the thymus, 
home continuously from the blood to lymph nodes and other secondary lymphoid 
tissue (Butcher and Picker, 1996; Mackay et al., 1990). Homing to lymph nodes 
occurs in high endothelial venules (HEV) which express molecules for the 
constitutive recruitment of lymphocytes. The initiation of a primary T cell response 
depends on dendritic cells (DCs) picking up antigens at peripheral sites and 
migrating to regional lymph nodes, where they present antigen to the naive T cells. 
Naive T lymphocytes only become activated and proliferate when their antigen 
receptors (TCRs) bind to cognate peptides presented on major histocompatibility 
complex (MHC) molecules (Rudolph et al., 2006; Stockinger et al., 2006). 
Recognition of antigen results in the triggering of the T cell receptor (TCR)/ CD3 
complex as well as CD4 or CD8 co-receptors with the formation of an 
immunological synapse between the T cell and APC. Cell triggering is also 
dependent on the ligation of additional co-stimulatory, accessory and adhesion 
molecules such as CD28, LFA-1, CD40L, OX40 that serve to augment T cell 
activation and expansion by stabilising the immunological synapse and inducing 
intracellular signalling molecules (Jenkins et al., 2001; Croft, 2003; Watts and 
DeBenedette, 1999; Watts, 2005). The number of T cells specific for a particular 
antigen is naturally very low. It was recently shown that specific naive CD4
+
 T cell 
populations vary in frequency from 20 to 200 cells in mice (Moon et al., 2007). 
Moreover, the size of the specific naive population size predicted the size and TCR 
diversity of the primary CD4
+
 T cell response after immunisation with relevant 
peptide. Therefore, variation in naive T cell frequencies can explain why some 
peptides are stronger immunogens than others (Moon et al., 2007).  
An encounter with an antigen induces the proliferation of T-cell clones, yielding 
approximately 1000 times more descendants with identical antigenic specificity 
(Blattman et al., 2002). Eventually, these activated lymphocytes acquire effector 
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functions and home to sites of inflammation. Some effector cells orchestrate humoral 
responses by interacting with activated B cells in lymphoid organs (King et al., 
2008). Activation of effector CD4
+
 cells at the site of inflammation results in cellular 
differentiation with resulting polarised patterns of cytokine production. Cytokines are 
key determinants of whether an uncommitted T cell develops into a mature Th1 or 
Th2 cell. IL-12 promotes the development of Th1 polarised cells that secrete IFN- 
and TNF-α whereas IL-4 promotes the generation of Th2 polarised cells that secrete 
IL-4, IL-5, IL-10 and IL-13 (Bird et al., 1998; Murphy and Reiner, 2002). Some 
CD4
+
 T cells secrete both types of effector cytokines and are known as Th0 cells. 
Th17 cells that produce interleukin 17 (IL-17) have also been identified (Harrington 
et al., 2005). These are highly proinflammatory and induce severe autoimmunity. IL-
6 and transforming growth factor-beta (TGF-beta) induce the differentiation of Th17 
cells from naive precursors, whereas IL-23 serves to expand previously differentiated 
Th17 cell populations, (Bettelli et al., 2007). Also it was shown that IFN-γ and IL-4, 
inducers of Th1 and Th2 development, respectively, suppressed development of 
Th17 cells (Harrington et al., 2005). In general, Th1 responses are thought to be 
protective against intracellular infections whereas Th2 and Th17 responses are 
effective against extracellular infections. Most effector cells die after antigen is 
cleared, but a few antigen-experienced memory cells remain for long-term 
protection. Different subgroups of memory cells patrol lymphoid organs and 
peripheral tissues to mount rapid responses whenever the antigen returns (Sallusto et 
al., 1999). 
1.2.2. Memory T cell response 
Memory or recall responses occur more rapidly and are more pronounced than 
primary responses (Ahmed and Gray, 1996; Hu et al., 2001). This may be due to an 
increase in the frequency of antigen specific memory T cells within the T cell pool 
compared with naïve cells. However, it is also thought that memory T cells have a 
reduced requirement for activation in that they respond to lower concentrations of 
antigen, need less co-stimulatory signals, need a shorter duration of antigenic 
stimulation (Berard and Tough, 2002). They also enter into cell cycle more rapidly 
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following TCR stimulation (Veiga-Fernandes et al., 2000). Memory T cells also 
express different patterns of adhesion molecules and chemotactic receptors, enabling 
them to interact with APCs more effectively and also to migrate into inflamed non-
lymphoid tissues. Memory T cells differ from naïve T cells in their tissue distribution 
and circulation pattern. They can be found in both lymphoid and non-lymphoid sites 
(Masopust et al., 2001; Reinhardt et al., 2001) and are readily activated by antigen in 
all tissues (Chalasani et al., 2002) (Klonowski et al., 2004; Ely et al., 2003). Tissues 
such as the liver, lung and gut are major reservoirs of antigen experienced T cells 
(Chalasani et al., 2002). 
1.2.3. Memory T cell phenotype 
CD45, the leukocyte common antigen, is used to differentiate naïve from effector 
and memory T cells. The relative expression of the CD45 isoform can be used to 
distinguish the state of T cell differentiation (Trowbridge and Thomas, 1994). CD45 
is an integral membrane protein tyrosine phosphatase (Charbonneau et al., 1988) and 
is expressed on all nucleated haematopoietic cells including leucocytes (Hermiston et 
al., 2003). The precise role and ligand for the receptor have yet to be fully 
determined (Holmes, 2006) however CD45 appears to play an important role in T 
cell signal transduction (Kung et al., 2000; Mustelin et al., 2003). Naïve T cells 
express the CD45RA isoform, however following activation the expression of 
CD45RO is rapidly upregulated and CD45RA expression is lost over a few days 
(Akbar et al., 1988). All CD45RA
+
 naïve T cells also express high levels of 
CD45RB. CD45RO
+ 
T cells can be divided in to CD45RB high and low subsets 
depending on whether they have recently been primed or have undergone numerous 
rounds of stimulation and are highly differentiated respectively (Salmon et al., 1994). 
The loss of the co-stimulatory molecules CD27 and CD28 on memory T cells can 
also be used to identify cells with a more differentiated phenotype (Romero et al., 
2007). 
Recent studies have shown that human memory CD8
+
 T cells can re-express 
CD45RA and lose CD45RO expression in a process known as reversion (Dunne et 
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al., 2002; Faint et al., 2001; Wills et al., 1999). CD8
+
 revertant T cells, unlike naïve 
T cells, express low levels of L-selectin (CD62L) and CCR7 but high levels of LFA-
1/CD11a. Limited evidence also suggests that CD4
+
 T cells may also revert to 
CD45RA
+
 phenotype (Bell et al., 2001). The precise role of revertant memory cells 
has yet to be identified but they may form a more stable, non-cycling memory 
population. 
CD45RO
+
 memory T cells can be further divided on the basis of their migratory 
ability. The so called central memory cells express a repertoire of homing molecules 
similar to that of naive T cells including CD62L and CCR7 and migrate 
preferentially to secondary lymphoid organs whilst effector memory cells lack 
expression of CD62L and CCR7 and migrate to peripheral tissues (Sallusto et al., 
1999). Central memory cells lack immediate effector function, but they proliferate 
well, produce IL-2, efficiently stimulate dendritic cells and differentiate into CCR7
-
 
effector cells upon secondary stimulation. In contrast, effector memory T cells do not 
express CD62L or CCR7 (Sallusto et al., 2004), express organ specific tissue homing 
receptors and can reside in both secondary lymphoid tissues as well as non-lymphoid 
tissues (Campbell et al., 2003). These cells have been found to rapidly secrete 
effector cytokines IFN-, IL-4 and IL-5 after restimulation (Sprent and Surh, 2002) 
but may not proliferate as efficiently as the central memory T cells. It has therefore 
been proposed that the effector memory subset is specialised for quickly entering 
inflamed tissues in order to provide immediate effector function whereas the central 
memory subset is responsible for a more sustained memory response (Sallusto et al., 
2004). 
1.2.4. Delayed Type Hypersensitivity Responses and the Skin 
Delayed type hypersensitivity (DTH) responses in the skin can be induced by either 
the topical application of hapten or the intradermal injection of antigen in to the skin 
and are representative of a cutaneous T cell mediated memory response (Turk, 1980). 
The delayed type hypersensitivity response to the intradermal injection of bacterial, 
viral and fungal antigens can therefore be used to assess individuals‟ cell-mediated 
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immune responses to particular antigens (Takahashi et al., 2003; Sadaoka et al., 
2008; Ahmed and Blose, 1983). Moreover since the time of antigen 
application/injection is known the kinetics of the response can be effectively 
monitored. A positive skin test denotes prior antigenic exposure, T cell competency 
and an intact inflammatory response (Ahmed and Blose, 1983). 
Responsiveness to DTH skin testing is assessed by the diameter of induration 
induced in the forearm skin in humans at 48 hours or by the amount of ear or footpad 
swelling at 24 hours in mice (Ahmed and Blose, 1983; Turk, 1980). In humans, 
following the injection of intradermal antigen, a clinical response is seen within a 
few hours with white or rose-coloured induration of the skin. The visible response in 
the skin peaks by 48-72 hours with a localized red, indurated area of skin. Rarely, 
vesicles and petechiae may also be seen. Ulceration at the site of injection has also 
been reported. The clinical response then reduces and resolves by 10-14 days (Turk, 
1980; Ahmed and Blose, 1983). 
DTH responses are used clinically to detect either infection with or previous 
exposure to various pathogens including Mycobacterium tuberculosis (Ahmed and 
Blose, 1983; Turk, 1980). The classical model of DTH is the Mantoux test where a 
sterile aqueous solution of tuberculin purified protein derivative, a complex mixture 
of peptides and carbohydrates derived from M. tuberculosis, is injected intradermally 
in to the skin. It is used widely as an experimental model in that it produces a 
reproducible clinical response in the skin in young, healthy individuals previously 
exposed to M. tuberculosis and those immunized with the Bacillus of Calmette and 
Guerin (BCG) vaccine, prepared from live attenuated strains of M. Bovis (Turk, 
1980; Ahmed and Blose, 1983). The likelihood of previous immunisation versus 
acute infection is determined by the diameter of the clinical response with a diameter 
of over 15mm regarded as suspicious of current infection (Tissot et al., 2005), 
warranting further investigation (NICE guidelines, March 2006). 
DTH responses against common pathogens such as Candida or vaccine antigens 
(Tetanus) can also be used clinically as a measure of overall cell mediated immunity. 
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The Candin skin test, using a sterile solution produced from the culture filtrate and 
cells of two strains of Candida albicans, has been licenced for the evaluation of 
cellular immune responses in the skin in patients with HIV (Ahmed and Blose, 
1983). 
The DTH response in the skin is biphasic with an early non-specific infiltration of 
cells that occurs in all individuals and a second specific peak that is only seen in 
those who have previously been sensitized to the antigen (BOUGHTON and 
SPECTOR, 1963). First the presence of antigen and trauma to the skin induce non-
specific “danger signals”, that recruit and activate cells of the innate immune system 
(Matzinger, 2002). These early signals are crucial for the conditioning of the 
inflammatory environment and to enable the recruitment of leucocytes from the 
blood (Kupper and Fuhlbrigge, 2004). Histological analysis shows that at around 4-6 
hours there is an infiltration of neutrophils into the skin (Platt et al., 1983). Injection 
of latex beads or simple wounding to the skin induces a similar accumulation of 
neutrophils (John and Hunter, 2008). This is followed by macrophages that peak in 
numbers at around 24-48 hours. Around 12 hours after challenge T lymphocytes and 
dendritic cells have been shown to appear around dermal blood vessels (Platt et al., 
1983). After 48 hours the majority of infiltrating cells are T lymphocytes with CD4
+
 
lymphocytes exceeding CD8
+
 lymphocytes at all time points. Only a very small 
number of B lymphocytes have been observed at the site of DTH responses (Platt et 
al., 1983; Gibbs et al., 1984; Poulter et al., 1982). The majority of cells are seen to 
accumulate perivascularly, however T cells and macrophages are also found within 
the interstitium in the upper dermis and also around adnexal structures such as hair 
follicles and sweat glands. Lymphocytes may also be seen infiltrating the epidermis 
(Gibbs et al., 1984; Platt et al., 1983; Poulter et al., 1982). 
It is very important that memory T cells migrating via the blood stream are able to 
enter the tissue at the site of the antigenic insult, via the endothelium that had been 
activated by the original danger signals to amplify the response (Kupper and 
Fuhlbrigge, 2004; Campbell and Butcher, 2002; Greening et al., 2003). The fact that 
non-immune individuals do not mount a DTH response to antigen, despite the fact 
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that equal levels of antigen as well as trauma to the skin occurs, highlights the 
importance of the memory T cell recruitment for the amplification step of this 
response to take place (Reed et al., 2004). There are therefore antigen-specific as 
well as antigen-non-specific events that have to be induced and co-ordinated to 
enable a response to take place and both are required for the clinical response 
(erythema and induration) in subjects who are immune (Turk JL., 1980).  
1.2.5. Initiation of DTH responses in the skin 
The conventional model of DTH responses in the skin suggests that lymphocytic 
recruitment to the skin occurs following secondary lymph node T cell proliferation 
after migration of antigen presenting cells from the skin to the draining lymph node. 
Although Langerhans cells are conventionally regarded as the main antigen 
presenting cells of the skin (Mathers and Larregina, 2006), their importance in 
initiating memory immune responses in the skin has been questioned (Grabbe et al., 
1995) and it is unknown whether they are able to take up and process antigen that has 
been injected intradermally. Their contribution to the DTH response is therefore 
unclear. Another population of dendritic cells in the dermis, known as dermal 
dendritic cells has been shown to be found in close contact with resident T 
lymphocytes in normal skin suggesting that communication between these two cell 
types might occur early in the immune response to antigen (McLellan et al., 1998). 
Other cells within the skin also have antigen-presenting capability such as 
macrophages (Geppert and Lipsky, 1989) and keratinocytes (Albanesi et al., 1998; 
Barker et al., 1991; Roychowdhury and Svensson, 2005; Wittmann and Werfel, 
2006) and may play a more prominent role in antigen presentation following 
secondary immune challenge. Macrophages have been shown to remain resident in 
skin however and therefore antigen presentation would have to occur locally in the 
skin perhaps to skin resident T cells, whereas the dermal dendritic cell is known to 
transmigrate across lymphatic channels to draining lymph nodes (Randolph et al., 
1999). In addition human dermal microvascular endothelial cells (DMEC) may 
present antigen to circulating memory cells. DMEC express high levels of MHC 
class 1 and class 2 molecules at basal resting levels, can upregulate expression of 
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these molecules in the presence of IFN-γ and can induce human CD4+ and CD8+ 
memory but not naïve T cells to proliferate and secrete cytokines in vitro (Pober et 
al., 2001; Vora et al., 1994). 
Normal skin contains T cells at a density of ~ 1 x10
6
/cm
2
. Moreover there is an 
estimated 20 billion T cells in the entire skin surface, nearly twice the number in the 
entire circulation (Clark et al., 2006). It is thought that this large number of T cells 
provides cutaneous immunosurveillance (Kupper and Fuhlbrigge, 2004; Clark, 
2009). Skin resident T cells are predominantly CD4
+
 CD45RO
+
 memory T cells 
which are able to home to the skin because of their high level expression of 
cutaneous lymphocyte antigen (CLA), CCR4 and CCR6 (Clark et al., 2006; Kupper 
and Fuhlbrigge, 2004). The CCR8-CCL1 interaction is also important for 
homeostatic cutaneous T cell traffic (Schaerli et al.,2004). Skin resident T cells have 
a remarkably diverse TCR repertoire, and most have a Th1 effector memory cell 
phenotype, although Th2 cells, central memory cells and functional T regulatory 
cells are also present (Clark et al., 2006).  
It is possible that interactions between resident T cells and antigen presenting cells 
are responsible for the initiation of DTH responses in the skin without the need for 
the initial migration of dendritic cells to the lymph nodes. Although T cell activation 
has been observed in draining lymph nodes following secondary challenge, this 
occurs at a reduced rate compared with the primary response (Jones et al., 2000).  
Based on calculations of circulating volumes and cardiac output it has been estimated 
that the time taken for antigen to reach the inguinal lymph nodes from the toe would 
take around 12 hours (Mestas and Hughes, 2004), however DTH responses are seen 
as early as 4 hours. In addition, recall immune responses in humans occur in spite of 
compromised afferent lymphatics (Mallon et al., 1997). All of these findings suggest 
that localised initiation of the secondary immune response may occur within the skin. 
The close apposition of antigen presenting cells and T cells within the skin during 
recall responses (Katou et al., 2000; Willis et al., 1986) may indicate that the 
activation of resident antigen- specific T cells by antigen presenting cells within the 
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skin is possible. Activation of antigen specific cells within the skin could potentially 
result in the initiation of the immune response via the secretion of acute phase pro-
inflammatory mediators such as TNF- and IFN- resulting in the activation and 
recruitment of monocytes, neutrophils and memory T cells. Resident T cells may 
also be able to traffic to the lymph node where they are able to accelerate appropriate 
T and B cell responses. Figure 1-1 shows an overview of the roles of DCs, 
macrophages and T cells in the secondary cutaneous immune response. 
One of the problems with this model however is the large diversity of antigen-
specific cells required in order to accommodate the vast array of antigens that are 
encountered by the skin. Antigen specific cells may only be resident at the sites of 
previous antigenic challenge. This theory is supported by the observation that 
repeated allergen exposure to a site of previous allergic contact dermatitis in guinea 
pigs results in a more rapid clinical response, not seen at other non-exposed sites 
(Rustemeyer et al., 2002). In addition, in humans, IFN-γ producing CD8+ T cells 
have been found in the epidermis of fixed drug eruptions before and after secondary 
challenge (Mizukawa et al., 2002). 
 
 
Chapter 1 
Page 11 
 
Figure 1-1: The role of DCs, macrophages and memory T cells in secondary 
cutaneous immune responses. 
Memory immune responses can be divided into 2 stages. First, DCs take up 
antigen following pathogen/allergen re-exposure and present it to effector 
memory T cells resident within the skin. These cells proliferate and effect 
clearance of the pathogen (1a). Recognition of non-specific danger signals by 
macrophages leads to their activation and release of inflammatory cytokines 
which leads to endothelial activation and nonspecific recruitment of antigen-
specific T cells from the blood (1b). The small numbers of antigen-specific T 
cells recruited into the skin in this way can also participate in clearance of the 
pathogen. Second, DC carry endocytosed antigen to the skin-draining lymph 
nodes where it is presented to central memory T cells. These central memory T 
cells then give rise to new populations of skin-homing effector memory T cells 
that migrate to the skin and clear the pathogen/allergen (Figure adapted from 
Clark, R.A., 2009). 
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1.2.6. T cell migration 
For a secondary memory cutaneous immune response to develop, it is essential that 
circulating memory T cells are attracted to the area of inflammation and allowed to 
migrate into the skin by activated dermal post-capillary venule endothelium. For this 
to occur both the T cell and the endothelial cells must express corresponding 
adhesion molecules so that the T cell binds tightly to the endothelium before 
transmigration of the T cell into skin can occur (von Andrian and Mackay, 2000). 
Expression of different adhesion molecules on T lymphocytes allows homing to 
different organs, for example all T cells bound for the skin express the cutaneous 
lymphocyte antigen (CLA(Berg et al., 1991). Gut-homing T cells are identified by 
their expression of CCR9 and α4β7 integrin (Butcher et al., 1999). The leucocyte 
adhesion cascade consists of three main sequential steps: selectin-mediated rolling, 
chemokine-triggered activation and integrin-dependent arrest. Transmigration is then 
mediated mainly paracellularly or transcellularly (in the case of central nervous 
system) by CD31 (platelet/endothelial cell adhesion molecule, PECAM-1), CD99 
and junctional adhesion molecule (JAM) (Ley et al., 2007). The adhesion molecules 
involved in migration of T cells into skin are shown in Table 1-2 
Table 1-2: Adhesion molecules involved in T cell transendothelial migration 
into skin 
Step in leucocyte migration Lymphocyte adhesion 
molecule 
Endothelial adhesion 
molecules 
Rolling CLA 
PSGL-1 
E-selectin 
P-selectin 
Arrest Integrins 
CD11a (LFA-1) 
VLA-4 
Immunoglobulin superfamily 
ICAM-1 
VCAM-1 
Transmigration CD31(PECAM-1) 
? 
CD31(PECAM-1) 
Junctional adhesion  
molecule (JAM) 
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1.2.6.1. Leucocyte rolling 
Initial tethers are formed between selectins expressed on the endothelium (E and P-
selectin) which bind their ligands (oligosaccharides related to sialyl-Lewis
x
) on 
circulating T cells. In the skin, the selectin expressed on the endothelium of greatest 
importance is E-selectin (ELAM-1) along with the less skin specific P-selectin 
(Picker et al., 1991; Yan et al., 1994). E-selectin expression is increased in response 
to exposure to the pro-inflammatory cytokines interferon-gamma (IFN-γ) and TNF-α 
whilst P-selectin is constitutively expressed by endothelial cells. Mice deficient in 
both E and P-selectins display defects in leucocyte extravasation as well as 
susceptibility to opportunistic bacterial infections (Frenette et al., 1996). Selectins 
bind their corresponding ligands on T cells which include L-selectin, which mediates 
migration to lymph nodes and spleen, P-selectin glycoprotein ligand-1 (PSGL-1) and 
cutaneous lymphocyte antigen (CLA), which is a modified PSGL-1 molecule and is 
expressed on memory but not naive T cells. E-selectin binds cutaneous lymphocyte 
antigen (CLA) on skin-homing memory T cells (Berg et al., 1991). Selectin mediated 
bonds are impermanent and as the flowing blood exerts pressure, adhesion bonds 
dissociate at the upstream end of the cell and new bonds form downstream. This 
results in a rolling motion (von Andrian and Mackay, 2000).  
1.2.6.2. Leucocyte activation and arrest 
To stop rolling cells must engage additional (secondary) receptors. All secondary 
adhesion molecules belong to the integrin family, specifically CD11a (also referred 
to as LFA-1/CD11aCD18/αLβ2) and the two α4 integrins: very late antigen-4, VLA-4 
(α4β1) and α4β7 (von Andrian and Mackay, 2000). CD11a and VLA-4 bind ICAM-1 
and VCAM-1 on endothelium respectively. α4β7 binds mucosal-addressin cell 
adhesion molecule 1 on endothelium which enables homing of lymphoctes to gut 
(von Andrian and Mackay, 2000). Integrins must be activated to mediate adhesion. 
Rolling T cells activate integrins when they receive signals from chemokines on 
endothelial surfaces (von Andrian and Mackay, 2000). Chemokines are secreted 
polypeptides which can bind to heparin-like glycosaminoglycans on cell surfaces and 
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in the extracellular matrix. Chemokine receptors on T lymphocytes track down and 
bind to these immobilised chemokines (a process known as haptotaxis) (Carter, 
1965). CCR4 is a crucial chemokine receptor for skin homing of T cells as it allows 
binding to its agonist thymus and activation-regulated chemokine, TARC, secreted 
within inflamed skin tissue (Imai et al., 1997). After the arrest phase leucocytes then 
need to penetrate the endothelial cells barrier and its associated basement membrane 
and the pericyte sheet (a discontinuous layer of smooth muscle cells wrapped around 
endothelial cells of almost all post-capillary venules) (Ley et al., 2007). 
1.2.7. T cell proliferation and clonal expansion during DTH responses in the 
skin 
During the course of the DTH response there is initial expansion and then subsequent 
contraction of T cell numbers at the site of inflammation (Poulter et al., 1982; Platt et 
al., 1983). Although studies in mice have demonstrated the persistence of memory T 
cells within non-lymphoid tissues that appear to convey protective immunity (Hogan 
et al., 2001; Masopust et al., 2001), other studies have shown that memory T cells 
resident within non-lymphoid tissues do not proliferate upon re-activation (Harris et 
al., 2002; Ostler et al., 2001). Blocking chemokine or integrin mediated recruitment 
of T lymphocytes during DTH responses in mice diminishes the response (Grabbe et 
al., 2002; Reiss et al., 2001) suggesting that recruitment of T cells within the 
circulation or resident within secondary lymphoid tissues is critical in mediating a 
recall response. In mice, therefore, the increase in the number of lymphocytes at the 
site of secondary immune responses is unlikely to be due to proliferation of antigen-
specific cells within non-lymphoid tissues. 
Published work from our laboratory, however, suggests that the expansion of PPD 
specific CD4
+
 T cells during the course of the Mantoux test response in humans is 
due in part to the in situ proliferation of T cell clones present in the skin at early time 
points (Reed et al., 2004). This conclusion is supported by the findings that there was 
a high level of the proliferation marker Ki67 present in the skin at Day 7 and that 
there was an increase in the number of antigen specific cells up to day 14. However, 
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there was no associated change in the number of circulating Ki67 or PPD-specific T 
cells in the peripheral blood that would be expected if the T cells were recruited to 
the skin following proliferation in the lymph node (Reed et al., 2004). 
DTH responses may therefore be mediated by several mechanisms in different 
species, some of which may become redundant under certain conditions, including 
activation of resident cells and the recruitment of memory T cells from the peripheral 
blood some of which will have been pre-activated in the draining lymphoid tissue. 
1.2.8. Regulatory T cells and their role in cutaneous memory responses 
Certain T cells, referred to as suppressor or regulatory T cells (Tregs) actively 
suppress the actions of other T cells that can cause tissue damage. Tregs play an 
active part in both immunological self-tolerance and in the resolution of an immune 
response to non-self antigens (Sakaguchi, 2004). 
They have been extensively studied over the past decade since the identification of 
suppressive CD4
+
CD25
+
 T cells in mice (Sakaguchi et al, 1995). Their importance in 
immune regulation was evident from the initial demonstration that the depletion of 
this subset (~10%) from a population of CD4
+
 T cells from a normal adult mouse 
resulted in the development of a spectrum of autoimmune diseases when the 
remaining CD4
+
CD25
-
 T cells were transferred to immunocompetent recipients. 
Foxp3 is a transcription factor selectively expressed by CD4
+
CD25
+
 T cells and is 
required for Treg development. Mice lacking expression of Foxp3 (scurfy mice) and 
humans with IPEX (Immune dyregulation, polyendocrinopathy, enteropathy, X-
linked) syndrome are affected by a fatal autoimmune syndrome (Hori et al., 2003). 
These disorders have led many to suggest that Foxp3 is a definitive marker of 
regulatory activity (Fontenot & Rudensky, 2005). However, in humans, it has been 
shown in a number of studies that activated responder CD4
+
 T cells can transiently 
express Foxp3 (Walker et al, 2003; Morgan et al, 2005; Wang et al, 2006). The 
balance between responsive T cells and Tregs during an immune response is crucial 
Chapter 1 
Page 16 
to maintain controlled immunity and both cell types need to be present for the 
lifetime of the organism (Akbar et al., 2007). 
Various hypotheses have been proposed, covering how they function and where they 
are generated (Grossman et al, 2004; Asseman et al, 1999; Oida et al, 2006). Tregs 
are widely thought to be self-reactive cells, generated in the thymus (Hsieh et al, 
2006). Whereas autoreactive T cells are generally deleted in the thymus (Hoffmann 
et al, 1995; Klein et al, 1998), Tregs are hypothesised to escape deletion and instead 
gain suppressive capacity (Jordan et al, 2001; Liu, 2006). However, there has been an 
accumulation of evidence suggesting that Tregs  may be generated in the periphery 
from mature conventional T cells as well (Seddon & Mason, 1999; Apostolou & Von 
Boehmer, 2004; Cobbold et al, 2004). A recent paper has challenged the notion that 
Tregs are specific for self-antigens (Pacholczyk et al, 2007), finding that 70% of the 
most frequent conventional CD4 TCRs were also expressed by regulatory T cells. A 
study in humans also found a significant overlap in TCR repertoire between 
regulatory and responder CD4
+
 T cells (Fazilleau et al, 2007(Vukmanovic-Stejic et 
al., 2006). 
On average, ninety to ninety-five percent of regulatory T cells in adult humans 
express CD45RO (Taams et al, 2001) thus placing them in the memory compartment 
in humans (Akbar et al, 1988; Merkenschlager & Beverley, 1989). The remaining ten 
percent of Tregs have a naïve phenotype, expressing CD45RA. A high percentage of 
circulating human and mouse Tregs express CLA and they are found in normal skin 
from both humans and mice. This suggests that cutaneous Tregs may have an 
important immunoregulatory function at this site even in the absence of infection or 
inflammation. It was shown that after transfer of Tregs into Treg cell-deficient scurfy 
mice, Tregs upregulated expression of cutaneous homing receptors such as CLA and 
migrated to the skin. Loss of fucosyltransferase VII(FuT7) enzyme, which leads to 
generation of part of the CLA molecule, dramatically reduced Treg cell accumulation 
within the skin, and resulted in selective onset of severe cutaneous inflammation 
(Dudda et al., 2008). Skin resident Treg cells are therefore essential for maintaining 
normal cutaneous immune homeostasis. 
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1.3. Innate immune cells in human skin and their blood precursors  
The innate arm of the immune system consists of monocytes, polymorphonuclear 
(PMN) and natural killer (NK) cells. Neutrophils are the first inflammatory cells to 
accumulate at the site of simple skin trauma (Peters et al., 2008). Blood monocytes 
represent 10% of circulationg leucocytes in human blood and give rise to 
macrophages and some DCs in skin. 
1.3.1. Blood Monocytes and their relationship to tissue macrophages and DCs 
Monocytes, macrophages and DCs are all phagocytic cells thought to be interrelated 
and collectively referred to as the mononuclear phagocyte system (MPS) (Sasmono 
et al., 2003). The MPS was initially defined as a population of cells, derived from a 
bone marrow progenitor, that differentiate and enter the blood as monocytes and then 
enter tissues to become resident tissue macrophages and antigen-presenting cells 
(van Furth and Cohn, 1968). Indeed the best known function of monocytes is as a 
systemic reservoir of myeloid precursors for the renewal of some tissue macrophages 
and antigen-presenting dendritic cells (Randolph et al., 1999; Geissmann et al., 2003; 
Varol et al., 2007). However it is now recognised that not all DCs arise out of 
circulating monocytes (Auffray et al., 2009). The potential mechanisms for the 
renewal of individual subsets include a) self-renewal of resident post-mitotic cells, b) 
migration, homing, and limited proliferation of adult bone-marrow-derived 
progenitor cells in peripheral tissues (Massberg et al., 2007); and c) the extravasation 
and differentiation of circulating precursors such as blood monocytes. These 
mechanisms are not mutually exclusive and they are likely to depend on 
environmental cues such as inflammation. Langerhans cells of the epidermis are an 
example of the first possibility, in that most are self-regenerating within the skin 
(Merad et al., 2002). This was shown after syngeneic bone marrow transplantation 
where most Langerhans cells remain host-derived. Conventional dendritic cells 
(cDCs) are present in all lymphoid organs and renew in the steady state from a bone 
marrow precursor without a monocyte intermediate (Waskow et al., 2008; Fogg et 
al., 2006; Liu et al., 2007). A third group of cells represents short lived cells that 
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differentiate from blood monocytes in response to inflammation or infection such as 
monocyte-derived DC or TNF-α and iNOS-producing (Tip)-DCs (Randolph et al., 
1999; Geissmann et al., 2003; Serbina et al., 2003). An overview of the mononuclear 
cell subsets located in the epidermis and dermis of normal human skin is shown in 
Figure 1-2. 
 
Figure 1-2: Cellular components of the innate immune system in human 
skin during steady state and inflammation. 
Non-inflamed skin contains epidermal Langerhans cells, BDCA-1
+
 resident 
dermal DCs, plasmacytoid DCs and macrophages. In addition inflamed skin 
contains a population of inflammatory DCs (TNF-α and iNOS-producing DCs 
called Tip-DCs). Currently the macrophage population expressing CD68 and 
CD14 can be further subdivided into classically activated macrophages (M1), 
and alternatively activated macrophages (M2). Common markers used to identify 
these leucocyte populations are indicated. Circular arrows indicate the self-
renewing potential of LCs under conditions of tissue homeostasis. Circulating 
blood monocytes are potential precursors of LCs, macrophages and inflammatory 
DCs. Circulating BDCA-1
+ 
DCs are putative precursors for resident dermal DCs. 
(Figure adapted from Nestle, F.O. and Nickoloff, B.J., 2007) 
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1.3.2. Blood Monocyte Subsets 
There are three well-defined subsets of human monocytes defined by the expression 
of CD14 and CD16 (CD14
+
CD16
-
, CD14
+
CD16
+
 and CD14
low
CD16
+
)(Auffray et al., 
2009; Passlick et al., 1989).The two main subsets both express CD14 and are either 
positive or negative for expression of CD16. They express distinct chemokine 
receptors as shown in Table 1-3 below. There are two main subsets of mouse 
monocytes with important species-specific differences to human monocytes. First, 
the relative frequencies of the two major subsets are different in mice and humans. 
Under resting conditions, CD14
+
 monocytes predominate in the bloodstream of 
humans, whereas Ly6C
+
 and CX3CR1
+
 monocytes in mice are present in roughly 
similar proportions (Serbina et al., 2008). Second, human monocyte subsets are 
similar in chemokine receptor expression to known mouse monocyte subsets but the 
function of each human monocyte subset and the equivalent mouse counterpart are 
reversed rendering any comparison in monocyte biology between the two species 
confusing (Serbina et al., 2008; Auffray et al., 2009). The CD14
+
CD16
- 
subset in 
humans is similar to the CD115
+
Ly6C
+ 
(Gr1
+
) subset in mice but their functions 
differ in that in humans this subset is not inflammatory whereas in mice they give 
rise to tissue inflammatory DC, Tip-DC and M1-type macrophages (Geissmann et 
al., 2003). The CD14
+
CD16
+ 
subset in humans is phenotypically similar to the 
CD115
+
Ly6C
- 
(Gr1
-
) subset in mice with similar expression of CX3CR1 (high) and 
CCR2 (negative). In mice they have been found to patrol blood vessels in the steady 
state and are capable of extravasation into tissue and responsible for a very early 
inflammatory response during infection. They also differentiate into alternative 
macrophages (M2 type) after extravasation. In humans this subset of monocytes is 
pro-inflammatory (Geissmann et al., 2003). However within this subset of human 
CD16
+ 
monocytes there is a third well defined subset that shows low expression of 
CD14 (CD14
low
CD16
+
) and no expression of CD64 or CD32, poor phagocytic 
function and does not release TNF-α or IL-1 (Auffray et al., 2009). 
The study of monocyte subsets is hampered by the fact that monocytes adapt to their 
environment and change phenotypes easily. Also isolating them and culturing them 
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in vitro notably affects their phenotype and behaviour. An important development in 
their study has been the ability to track these cells in vivo by performing intravital 
studies in mice (Auffray et al., 2007). This technique using intravital microscopy 
techniques allowed imaging of dermal blood vessels in vivo in mice genetically 
engineered to express green fluorescent protein (GFP) on their monocytes. This 
showed that murine CD115
+
Ly6C
-
(Gr1
-
) monocytes exhibit a constitutive crawling 
on the luminal side of the dermal endothelium, in steady-state conditions (Auffray et 
al., 2007). They are therefore ideally located to survey endothelial cells and 
surrounding tissues. During mouse peritoneal infection with Listeria 
monocytogenes(Lm) it has been shown that these monocytes are the main blood cell 
type that extravasates into the peritoneum during 1 and 2 hrs after infection and are 
the only producers of TNF-α, a cytokine central to macrophage-mediated 
inflammation (Auffray et al., 2007). Therefore they are major players in the initial 
innate immune response to infection. It would be interesting to find out if similar 
patrolling macrophages are present in human dermal endothelium in equal numbers 
in young and old skin. 
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Table 1-3: Human and mouse monocyte subsets 
HUMAN 
MONOCYTE 
SUBSET 
CHEMOKINE 
RECEPTORS 
CYTOKINES 
PRODUCED IN 
RESPONSE TO 
LPS in vitro 
FUNCTION SIMILAR 
MOUSE 
SUBSETS 
(FUNCTION) 
CD14
high
CD16
- 
(80-90% of blood 
monocytes) 
CCR2
hi
 
CX3CR1
lo
 
IL-10 Not good 
producers of 
TNF- α/IL-1 
CD115
+
Ly6C
-
(Gr1
-
) 
CX3CR1
hi
 
CCR2
- 
(give rise to 
tissue 
inflammatory 
DC‟s and M1 
macrophages)  
CD14
+
CD16
+ 
(~10% of blood 
monocytes) 
CCR2
lo
, 
CX3CR1
hi
 
CD64
+
 
CD32
+
 
TNF- α 
IL-1 
Pro-
inflammatory 
CD115
+
Ly6C
+ 
(Gr1
+
) 
(Patrol blood 
vessels in the 
steady state, 
give rise to 
AAM in tissues) 
1.3.3. Macrophages 
Macrophages play a role in both innate and adaptive immunity through their ability 
to recognize „„danger signals‟‟ via toll-like receptors (TLRs) and other pattern-
recognition receptors (PRRs); through their effector mechanisms, including 
phagocytosis, nitric oxide production, and killing of bacteria; and through their 
ability to produce a  wide array of cytokines and chemokines. In the past CD14 and 
CD68 have been used to identify macrophages in the skin but it is now recognised 
that these surface markers are also shared by dermal DCs (Zaba et al., 2007). 
Moreover, macrophages can process antigen after activation and present antigen 
derived peptides via MHC class II molecules to CD4
+
 T cells. Importantly, 
macrophages are involved in both the initiation and the resolution of an 
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inflammatory response, and two corresponding activation states for macrophages 
have been described in vitro (Goerdt and Orfanos, 1999; Gordon, 2003). The initial 
inflammatory response is carried out by macrophages that produce high amounts of 
proinflammatory cytokines and reactive oxygen species (Goerdt and Orfanos, 1999). 
These macrophages are also referred to as classically activated or M1 macrophages 
and can be generated in vitro by activation with IFN-γ/LPS. The resolution phase is 
associated with macrophages that produce mainly anti-inflammatory cytokines and 
have a higher phagocytic capacity, and an increased expression of the mannose 
receptor CD206 and/or the haemoglobin scavenger receptor CD163 (Tiemessen et 
al., 2007). These macrophages are often referred to as M2 or alternatively activated 
macrophages (AAM) and can be obtained in vitro after macrophage stimulation with 
IL-4/IL-13 (Stein et al., 1992; Edwards et al., 2006), a combination of immune 
complexes and LPS (Edwards et al., 2006), or IL-10 or glucocorticoids (Buechler et 
al., 2000). The three different induction methods lead to more or less distinct M2 
macrophage subsets (also referred to as M2a, M2b, and M2c, respectively), each 
with a typical cytokine/chemokine and cell surface marker profile (Sica et al., 2006), 
although recent data indicate that a certain degree of versatility exists between the 
subsets (Lumeng et al., 2007; Arnold et al., 2007). The excessive presence or activity 
of either M1 or M2 subsets may cause damage to the host, because for M1 subsets 
this could promote immune responses to healthy tissue resulting in inflammation, or, 
conversely for M2 subsets, prevent an appropriate immune response leading to 
hampered tumour immunity (Sica et al., 2006; Van Ginderachter et al., 2006). 
Understanding the mechanisms behind the homeostatic control of macrophage 
function is, therefore, of fundamental importance and it has recently been shown that 
CD4
+
CD25
+
FoxP3
+
 Tregs have a role to play in inducing alternative activation 
(Tiemessen et al., 2007). 
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1.3.4. Dendritic cells 
1.3.4.1. Blood dendritic cells 
The myeloid blood DC population represents 5% of monocytic-like cells (0.5% of 
PBMCs in humans). These blood DCs express class II antigens and CD11c and are 
negative for CD14 and CD16.They stimulate T cell proliferation in vitro 
(Banchereau et al., 2000; Banchereau and Steinman, 1998). 
1.3.4.2. Conventional DCs 
The term conventional DCs (cDCs) is used to refer to DCs present in all lymphoid 
organs, such as the spleen and lymph nodes. They have a short half-life and renew in 
the steady state from a bone marrow precursor without a monocytic intermediate. 
Lymphoid tissue–resident DCs are the most studied DC populations in mice, but 
little information is available on their human counterparts. In mice, splenic DCs 
constitutively express MHC class II and the integrin CD11c (Shortman and Liu, 
2002).  
1.3.4.3. Dermal DCs 
These cells have the capacity to take up cutaneous antigens, mature and migrate to 
draining lymph nodes, and present these antigens to T and B cells (Dubois et al., 
1998; Nestle et al., 1998; Kissenpfennig et al., 2005). This process is important both 
during primary skin infections and also in the secondary memory cutaneous immune 
response. There is no single or specific marker for these cells although the integrin 
CD11c is probably the best tool we currently have to identify them (Zaba et al., 
2007). Dermal DCs have been classified into resident dermal DCs and an additional 
group of DCs that appear or develop during inflammation (termed “inflammatory” 
dermal DCs) (Zaba et al., 2009; Shortman and Naik, 2007). They differ in their 
expression of BDCA-1 (Figure 1-1).  
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1.3.4.3.1. Resident dermal DCs 
These are identified by their expression of BDCA-1(CD1c). BDCA-1 colocalises 
with nearly all CD11c
+
 cells. In the steady state, they are relatively immature with 
modest T cell stimulatory ability, but their immunostimulatory capacity can be 
greatly increased with DC maturing stimuli (Zaba et al., 2007). These BDCA-1
+
 DCs 
are also CD11c
+
 HLA-DR
+
CD45
+
CD14
- 
and are also CCR7
+
 and are responsive to 
the lymph node chemokine CCL19, suggesting that these cells can migrate to 
draining lymph nodes for antigen presentation (Angel et al., 2006). They are thought 
to arise from circulating BDCA-1
+
 DCs (Johnson-Huang et al., 2009). 
1.3.4.3.2. Inflammatory dermal DCs 
These inflammatory dermal DCs are CD11c
+
 BDCA-1
-
. This indicates that they may 
be derived from circulating DC precursors migrating into the skin due to 
inflammatory or chemotactic signals. Considerable evidence however suggests that 
these cells originate from circulating monocytes (Randolph et al., 1999; Geissmann 
et al., 2003; Serbina et al., 2003; Sunderkotter et al., 2004). They have been mainly 
studied in the context of psoriatic inflammation where a 30-fold increase in CD11c
+
 
DCs in the dermis is seen (Zaba et al., 2007). In psoriasis these DCs have been 
shown to produce mediators, such as TNF-α and inducible nitric oxide synthase 
(iNOS) and have been termed Tip-DCs (Lowes et al., 2005). Tip-DCs were first 
described in a murine model of Listeria monocytogenes infection where following 
infection, Ly6C
+
(Gr1
+
) blood monocytes egress massively from bone marrow to the 
bloodstream in a CCR2-dependent fashion and differentiate into cells that produce 
TNF-α and inducible nitric oxide synthase (Serbina et al., 2003). 
1.3.4.4. Langerhans cells 
Langerhans cells (LCs) are dendritic antigen-presenting cells of the epidermis and 
constitute the first immunological barrier against pathogens and environmental 
insults. The exclusive identifying feature of these cells is the presence of Birbeck 
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granules, intracellular organelles only observable with electron microscopy (Birbeck 
et al., 1961). Langerin (CD207) is a type II C-type lectin that is present on the cell 
surface of Langerhans cells and involved in the formation of Birbeck granules 
(Valladeau et al., 2000). Other useful but non-specific markers for Langerhans cells 
are CD1a (Fithian et al., 1981), an MHC I-like molecule that presents microbial 
lipids to T cells (Mizumoto and Takashima, 2004), MHC Class II (De Panfilis et al., 
1988) and CD39, a membrane ATPase (Wolff and Winkelmann, 1967).  
As described above, LCs self-replenish within the epidermis under steady state 
conditions (Merad et al., 2002) but in inflammation leave the skin in great numbers 
and therefore need to be replenished by blood precursors, most likely monocytes 
(Ginhoux et al., 2006). They are traditionally thought to be the main antigen 
presenting cell in models of contact hypersensitivity; LCs are thought to capture 
antigen they encounter in the epidermis, antigen-laden LCs migrate subsequently via 
dermal lymph vessels to the draining lymph node (Stoitzner et al., 2002). Human 
skin is daily exposed to an array of environmental haptens, but it rarely results in 
contact hypersensitivity. Therefore, tolerance induction must be the default setting of 
the T cell response against encountered haptens. Even though LCs were described 
140 years ago, their exact in vivo function still remains elusive. Recent scientific 
evidence obtained using LC-depleted genetically modified mice adds to potential 
confusion by demonstrating that following application of hapten to the LC-deficient 
mice the contact hypersensitivity response was diminished (Bennett et al., 2005), 
enhanced (Kaplan et al., 2005) or unchanged (Kissenpfennig et al., 2005). Therefore, 
it remains controversial whether LCs are dispensable for the induction of skin 
immunity. Also Langerin
+
 DCs in the dermis and skin-draining lymph nodes have 
been recently described in mice which do not merely represent LCs en route to 
lymph nodes and are distinct from LCs in terms of being CCR2
+
 rather than CCR6
+ 
and are also radio-sensitive as opposed to radio-resistant like LCs (Bursch et al., 
2007). Dermal Langerin
+
 cells can traffic from the skin to draining lymph nodes both 
in the steady state and after the application of hapten to the skin (Kissenpfennig et 
al., 2005). These cells are also capable of participating in skin immune responses. It 
is possible that LCs in general are required for maximal contact hypersensitivity 
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responses but nonepidermal Langerin
+
 DCs can mediate the contct hypersensitivity 
response in the absence of epidermal LCs (Bursch et al., 2007).  
In our skin model using intradermally injected skin test antigen, it is likely that 
antigen presentation is mediated by dermal DCs and not LCs in the epidermis as the 
mode of injection of antigen bypasses the epidermis. We therefore mainly focus on 
dermal dendritic cell biology throughout the study. 
1.3.4.5. Plasmacytoid dendritic cells (pDCs) 
This subset represents 0.5% of PBMCs in human and are the most potent IFN-α-
producing cells in response to viral pathogens (Cella et al., 2000; Siegal et al., 1999). 
Human pDCs express very low to no level of CD11c, they express CD4 and 
CD45RA antigens, the c-type lectin receptor BDCA2, and the molecule BDCA4, a 
neuronal receptor often used to isolate pDCs, and high levels of the interleukin-3 (IL-
3) receptor (CD123) (Colonna et al., 2004). These cells are normally found in the 
circulation and are rare in normal skin, but accumulate under conditions of chronic 
skin inflammation such as psoriasis and are implicated in its pathogenesis (Nestle et 
al., 2005). 
1.4. Pattern recognition receptors 
Innate immune cells rely on pattern recognition receptors (PRRs) to detect the 
presence of pathogens (Gilliet et al., 2008). PRRs are host receptors that can sense 
pathogen-associated molecular patterns (PAMPs) such as bacterial 
lipopolysaccharide (LPS) and initiate signalling cascades that lead to an innate 
immune response. PRRs can be membrane bound, for example Toll-like receptors 
(TLRs), or soluble cytoplasmic receptors such as Nod-like receptors.  
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1.4.1. Toll-like receptors 
TLRs are a family of molecules found spanning the cell membrane and consisting of 
an ectodomain, a transmembrane domain and a cytoplasmic domain known as the 
TIR (Toll/IL-1 receptor) domain. Since the first mammalian TLR (now known as 
TLR4) was identified (Medzhitov et al., 1997), 10 TLRs have been identified in 
humans and 12 in mice (Gilliet et al., 2008). The TLR ectodomains bind to PAMPs, 
such as the bacterial cell-wall component lipopolysaccharide (a ligand of TLR4) 
(Medzhitov et al., 1997; Poltorak et al., 1998), bacterial flagellin (a ligand of TLR 5) 
(Hayashi et al., 2001), and lipoprotein and peptidoglycan (which are recognised by 
TLR2 complexed with TLR1 or TLR6) (Schwandner et al., 1999). These TLRs, 
which are located on the surface of host cells lead to immediate detection of and 
response to microorganisms in their environment (Akira and Takeda, 2004). Other 
TLRs including TLR3, TLR7, TLR8 and TLR9 are located in intracellular 
endosomal-lysosomal compartments, where they are involved in the detection of 
microbial nucleic acids (Gilliet et al., 2008). Myeloid DCs express all TLRs except 
TLR7 and TLR 9 which are selectively expressed by pDCs, suggesting that innate 
immune cells complement each other in their expression of a range of TLRs 
(Jarrossay et al., 2001). TLR activation by their ligands leads to the activation of 
multiple signalling pathways, and initiates the transcription of genes encoding 
cytokines, chemokines and co-stimulatory molecules (Gilliet et al., 2008) leading to 
the development of distinct T helper responses to microorganisms (Palm and 
Medzhitov, 2007). 
1.5. Chemokines and cytokines and their role in memory responses in the 
skin 
Cytokines released early on in the response are crucial for endothelial activation and 
early inflammatory cell transmigration. Cytokines and chemokines are thought to be 
involved in all phases of inflammation in the skin. Multiple cell types in the skin, 
including keratinocytes, T and B lymphocytes, monocytes, endothelial cells, 
fibroblasts, mast cells, dendritic cells, granulocytes and platelets are known to 
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produce cytokines (Bos Jan D, 2004). The initiation of the response to infection in 
the skin, known as the acute phase response, is thought to be dependent on the 
production of tumour necrosis factor alpha (TNF-α), IL-6 and IFN- (Janeway CA, 
2009). TNF-α is secreted by a variety of cells including monocytes and macrophages, 
T cells, fibroblasts and endothelial cells (Tracey and Cerami, 1994). Following 
stimulation by exogenous factors such as bacterial lipopolysaccharide, viruses and 
other organisms large quantities of TNF- α are released within minutes and synthesis 
is rapidly increased under the influence of IFN- (Beutler et al., 1986). 
TNF-α acts to increase vascular permeability and blood flow resulting in the 
observed erythema and induration at the site as well as increasing expression of 
various adhesion molecules E-selectin, intercellular adhesion molecule-1 (ICAM-1) 
and vascular cell adhesion molecule (VCAM-1) on the endothelium (Groves et al., 
1995) with resulting recruitment of lymphocytes to the site of the immune response 
and also activation and chemotaxis of neutrophils and monocytes (Ming et al., 1987).  
IFN- produced predominantly by activated T lymphocytes increases MHC-II 
expression on monocytes and macrophages (Kelley et al., 1984) in addition to 
stimulating further release of TNF- by monocyte activation (Nedwin et al., 1985).  
IL-6 is produced by activated monocytes and is important for T cell activation and 
differentiation (Diehl and Rincon, 2002; Horn et al., 2000). 
Following acute initiation of the immune response in the skin further cellular 
activation and recruitment is mediated by the production of a range of cytokines and 
chemokines from several resident skin cell types. MCP-1 and MIP 1- are classified 
as CC (cysteine-cysteine) chemokines and are thought to have an essential role in 
humans in the activation and chemoattraction of monocytes to sites of inflammation 
(Lu et al., 1998; Wolpe et al., 1988). The CXC (Cysteine-X-cysteine) chemokines, 
such as IL-8 and IP-10, are thought to attract and activate neutrophils (Schroder, 
1995). A mixture of both CC and CXC chemokines have been shown to have an 
effect on the induction of directional migration of human T cells and T cell subsets 
including memory effector T cells (Rossi and Zlotnik, 2000).  
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1.6. Ageing and the immune system 
Humans now live longer than ever before and human life-expectancy is still 
increasing. It has been predicted that by 2050 approximately 40% of the population 
will be over 60 years of age in Europe and the United States (Lutz et al., 1997). 
Ageing of the organism is associated with a number of physiological and 
pathological changes including skin atrophy, atherosclerosis and decreased fertility. 
Moreover the incidence and severity of infectious diseases, such as pneumonia 
(LaCroix et al., 1989), meningitis (Gorse et al., 1984), sepsis (Chattopadhyay and Al 
Zahawi, 1983), infection of the urinary tract (Ackermann and Monroe, 1996) or 
infection with respiratory syncytial virus (Barker and Mullooly, 1980) or influenza 
(Sprenger et al., 1993), are increased in elderly individuals. In fact, after suffering 
from urinary-tract infection or tuberculosis, the mortality rate of elderly patients is 
ten-fold higher than that of young patients (Yoshikawa, 1997). There is also reduced 
effectiveness of vaccination with infection being prevented in 70-90% of subjects 
aged <65 who had been vaccinated with the influenza vaccine compared to only 30-
40% prevention in those aged >65 years (Murasko et al., 2002). All of these factors 
contribute to the increased morbidity and mortality in the elderly population and 
places ever increasing significant demands on the provision of healthcare for this age 
group. The information obtained out of studies of the immune system in the ageing 
population should therefore be of practical relevance to increasing the efficacy of 
vaccination in the elderly and restoring immunity in immunocompromised 
individuals. 
1.6.1. Studying ageing and the immune system  
There are two important considerations when studying the effects of ageing 1) mouse 
studies are limited in that mouse longevity is different to human longevity 2) in an 
attempt to isolate ageing changes from the external changes of disease and 
medication most studies on ageing include only the very healthy elderly. This is 
accomplished by the exclusion of subjects who have evidence of disease or use 
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medications by applying rigorous criteria as defined by the SENIEUR protocol 
(Ligthart at al 1984). These two issues will be discussed below. 
1.6.1.1. Murine models  
Murine models are generally considered to be the mainstay of in vivo immunological 
experimentation as they allow for elegant manipulation of the immune system and in 
many ways mirror the human immune system. The use of murine models to study 
ageing is still controversial however (Aspinall, 1999). Mice and men have 
dramatically different lifespans. Moreover, whereas telomere shortening is a marked 
characteristic of ageing in humans, mice have significantly (10X) longer telomeres 
(Kipling and Cooke, 1990) which makes telomere shortening less significant in the 
study of murine ageing . Also mice do not lose CD28 expression on T lymphocytes 
as they differentiate unlike CD8
+ 
and CD4
+
 human T cells (Engwerda et al., 1994). 
Mice also have a reduced antioxidant defence and therefore may be more susceptible 
to the effects of oxidative stress with ageing compared with humans (Pawelec et al., 
1999) 
In the context of examining immune responses in the skin, DTH responses are 
assessed by the measurement of either footpad or ear swelling in mice compared with 
the forearm in humans. Previous experiments in humans have shown variation in the 
DTH response according to anatomical site (van Strien and Korstanje, 1994; 
Wammanda et al., 2006) and therefore comparison of a forearm in a human and a 
footpad or ear in a mouse is difficult. In rats the resident T cells in the skin are also 
different with gamma delta TCR bearing T cells being predominant compared with 
alpha beta TCR in humans (Elbe et al., 1996). The duration of the response is altered 
in mice with a peak response at 12 hours compared with 2-3 days in humans (Mestas 
and Hughes, 2004). This may be reflective of differences in antigen presentation and 
time required for antigen to be transported to the draining lymph nodes. Whereas the 
cutaneous DTH response consists primarily of lymphocytes in humans, it is 
neutrophil rich in mice (Crowle, 1975). Elicitation of the response also requires 
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much higher concentrations of antigen in mice compared with humans (Mestas and 
Hughes, 2004). 
Therefore many of the hallmarks of human cell ageing are absent on mouse cells and 
the timeframe of an immune response is different in mouse skin compared to human 
such that any study using a mouse model to define human ageing must be interpreted 
with caution for the reasons mentioned above. 
1.6.1.2. The SENIEUR protocol 
One of the difficulties with analyzing data from human studies is the presence of 
confounding factors due to poor standardization of the groups studied. In an attempt 
to isolate aging changes from external changes of disease and medications, most 
studies on aging have included only the very healthy elderly. This has been 
accomplished by the exclusion of subjects who have evidence of disease or use 
medications, by applying rigorous criteria as defined by the SENIEUR protocol 
(Ligthart et al., 1984). The criteria of the SENIEUR protocol exclude subjects on the 
basis of unhealthy lifestyle choices; any clinical information that suggests the 
presence of infection, inflammation, malignancy, or other immune disorders; any 
laboratory data that suggests abnormal organ function; and administration of 
medications for the treatment of a defined disease. These stringent criteria exclude 
90% of subjects aged >65 years and 25% of younger subjects (Wick and Grubeck-
Loebenstein, 1997; Rowe and Kahn, 2000). Applying such strict inclusion criteria is 
therefore now thought to limit understanding of the mechanisms of vulnerability to 
infections in the elderly and might be the reason why to date there has been no 
compelling scientific evidence to show that changes observed between T cell 
phenotype and function in the old have direct relevance to the common infections 
seen in the aged population (Castle, 2000). The study of individuals who are 
excluded by the SENIEUR protocol but well characterized in terms of clinical co-
morbidity may be more relevant to the development of strategies to enhance quality 
of life with ageing. In this thesis, a modified version of the SENIEUR protocol was 
employed with a view to excluding significant comorbidity but selecting a 
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representative group of old individuals. Our exclusion criteria are described in detail 
in Chapter 2: Materials and Methods. 
1.6.2. Ageing and its effect on T cells  
T cells develop in the thymus. Thymic involution starts as early as the first year of 
age in humans and by the time of middle age, most parenchymal tissue is replaced by 
fat, although functional thymic tissue remains in humans at least until the sixth 
decade of life. Therefore both in mice and humans, there is extremely limited 
generation of naive T cells with increasing age (Linton and Dorshkind, 2004; Haynes 
et al., 2000; Jamieson et al., 1999). This means that immunity is maintained by 
turnover of existing populations of cells. The quantity of T lymphocytes stays 
relatively stable over time and with increasing age as there are homeostatic 
mechanisms in place to replace or remove the expanded populations of effector T 
cells (Akbar et al., 2000). However, it has been shown that despite maintenance of 
normal T cell numbers with age, there is a considerable decrease in CD4 and CD8 
mediated responses (Grubeck-Loebenstein and Wick, 2002; Effros et al., 2003). For 
example, naive CD4 T cells in the aged secrete less IL-2, leading to decreased 
expression of CD25, and show reduced proliferation and incomplete differentiation 
to T helper type 1 or type 2 effector cells (Linton et al., 1996). In addition CD4 
memory T cells derived from aged naive precursors divide and produce cytokine 
poorly, whereas CD4 memory T cells derived from young mice function well into 
old age. 
The proportionate representation of particular antigen specific T cells within the T 
cell pool can be altered with ageing with large expansions of terminally 
differentiated effector memory cells (Fletcher et al., 2005). This is particularly true 
for T cells that are specific for agents that cause persistent infection such as 
Cytomegalovirus(CMV), in which repeated episodes of cellular expansion can lead 
to huge clones of highly differentiated, senescence prone and poorly functional 
CMV-specific CD8
+
 T cells (Ouyang et al., 2004). This is to the detriment of 
immunity to other non-chronic infections and in the case of cytomegalovirus (CMV) 
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infection might be detrimental to host survival as CMV seropositivity has been 
shown to be predictive of decreased survival of ageing individuals (Pawelec et al., 
2009; Wikby et al., 2002).  
Another key difference between T cells in young and old is that a significant 
proportion of effector memory T cells in the old are CD45RA
+ 
 (Pawelec et al., 2009; 
Almanzar et al., 2005), a marker usually associated with naive T cells (as described 
above-section 1.2.3 “Memory T cell phenotype”). This phenomenon is mainly seen 
in the CD8
+
 T cells and to a lesser extent in CD4
+
 T cells (Amyes et al., 2003). In 
young subjects these CD8
+
CD45RA
+
 revertant T cells have similar telomere lengths 
to the central memory pool and do not require proliferation to mediate effector 
function and are resistant to apoptosis (Dunne et al., 2005). This might be beneficial 
in that it minimises the impact of telomere erosion and replicative senescence on 
memory T cell populations to persistent infections. On the other hand the memory 
CD8
+
CD45RA
+
 T cells, that are significantly increased in old subjects, have very 
short telomeres and might be poorly functional suggesting that during the course of 
ageing, these populations are eventually driven to end-stage differentiation (Akbar 
and Fletcher, 2005; Plunkett et al., 2005). 
1.6.3. Ageing and its effect on Innate Immunity 
Monocytes and macrophages from aged mice show a reduced functional potential. 
Both splenic and activated peritoneal macrophages from aged mice express much 
lower amounts of Toll-like receptors and alterations in the secretion of various 
chemokines and cytokines that include IL-6 and tumour necrosis factor (Lloberas and 
Celada, 2002; Plowden et al., 2004). Studies on monocytes from whole blood have 
shown reduced production of TNF-α after stimulation with LPS in old humans (Gon 
et al., 1996) and mice (Effros et al., 1991). Also, monocytes and macrophages from 
old mice have been shown to inhibit T cell proliferative responses (Pawelec et al., 
1998). Very little is known about dendritic cell changes with age, although the 
number of Langerhans cells in the epidermis has been reported by some to decrease 
with age (Uyemura et al., 2002; Sprecher et al., 1990).  
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1.6.4. Ageing and its effect on skin structure and cellular constituents 
Cutaneous ageing is a complex process and comprises both intrinsic ageing, thought 
to be genetically determined, and extrinsic ageing caused by environmental factors 
such as exposure to ultraviolet irradiation. Although there are microscopic 
differences between intrinsically and extrinsically aged skin, similar changes at a 
macroscopic level are seen with increased skin fragility, loss of elasticity, increased 
transparency, wrinkling and increased laxity (Leyden, 1990). These changes are 
thought to occur as a result of reduced proliferative capacity, cellular senescence and 
reduced biosynthetic capacity of skin-derived cells such as fibroblasts in addition to 
the increased production of degradative enzymes including the matrix 
metalloproteinases (MMPs) (Jenkins, 2002; Berneburg et al., 2000; Rabe et al., 
2006). 
Collagen is the most abundant extracellular component of the skin, accounting for 
80% of dry weight, and provides the strong tensile properties of the dermis.  An 
elastic fibre network provides elasticity accounts for 2-4% of extracellular matrix of 
sun-protected skin. Glycosaminoglycans/ proteoglycan macromolecules play a role 
in hydrating the skin and biological signalling. All three of these components are 
affected by ageing. In intrinsic skin ageing a reduction in the number and 
biosynthetic capacity of fibroblasts is observed with an associated gradual loss of 
elastic tissue in the papillary dermis and a reduction in collagen content (Jenkins, 
2002). In extrinsic skin ageing there is an accumulation of elastotic material, with 
thickened, tangled granular amorphous structures thought to be degraded elastic 
fibres, and dysregulation of elastin and fibrillin production. This results in an 
associated gross distortion of the dermal matrix (Jenkins, 2002; El Domyati et al., 
2002). As with intrinsic ageing, a reduction in the collagen network is also seen. 
1.7. Aims and Objectives 
Immunity declines with age (Yoshikawa, 2000). This may explain the increase in 
frequency of cutaneous tumours and infections in older individuals (Laube, 2004; 
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Diffey and Langtry, 2005). Most studies directed at identifying age-related defects in 
old humans have focused on circulating leukocyte populations but it is not clear if 
the results obtained can be extrapolated to the behaviour of leucocytes within tissues 
during immune responses. Clearly a more informative experimental system is 
required to define the nature of attenuated cutaneous immunity during ageing in 
humans. 
Given the demographic increase in age in the population it is essential that we have 
not only the tools to assess immunity but also have an understanding of the changes 
that occur in immunity with ageing. 
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AIM 
To characterise the effects of ageing on the immune system in the skin in healthy old 
individuals. 
OBJECTIVES 
The objectives of this project were to: 
1. Study the correlation between clinical DTH responses to the intradermal 
injection of antigen in the skin and peripheral blood responses to antigen in 
the old and young. 
2. Characterize the lymphocytic response to the intradermal injection of antigen 
in the old. 
3. Compare T lymphocyte migration from peripheral blood into skin in young 
and old subjects.  
4. Characterise the innate immune response to the intradermal injection of 
antigen in young and old subjects 
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Chapter 2. Materials and Methods 
2.1. Volunteer recruitment 
This work was approved by the Ethics Committee of the Royal Free Hospital. 
Healthy young individuals under the age of 40 (n=71; 34 females, 36 males, median 
age=30 years,) and old individuals over 70 years (n=81, 49 females, 32 males median 
age=79.50 years) were recruited for the study. All volunteers were Caucasian and 
living in the Greater London area. Exclusion criteria based on a modified version of 
the SENIEUR protocol were employed to recruit old people in order to reduce 
confounding factors due to associated significant comorbidity (Ligthart et al., 1984). 
For our study, we adhered to all the original clinical exclusion criteria detailed in the 
SENIEUR protocol (Table 2-1) but to obtain a more representative sample of the 
elderly population we did not screen for and omit elderly volunteers based on 
biochemical or haematological abnormalities and we also did not exclude individuals 
on prescribed medications for defined disease, unless these medications were known 
to be immunosuppressive. All volunteers provided written informed consent and 
study procedures were performed in accordance with the principles of the declaration 
of Helsinki. 
Table 2-1: Exclusion Criteria 
Past history of TB 
Significant co-morbidity (renal impairment or failure, heart failure, diabetes) 
Past history of inflammatory skin disorder 
Past history of neoplasia in the last 10 years 
Previous treatment with chemotherapy or radiotherapy 
Immunosuppressive medication 
Recent infection or immunisation (within last month) 
Pregnancy and breast feeding 
Previous history of hypersensitivity to skin testing 
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2.2. Skin testing 
Delayed type hypersensitivity responses (DTH) were induced by intradermal 
injection of antigen on non sun exposed skin of the medial proximal volar forearm. 
Increased resistance to injection and appearance of a pale skin bleb at the site of 
injection were signs of correct intradermal injection of antigen. The injection site was 
sampled by skin biopsy or skin suction blister at an allotted time point between 0 and 
7days after the skin test injection. 
2.2.1. Candida skin testing 
Candin skin test solution 0.02ml (Allermed Laboratories Inc) was injected in 40 
young and 34 old subjects. 
2.2.2. Mantoux test 
Tuberculin purifed protein derivative (PPD) 0.1ml (1 unit) of 10U/ml (Evans 
Vaccines Ltd) was injected in 20 young and 32 old individuals in the first part of the 
study. For the Treg blister experiments (see chapter 6). Mantoux test from Statens 
Serum Institute (SSI) was used 0.1 ml of 2TU/0.1ml (n= 15 young) due to lack of 
availability of the Evans Vaccine manufactured Mantoux test in the UK in 2007. 
2.2.3. Assessment of skin test responses 
Induration, palpability, and the change in erythema from baseline were measured and 
scored on day 3. Baseline skin erythema at the site of antigen injection was measured 
using a DermaSpectrometer (Cortex Technology, Hadsund, Denmark).  This is a 
portable, handheld device that allows the measurement of the skin erythema index 
(EI) by measuring light absorption coefficients (Figure 2-1B).  The mean of 3 
measurements was recorded.  At Day 3 and at the time of sampling (if different from 
Day 3) the change in EI from baseline, palpability and size of induration were 
measured.  The change in EI was calculated by subtracting the baseline measurement 
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from the EI taken when measuring the response. The size of induration was 
determined by measuring the maximum diameter of the indurated skin. The change 
in EI, induration and palpability were then scored according to Table 2-2 and the sum 
of the scores was combined to give an overall clinical score. Non-responding 
individuals were defined as having a clinical score of 0 at Day 3. 
Table 2-2: Clinical Scoring System 
Clinical Score 0 1 2 3 4 5 Score 
Erythema-index (EI) 0 1-5 6-10 11-15 >16   
Size of Induration (mm) 0 1-5 6-10 11-15 16-20 >21  
Palpability Nil 
Just 
palpable 
Easily Marked 
Very 
marked 
  
      Total  
2.3. Skin sampling  
Skin suction blisters were raised or 5mm punch biopsies were taken from the site of 
skin testing. Samples were collected at various time points between 0 and 7 days 
after injection of antigen. Each volunteer was allotted to a specific sample time-point 
and either paired skin suction blisters and punch biopsies or blisters or biopsies alone 
were taken (Figure 2-1 and Error! Not a valid bookmark self-reference.). 
Repeated skin testing to the same skin test antigen in the same individual was 
avoided in order to prevent boosting of the immune response from repeated antigenic 
exposure (which has previously been observed by our group). 
2.3.1. Suction blisters 
2.3.1.1. Suction blister induction  
Skin suction has previously been shown to result in the formation of a split between 
the epidermis and dermis at the level of the lamina lucida (Kiistala, 1968; Vermeer et 
al., 1979). Suction blisters were induced by the application of negative pressure of 
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25-40kPa (200-300mmHg below atmospheric pressure) via a suction chamber 
(Medical Engineering, Royal Free Hospital, UK) centred over the site of testing for 
2-4 hours using a clinical suction pump (VP25, Eschmann, Lancing, UK) (Error! 
Not a valid bookmark self-reference.). The pump has a gauge that allows for 
constant negative pressure to be applied to the skin. Suction cups were made of 3 
main components: A template, a cup made of nylon and a see through Perspex lid. 
Rubber O-rings were fitted around the lid and template to allow an airtight seal to be 
formed between all 3 components when fitted together. The pump has sterile 
disposable tubing and liners that were changed in between volunteers. Skin suction 
chambers with apertures of 15mm, 12.5mm and 10mm were used according to the 
size of the response and skin elasticity. In all cases, the size of suction chamber 
aperture selected ensured that the whole of the area of induration was sucked up into 
the chamber with minimal incorporation of normal surrounding skin. 
Suction was applied until a unilocular blister measuring 10-15mm was formed over 
the site of the skin test. The blister was then protected overnight with a rigid adhesive 
dressing assembled using a Comfeel plus ulcer dressing (Coloplast, Peterborough, 
UK), a universal top (Sterilin, Fisher Scientific UK Ltd, Loughborough, UK), 
Micropore tape (3M healthcare, Loughborough, UK) and Tubigrip bandaging (Seton 
Healthcare Group plc, Oldham, UK). 
Blister fluid was aspirated from the blister at 18-24 hours after induction using a 
sterile 23G needle and a 2ml syringe (Tyco Healthcare UK Ltd, Gosport, UK).  The 
fluid was aspirated at the 18-24 hour time point in order to ensure maximal 
accumulation of cells within the blister fluid from the site of antigenic challenge in 
the skin.  The recorded time of sampling was the time from skin injection to blister 
fluid aspiration.  The volume of fluid recovered from the blister was recorded and 
suspended in 1.5ml conical tubes (Alpha Laboratories Ltd, Eastleigh, UK).  The 
aspirated blister site was dressed with Betadine dry powder spray (Seton Healthcare 
Group plc, Oldham, UK) and a Mepore dressing (MoInlycke Health Care Ltd., 
Dunstable, UK). Volunteers were advised to leave the dressing in place and to keep it 
dry for 24 hours before removing it and leaving the wound open to the air.  The 
Chapter 2 
Page 41 
suction cups were dismantled after use and disinfected in Barrycidal 36 (Heraeus 
Instruments Ltd, Brentwood, Essex, UK) for a minimum of 24 hours. 
2.3.1.2. Suction blister cell isolation 
The blister fluid was microcentrifuged at 650xg (3000 rpm) for 4 minutes 
(Microcentaur, MSE, Sanyo) to pellet the cellular contents.  The supernatant was 
removed and aliquotted in to 1ml cryogenic tubes (Nunc, Thermofisher Scientific, 
Roskilde, Denmark) and stored at -80C until analysed. The blister cell pellet was 
resuspended in 500l of RPMI 1640(GIBCO, BRL Life Technologies, Paisley, UK) 
containing 10% human AB serum, 100U/ml penicillin, 100g/ml streptomycin and 
2mM L-glutamine (all from Sigma Aldrich, Gillingham, Dorset, UK).  
2.3.1.3. Counting of blister cells 
Blister white and red cell numbers were quantified using a haemocytometer.  Cellular 
viability was assessed by trypan blue exclusion.  A 10l aliquot of blister cell 
suspension was mixed 1:1 with Trypan blue (Sigma- Aldrich, Gillingham, Dorset, 
UK) and viable non-stained cells were counted. 
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Figure 2-1: The clinical DTH response in the skin and skin sampling 
(A) The skin test response to the intradermal injection of antigen is characterized 
by the development of erythema and induration at the site of injection, reaching a 
peak at 2-3 days. (B) The erythema index at the site of the response was 
measured at baseline, at day 3 and at the time of sampling using a 
DermaSpectrometer.  The mean of 3 measurements was recorded. (C) Following 
skin testing on the inner aspect of the forearm, skin samples were collected at 
various time points from 0-15 days after injection. Skin suction blisters were 
raised primarily to obtain either cutaneous lymphocytes or monocytes. (D) Skin 
biopsies were also taken. Whenever possible, paired biopsies and blisters were 
taken from opposite forearms. Venous blood was also taken for PBMC isolation. 
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Figure 2-2: Skin suction blister induction. 
Skin suction blisters were induced over the site of skin testing (1). A suction cup 
was centred over the site of injection (2) and a negative pressure of 25-40kPa 
(200-300 mmHg) below atmospheric pressure was applied until a unilocular 
blister (3) was formed. The blister was dressed with a 5X5cm Comfeel dressing 
(3), a trimmed universal container top (4), micropore tape (5) and a tubigrip 
bandage (6). Blister fluid was aspirated the following day using a sterile 23G 
needle and a 2ml syringe (7). 
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2.3.2 Skin biopsy 
2.3.2.1. Biopsy procedure 
A 5mm punch biopsy was taken from the centre of the site of injection of antigen or 
normal skin (Figure 2-1D).  The surrounding skin was infiltrated with 1% lidocaine 
hydrochloride local anaesthetic (Hameln Pharmaceuticals Ltd, Gloucester, UK) prior 
to biopsy. The wound was closed with 4/0 Surgipro polypropylene suture (Tyco 
Healthcare UK Ltd., Gosport, UK). The skin was transported from the clinic to the 
lab in sterile saline within 20 minutes of obtaining it to prevent dessication of the 
skin sample.  
2.3.2.2. Biopsy storage and sectioning 
Biopsies were mounted in OCT(optimal cutting temperature compound; Bright 
Instrument Company Ltd, Huntingdon, UK) on cork disks, orientated so that the 
epidermis was perpendicular to the cork disk, and snap frozen in isopentane (Sigma-
Aldrich, Gillingham, Dorset, UK) cooled in a bath of liquid nitrogen. The samples 
were then stored in a freezer at -80C. 6m frozen sections were cut at -20C using a 
Bright 5040 microtome (Bright Instrument Company Ltd., Huntingdon, UK) on to 
poly-L-lysine coated glass slides (Sigma-Aldrich, Gillingham, Dorset, UK). Poly-L-
lysine coated slides were used in order to promote strong adhesion of the skin section 
to the slide. Two sections were mounted on to each slide. The sections were then left 
overnight to air-dry and then fixed in fresh acetone for 10 minutes, followed by 99% 
Ethanol for 10 minutes. The sections were air-dried for 10 minutes and then cling-
filmed wrapped and stored until use in a freezer at -80C. 
Chapter 2 
Page 45 
2.4. Blood sample 
2.4.1. PBMC isolation 
Heparinised blood was collected from young and old volunteers prior to skin testing 
or at the time of blister aspiration. Heparinised blood was mixed 1:1 with Hanks 
Balanced Salt Solution (HBSS) (GIBCO, BRL Life Technologies, Paisley, UK) and 
layered on to Ficoll-Paque (Amersham Biosciences UK Ltd, Chalfont St. Giles, UK) 
in 50ml Falcon tubes. This was centrifuged for 20 minutes at 800xg with no brake. 
The buffy coat at the interphase layer was harvested and then washed twice for 10 
minutes in excess HBSS by centrifugation at 650xg for the first wash and 300xg for 
the second wash. The cells were finally resuspended in complete medium as for the 
blister cells (RPMI 1640 [GIBCO, BRL Life Technologies, Paisley, UK] containing 
10% human AB serum, 100U/ml penicillin, 100g/ml streptomycin and 2mM L-
glutamine [all from Sigma Aldrich, Gillingham, Dorset, UK]). Typically, 1-2 x10
6
 
cells were isolated per 1ml of venous blood. For experiments where CLA expression 
on antigen specific cells was analysed, unsupplemented X-Vivo medium 
(Biowhittaker, Cambrex Bioscience, Walkersville) was used to prevent the down-
regulation of CLA upon cell stimulation. 
2.4.2. CD4 isolation for migration experiments 
CD4 T cells were isolated using Magnetic Cell Sorting MACS (Miltenyi Biotec, 
Bisley, Surrey, UK) separation columns and by positive selection using CD4 
microbeads (Miltenyi Biotec).MACS allows the purification of cell subsets from 
complex cell mixtures. Cells can be specifically labelled using MACS MicroBeads. 
These are extremely small biodegradable super-paramagnetic beads that do not 
activate or influence cell function or viability. After magnetic labelling, the cells are 
passed through a separation column, which is placed in a strong permanent magnetic 
field. The column matrix serves to create a high-gradient magnetic field. The 
magnetically labelled cells are retained in the column, while non-labelled cells pass 
through. After removal of the column from the magnetic field, the magnetically 
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retained cells can be eluted. Purified cells can be used for in vitro cell culture or flow 
cytometry. MACS MicroBeads are submicroscopic and therefore the light scatter 
characteristics of labelled cells are unaffected. There are two general approaches to 
magnetic cell sorting: depletion and positive selection. 
2.4.2.1. Positive selection of cell subsets 
This involves the isolation of target cells as the positive magnetically labelled 
fraction and was used to purify CD4
+
 and CD25
+
T cells. PB CD4
+
 T cells were 
isolated as described above. The cells were washed in MACS buffer centrifuging at 
650 g for 5 minutes. For CD25+ purification, the cell pellet was resuspended in 90l 
of MACS buffer per 10
6
 total cells, to which 10l of CD25 Microbeads per 106 total 
cells was added. For CD4
+
 purification, the cell pellet was resuspended in 80l of 
MACS buffer per 10
6
 total cells, to which 20l of CD4 Microbeads per 106 total cells 
was added. The cells were vortexed and incubated for 10 minutes at 4°C before 
washing with MACS buffer by adding 10 the labelling volume and centrifuging at 
650 g for 5 minutes. MS and LS columns were used for the positive selection of up 
to 10
7
 and 10
8 
labelled cells respectively. MS columns were used for CD25
+
 cell 
selection and LS columns for CD4
+
 cell selection. The cell pellet was resuspended in 
500l or 1000l of MACS buffer per 107 or 108 CD4+ T cells respectively. MS 
columns were prepared by applying 500l of MACS buffer. The cell suspension was 
applied to the column, after which the column was washed 3 times with 500l of 
MACS buffer. The effluent unlabelled fraction representing enriched CD25

CD4
+
 T 
cells was collected. The column was then removed from the magnet and 1ml of 
MACS buffer was flushed through the column using a plunger. This effluent was 
also collected and consisted of the positive magnetically labelled fraction 
representing enriched CD25
+
 T cells. The LS column was prepared by rinsing with 
MACS buffer. The cell suspension was applied to the column. For CD4
+
 T cell 
isolation, only the positive fraction was collected. The LS column was removed from 
the magnet and 5ml of buffer was pipetted into the column and the labelled fraction 
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was immediately flushed out of the column by applying the plunger. This effluent 
consisted of the positive magnetically labelled CD4
+
 T cells. 
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2.5. Immunohistology 
2.5.1. Antibodies used in the study 
Table 2-3: Antibodies used for Indirect Immunohistochemistry 
a
= all are murine monoclonals unless stated 
Abbreviations: DAB= 3,3‟-diaminobenzidine tetrahydrochloride,  
AEC=3-amino-9-etyhlcarbazole
Antigen Source Clone
a 
Is
o
ty
p
e
 
D
il
u
ti
o
n
 Specificity Detection, developing agent 
CD3 Dako UCHT-1 IgG1k 1:10 All T cells Horseradish peroxidise 
conjugated polyclonal rabbit 
anti-mouse antibody, DAB 
CD4 BD  Pure leu-3a IgG1k 1:10 T helper/inducer cells Horseradish peroxidise 
conjugated polyclonal rabbit 
anti-mouse antibody, DAB 
CD8 Dako DK25 IgG1k 1:50 T cytotoxic/suppressor 
cells 
Horseradish peroxidise 
conjugated polyclonal rabbit 
anti-mouse antibody, DAB 
Ki67 Dako Ki-67 IgG1k 1:10 proliferating cells 
(except those in G0 
phase) 
Horseradish peroxidise 
conjugated polyclonal rabbit 
anti-mouse antibody, DAB 
CD163 Acris 5C6-FAT IgG1 1:100 Macrophages Biotinylated horse anti-
mouse antibody, avidin-
biotinylated enzyme complex 
(VECTASTAIN ABC, 
Vector Laboratories); AEC 
CD11c BD B-ly6 IgG1 1:100 Dendritic cells Biotinylated horse anti-
mouse antibody, avidin-
biotinylated enzyme complex 
(VECTASTAIN) AEC 
Isotype 
control 
IgG1k 107.3 IgG1k 1:10/1
.50/1.
100 
Isotype control  
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Table 2-4: Antibodies used for indirect immunofluorescence 
a
= all are murine monoclonals unless stated 
b
=all amplification/detection antibodies are from Invitrogen/Molecular probes 
unless stated 
o/n=overnight 
Antigen Source Clone
a 
Is
o
ty
p
e
 
D
il
u
ti
o
n
 Specificity Amplification/detection
b
 
INDIRECT IMMUNOFLUORESCENCE 
E-selectin 
(CD62E) 
Abcam ENA2 IgG1 1:50 Endothelial cells Goat anti-mouse Ig G(H+L)-
AlexaFluor546, 1:200 
VCAM-1 
(CD106) 
Abd 
serotec 
1.G11B1 IgG1 1:50 Endothelial cells, 
bone marrow 
stroma, follicular 
dendritic cells, 
osteoblasts, 
mesothelium 
Goat anti-mouse Ig G(H+L)-
AlexaFluor546, 1:200 
ICAM-1 
(CD54) 
Abd 
serotec 
84H10 IgG1 1:50 Most types of cells Goat anti-mouse Ig G(H+L)-
AlexaFluor546; 1:200 
CD163 Acris 5C6-FAT IgG1 1:100 Macrophages Goat anti-mouse IgG1 Alexa 
Fluor 568, 1:250 
CD11c BD B-ly6 IgG1 1:100 Dendritic cells Goat anti-mouse IgG1 Alexa 
Fluor 568, 1:250 
Foxp3-
biotin 
e-
bioscienc
e 
PCH101 
rat 
IgG2a 1:100 
o/n 
Regulatory T cells 
Activated T cells 
Streptavidin-Cy3 1:200 
(Cedarlane laboratories 
Limited CLCSA1010 
www.cedarlanelabs.com) 
CD4 (Pure 
Leu-3a) 
BD   IgG1k 1:10, 
o/n 
Helper T cells, 
Regulatory T cells, 
monocytes, 
macrophages, 
dendrit 
Donkey anti-mouse Ig G 
AlexaFluor488, 1:200 
Ki67 Dako Mouse 
antihuman 
IgG1k 
IgG1k 1:10o
/n 
Expressed in 
nucleus of cycling 
cells (except G0 
phase of cell cycle) 
Donkey anti-mouse Ig G 
AlexaFluor488, 1:200 
TNF-α 
FITC 
BD  6401.1111 IgG 1:10 TNF-α Goat Ig G A488 anti-
fluorescein/Oregon, 1:200 
DC-SIGN 
(CD209) 
FITC  
BD  DCN46 IgG2b 1:50 macrophages, 
immature dendritic 
cells 
Goat Ig G A488 anti-
fluorescein/Oregon, 1:200 
Isotype 
control 
BD MOPC-
31C 
IgG1 1:50 Isotype control  
DIRECT IMMUNOFLUORESCENCE 
CD31FITC BD  WM59 IgG1 1:50 Endothelial cells Nil additional 
Isotype 
control 
BD  MOPC-21 IgG1 
FITC 
1:50 Isotype control  
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2.5.2. Indirect Immunofluorescence 
In this technique the primary unconjugated antibody is allowed to bind to the antigen 
in the tissue section. A secondary fluorescently labelled antibody, raised in another 
animal host and specific for the animal and immunoglobulin class of the primary 
antibody is then applied to the section and allowed to bind the primary antibody. 
Table 2-4 shows the primary antibody and secondary amplification/detection 
combinations used in our study. In the case of CD31 staining we used a directly 
conjugated CD31FITC antibody which did not need amplification. For TNF-α FITC 
and DC-SIGN FITC a secondary anti-FITC antibody was used to amplify the signal. 
Frozen 6m skin sections were left in a moist staining box at room temperature, 
wrapped in cling film, for 15 minutes. The cling film avoids rapid condensation and 
consequent antigen destruction. The slides were then unwrapped carefully to avoid 
damaging the tissue sections and the sections were ringed with polysiloxane 
(Dakocytomation, Glostrup, Denmark) which acts as a water repellent. A drop of 
1xPBS (Sigma Aldrich) (dissolve 2 PBS tablets in 400ml sterile distilled water) was 
added to each ringed section to prevent drying. The slides were washed for 5 minutes 
in 1 xPBS. The PBS on the sections was removed by tapping the slides gently on the 
side and a drop of Dako non-serum protein block (Dakocytomation, Glostrup, 
Denmark) was added to the ringed sections for 20 minutes. This step minimises non-
specific antibody binding. Slides were again tapped vertically to get rid of excess 
blocking fluid. Primary antibodies diluted in 1 xPBS were added at 40 μl per section 
and incubated for 1 hour at room temperature in the dark .In the case of FOXP3 
staining, this primary antibody was left to incubate overnight as better staining was 
obtained with longer incubation times. Slides were washed twice for 10 minutes in 
the dark in 1xPBS, and then tapped vertically to get rid of excess fluid and any 
remaining excess fluid was soaked up with filter paper placed to the side of the 
specimen with care being taken not to disturb the specimen. The staining was then 
amplified with the appropriate secondary antibody. We followed a slightly different 
protocol for TNF-α and CD163/CD11c double labelling of skin tissue as this staining 
was carried out at Professor James Krueger‟s laboratory at the Rockefeller University 
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in New York using our collaborator‟s reagents and techniques. Day 3 candida 
stimulated skin were blocked in 10% normal goat serum (Vector Laboratories) for 30 
minutes. Primary antibody CD163 or CD11c was diluted in 10% goat serum and was 
incubated overnight at 4°C and amplified with: goat anti-mouse IgG1 conjugated 
with Alexa Fluor 568, followed by overnight incubation with directly conjugated 
TNF-α FITC and amplified with goat anti-FITC AlexaFluor 488.  
2.5.2.1. Double labelling 
If double staining and using two primary antibodies it is important that the antibodies 
are raised in different species and the secondaries are raised in the same species. This 
is to avoid any one secondary antibody binding to either primary. Using double 
labelling with two primaries on any one section enables proportions of single and 
double stained cells to be counted using a fluorescence microscope.  
2.5.2.2. Control slides 
Antibodies conjugated with a fluorochrome often gave background epidermal 
fluorescence. Dermal collagen fibres gave green autofluorescence. Appropriate 
isotype controls (Table 2-4) were used as well as imaging of unstained skin tissue and 
both of these controls allowed assessment of the degree of autofluorescence. 
When choosing fluorochrome combinations for colocalisation studies obtained with 
double labelling as above, their spectra must be unambiguously distinctive. Bleed-
through is the passage of fluorescence emission in an inappropriate detection channel 
caused by an overlap of emission spectra(Bolte and Cordelieres, 2006). Figure 2-3 
Figure 2-1illustrates the phenomenon of bleed-through when using a commonly used 
fluorochrome combination FITC and AlexaFluor546. For this reason, we always 
ensured we had single-labelled control slides for each fluorochrome used eg FITC 
and AlexaFluor546. In this way we could check for bleed through between 
fluorochromes by switching from visualising the control slide with the FITC filter 
(green) and then switching to the AlexaFluor filter (red) and ensuring that no FITC is 
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detected or captured during image acquisition using same setting as for experimental 
slides when visualising the slide with the AlexaFluor filter. 
 
Figure 2-3: Explanation of bleed-through illustrated with the fluorochrome 
couple fluorescein iso-thiocyanate/AlexaFluor546. 
Excitation spectra of FITC (broken blue line) and AlexaFluor546(broken green 
line). Emission spectra of FITC (solid blue line) and AlexaFluor 546(solid green 
line). The black bar marks the typical detection window of Alexa546. Note the 
overlap of FITC and Alexafluor 546 in this detection window (this represents 
what would appear as bleed through) 
2.5.2.3. Biotin-Streptavidin Cy-3 technique 
An indirect biotin/ streptavidin method was used to detect FOXP3 expression on skin 
tissue sections. In this technique, primary biotinylated rat anti-human antibody is 
allowed to bind with FOXP3 in the tissue sections. A secondary reagent consisting of 
streptavidin conjugated to a fluorochrome (in this case Cy3) is then added. 
Streptavidin has a strong affinity for biotin. Up to 150 biotin molecules can be 
complexed to a single second layer antibody, allowing for amplification of the 
staining signal. The staining steps employed for this technique were performed in 
precisely the same way as for the indirect immunofluorescence technique described 
above. 
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2.5.3. Indirect Immunohistochemistry 
2.5.3.1. Indirect immunperoxidase 
The indirect immunoperoxidase technique was used to detect numbers and 
distribution of T cells and to detect cellular proliferation in the skin biopsies. In this 
technique a primary unconjugated antibody is bound to the antigen of interest in the 
tissue section. A second horseradish-peroxidase conjugated antibody, raised in 
another animal host that is specific for the animal and immunoglobulin class of the 
primary antibody, is then bound to the primary antibody. The complex that is formed 
is visualized following incubation with an appropriate chromagen or substrate. In this 
study, the chromagen 3, 3‟-diaminobenzidine tetrahydrochloride (DAB) was used. 
This is converted by horseradish- peroxidase into an insoluble brown substrate, 
identifying the cell/ antigen of choice.  
Skin sections from normal and candida injected skin (n=25 young, 26 old) were 
stained with optimal dilutions of purified primary antibody. The primary antibodies 
used with this technique were mouse anti-human CD3 antibody (Dakocytomation), 
purified mouse anti-human CD4 antibody (BD Pharmingen), purified mouse anti-
human CD8 antibody  (Dakocytomation) and purified mouse anti-human 
Ki67antibody (Dakocytomation) Rabbit anti-mouse horseradish-peroxidase 
conjugated antibody (Dakocytomation) was then added. The staining signal for these 
antibodies was developed using chromagen 3‟-diaminobenzidine tetrahydrochloride.  
Frozen tissue sections were defrosted and placed in a moist staining box.  The 
sections were ringed with polysiloxane (Dakocytomation, Glostrup, Denmark) as a 
water repellent. 50l of 1x phosphate buffered saline (PBS) (GIBCO, Invitrogen, 
Paisley, UK) containing 10% human serum (Sigma Aldrich, Gillingham, Dorset, 
UK), 10% Aprotinin (Sigma- Aldrich, Gillingham, Dorset UK) and a pre-titrated 
concentration of primary antibody was carefully pipetted on to each slide. The 
antibodies used are listed in Table 2-3. Non-specific antibody binding was 
minimized by the addition of 10% human serum. 10% Aprotinin (a protease inhibitor 
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derived from bovine lung) was added to block any endogenous immunoperoxidase 
activity within the tissue. The slides were then left to incubate for 45 minutes at room 
temperature. The fluid on the sections was removed by gently tapping the slide and 
the sections were then washed with fresh 1xPBS for 5 minutes, followed by formalin 
buffered saline (4.5g sodium dihydrate phosphate, 6.5g di-sodium hydrogen 
orthophosphate, 100ml of 40% formaldehyde and 900ml of 1x PBS) for 10 minutes 
and finally 1xPBS for 5 minutes. 4l of horseradish peroxidase conjugated rabbit 
anti-mouse secondary antibody in 50l of 1xPBS with 10% human serum was then 
added to each section.  The sections were incubated at room temperature for a further 
45 minutes and then washed as previously. 
1 drop of Filtered Nickel DAB solution (95 mg of 3.3‟diaminobenzidine, 1.6g NaCl, 
0.136g Imidazole, 2g nickel sulfate dissolved in 180ml of Tris/HCL buffer with pH 
corrected to 7.4 with 1M TRIS) containing 1l/ml of 10% H2O2 (added immediately 
prior to use) was then added to each section using a Pasteur pipette. This was left for 
up to 7 minutes prior to rinsing with PBS for 3 minutes. Slides were then placed in 
Tris Cobalt to intensify the stain (1.2g TRIS base, 1g Cobalt Chloride dissolved in 
180ml distilled H2O with pH corrected to 7.2 with HCl) for 5 minutes and then 
rinsed in tap water. Sections were counterstained with 0.1% Nuclear fast red for 5 
minutes, rinsed in tap water and then dehydrated by washing for 10 seconds in 70% 
ethanol, 90% ethanol, twice in neat ethanol and then cleared in 50:50 Citroclear/ 
ethanol mix and finally neat Citroclear (HD Supplies, Aylesbury, Bucks, UK). 
Sections were left in the neat Citroclear for a further 10 minutes and then mounted in 
styrolite. 
2.5.3.2. Biotin-Avidin technique 
This method is more sensitive than the technique described above and was therefore 
used to identify the distribution of TNF-α, CD163 and CD11c in skin sections. With 
this technique the primary unconjugated antibody is allowed to bind to the antigen in 
the tissue section. This technique then employs the strong ability of biotin to 
complex with several molecules in two steps: first a secondary biotin conjugated 
Chapter 2 
Page 55 
antibody, raised in another animal host and specific for the animal and 
immunoglobulin class of the primary antibody, is applied to the section and allowed 
to bind to the primary antibody, secondly avidin linked to a biotinylated enzyme 
(“avidin:biotinylated enzyme complex”, which consists of many biotinylated enzyme 
molecules crosslinked by avidin into a three-dimensional array) is added to the 
previously formed primary antibody-secondary biotinylated antibody reactions. 
When the substrate 3-amino-9-etyhlcarbazole (AEC) is subsequently added, the 
enzyme linked to avidin and in the presence of hydrogen peroxide catalyses the 
colour producing reaction such that AEC changes to a dark brown pigment. AEC is a 
chemical derived from DAB and both give a dark brown pigment. AEC is mounted 
using aqueous mounting medium because the AEC is degraded in organic mounting 
media such as those we utilised for DAB staining. This also means that if air bubbles 
form under the coverslip one can dissolve the mountant in water and reapply the 
coverslip for further visualisation and imaging of section. 
Frozen 6m skin sections were prepared for staining as described in Section 2.5.2. 
The slides were immersed in PBS (0.1M, pH 7.5) and left to stand in PBS wash for 5 
minutes. The sections were then incubated for 20 minutes with 50 µl per skin section 
of 10% normal horse serum (prepared from the same species in which the secondary 
antibody was made). Excess serum was then blotted from sections. The primary 
antibody was pre-diluted in 1% normal horse serum and added to the tissue sections 
at the required dilution and left to incubate overnight at 4◦C. The sections were then 
rinsed twice by immersion in PBS and then left to stand in PBS for 5 minutes. This 
technique employs a commercially available Avidin-biotinylated enzyme 
complex(VECTASTAIN ABC, Vector laboratories) which is prepared at this stage 
by allowing 10 µl of agent “A” (Avidin DH) and 10 µl of agent “B”(biotinylated 
enzyme) to react in 1000 µl of 1% normal horse serum diluted in PBS. The substrate 
AEC is prepared prior to commencing of staining by dissolving 120mg of AEC in 
15ml of N,N-dimethyl formamide (SIGMA). 0.1M acetate buffer is prepared by 
adding 79ml of 0.1M sodium acetate (13.61 g/L distilled H20 and 21ml of 0.1M 
Acetic acid). The mixture is filtered through a 0.2 micron filter with a syringe and 
2.5 µl of 30% H202 is added to activate the reagent. The horse anti-mouse 
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biotinylated antibody is diluted at the required dilution (1:200) and incubated with 
the sections for 30 minutes at room temperature. The sections are then rinsed twice 
by immersion in PBS and then left to wash for 5 minutes. At this stage to ensure 
quenching of endogenous peroxidise the sections are incubated for 15-20 minutes in 
0.3% H202 (Henry Schein Hydrogen peroxide solution (1:10 dilution of 3% stock 
solution in distilled H20 and mixed well in graduated cylinder). The sections are then 
washed as before. Sections are then incubated for 40 minutes at room temperature 
with VECTASTAIN ABC (40µl per section). The slides are washed as before. The 
AEC reagent is now applied and the sections monitored until the desired staining 
intensity develops. The slides are then washed in distilled water and left to dry. Once 
dry the sections are mounted in Aqueous mounting medium.  
2.5.3.3. Control slides 
Three control preparations were used each time staining was performed. As a 
negative control, a section of both tonsil and skin tissue was incubated with normal 
mouse serum instead of primary antibody. In addition, where possible, a negative 
isotype control antibody for the same animal species as the primary antibody was 
also used at the same concentration on single sections of skin and tonsil (Table 2-4). 
Tonsil tissue was also stained as a positive control. Tonsil provides a rich source of 
cells including those stained for in the skin sections and allows for the distribution 
and staining of cells to be tested against tissue architecture. 
2.5.4. Imaging and Quantification/Assessment of Immunofluorescence 
micrographs 
2.5.4.1. Image acquisition and processing 
Images were acquired using appropriate filters of a Leica DMLB microscope with 
Leica N PLAN 20x /0.40 objective and a Cool SNAP-Pro cf Monochrome Media 
Cybernetics camera, controlled by Image-Pro PLUS 6.2 software. In the case of 
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CD163 and CD11c and TNF-α double labelling, the images were acquired in our 
collaborator‟s laboratory at the Rockefeller University in New York, using 
appropriate filters of a Zeiss Axioplan 2I microscope with Plan Apochromat 20 × 0.7 
numerical aperture lens and a Hamamatsu orca ER-cooled charge-coupled device 
camera, controlled by METAVUE software (Universal Imaging).  
One important factor to take into consideration when quantifying 
immunofluorescence is that procedures and parameters must be standardised. 
Therefore to ensure that immunofluorescence micrographs acquired from skin 
sections from young and old subjects were interpretable for analysis of staining 
intensity, the saturation, sensitivity and gain settings during acquisition were 
standardised on the image acquisition software. Staining for each antibody and each 
skin section from the same candida injection time-point was done on the same day, in 
order to avoid differences in staining intensity due to day-to-day fluctuations.  
Image processing when necessary eg to produce images for printing, was performed 
by using commercially available software (Adobe Photoshop CS3, San Jose, CA). 
With the use of the Adobe Photoshop “levels” and threshold” functions, the 
background was optimised (non-specific extracellular signalling was reduced to a 
uniform black background). These settings, used to optimise image quality on a 
control image from a young skin section, showing good expression of the marker 
being tested, were then used as standards for the processing of all subsequent cell 
images. All optimisation of image quality was performed on the whole image and not 
to selected features that needed to be highlighted. 
2.5.4.2. Image qualitative analysis and quantification of data used for 
colocalisation purposes  
Immunofluorescence microscopy images were used for analysis in the case of E-
selectin, VCAM-1, ICAM-1 expression on CD31 positive endothelial cells in skin 
tissue and for calculating proportions of cells expressing a particular marker out of 
the total population of interest e.g. CD163
+
 TNF
+ 
macrophages. Wherever the 
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staining was all or none, we manually counted cells (using Adobe Photoshop CS3 
manual count function) that were positive for the cell type identifying marker, such 
as CD163 then manually counted cells that were doubly positive for the second 
marker of interest (eg TNF-α) . For expression that was characterised by a variation 
in intensity of staining such as ICAM-1 we asked two independent observers to 
blindly assess the staining and label each slide as high intensity/moderate/low. 
Specialised software for quantitative analyses of immunofluorescent images is 
available and is generally based on global statistic analysis of pixel intensity 
distributions. However we felt that there are many potential pitfalls to analysing our 
immunofluorescent data in this way. The majority of colocalisation situations 
demand customised approaches as different tissues contain a plethora of structures 
with multiple morphologies. Firstly most software packages have been created with 
specific tissue and protein expression in mind(Belichenko et al., 1996; Bolte and 
Cordelieres, 2006). Skin tissue poses its own particular problems in that there is 
background autofluorescence caused partly by non-specific staining and partly by 
protein autofluorescence such as the epidermis and dense concentrations of cells, as 
well as collagen fibrils in the dermis. Both these types of fluorescence disturb the 
fluorescence of interest to a degree which varies in different areas. This makes it 
difficult to obtain pixel intensity measurements that we could be sure were coming 
from the area of interest eg the dermal endothelium and not background collagen 
fibril in close juxtaposition to the endothelium in the dermis. Another advantage of 
“naked eye” analysis of micrographs is that in some skin sections it was clear that 
there were some areas where the staining hadn‟t worked but there was good 
interpretable staining in the rest of the section. An image analysis program would not 
be able to factor this in and would give false low pixel readings for an area of the 
skin section which should have been discounted in the first place.  
2.5.5. Quantification of Immunohistochemistry 
Immunohistochemistry was analysed using a light microscope (Nikon Eclipse E600) 
and the 5 largest perivascular cellular infiltrates in the upper and mid-dermis were 
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photographed using Nikon DXM1200F camera and Eclipse Net software version 
1.16.3 for Nikon. The number of positive cells in these infiltrates was counted using 
Adobe photoshop CS3 software. The mean number of cells for the 5 perivasular 
infiltrates photographed per section was then calculated. The number of CD163
+
 and 
CD11c
+ 
cells/mm was counted manually using computer-assisted image analysis 
(NIH Image 6.1; http://rsb.info.nih.gov/nih-image). 
2.6. Skin Explant Culture 
Punch biopsies (5 by 5 mm) were obtained from the forearm as before and bisected 
with care. Each half was placed in medium alone or medium enriched with TNF-
α(110,000 U/ml) and IFN-γ(100U/ml) for 24 hours. The biopsies were then frozen in 
OCT(optimal cutting temperature compound; Bright Instrument Company Ltd). 6μm 
sections were cut and left to dry overnight and then fixed in ethanol and acetone and 
stored at -80ºC as before. 
2.7. Flow cytometry 
2.7.1. Surface staining by direct Immunofluorescence 
Four-parameter analysis of blister and blood T cell phenotype was performed on a 
FACSCalibur™ (Becton Dickinson). PBMCs were stained with antibodies to CD3 
(Dakocytomation), CD4, CLA, CCR4, CD11a (all from BDPharmingen). 
Appropriate isotype controls were used. Details of antibodies and dilutions used are 
found in Table 2-3. 
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2.7.2. Intracellular staining 
2.7.2.1. Detection of antigen specific cells 
For the detection of antigen specific cells, PBMCs (1x10
6
) or blister cells were 
stimulated with PPD at a final concentration of 10g/ml or Candida antigen at a final 
concentration of 40g/ml for 15 hours at 37C in a humidified 5% CO2 atmosphere. 
Brefeldin A (Sigma- Aldrich) was added at a final concentration of 5g/ml after 2 
hours of incubation. Unstimulated controls were also included. The cells were fixed 
and permeabilized (Fix & Perm ® Cell Permeabilisation Kit; Caltag Laboratories) 
before staining for CD4 and IFN-γ as described (Reed et al., 2004). 
2.7.2.2. Detection of TNF-α producing cells 
For the analysis of macrophage function PBMC and blister cells were washed and 
resuspended in RPMI 1460 supplemented with 1% penicillin/streptomycin, 1% 
glutamine and 10% heat-inactivated foetal calf serum (Cambrex, Nottingham, UK). 
Cells were stimulated with LPS (100ng/ml; Sigma) or medium as a control for 4hrs 
in the presence of Golgi Stop (Becton Dickinson, San Jose, California). Cells were 
stained for cell surface markers for 30min at 4°C, fixed in 2% paraformaldehyde and 
permeabilized with 0.5% saponin, then labelled with either anti-IgG1 APC or TNF-α 
APC (eBioscience). Cells were analyzed on FACS Canto II using FACS Diva 
software (Both Becton Dickinson) and further analyzed using FlowJo software 
(TreeStar, Inc). 
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Table 2-5: Antibodies used for flow cytometry  
Antigen Source Clone
a 
Isotype Dilution Specificity 
CD14APC Serotec UCHM-1 IgG2a 1/35 Monocytes, 
macrophages, dendritic 
cells 
CD163FITC Santa Cruz GHI/61 IgG1 1/20 Monocytes, 
macrophages 
CD45RA-
FITC 
BD L48 mIgG1 1/25 Naïve T lymphocytes, 
all B lymphocytes, Nk 
lymphocytes 
IFN-γ–APC BD B27 mIgG1 1/200 Activated Th0 and Th1 
Cd4+ T lymphocytes, 
activated Cd8+ T 
lymphocytes, NK cells 
IFN-γ–FITC BD 25723.11 mIgG2b, κ ~1/5 Activated Th0 and Th1 
Cd4+ T lymphocytes, 
activated Cd8+ T 
lymphocytes, NK cells 
IL-2–FITC BD 5344.111 mIgG1, κ  Activated CD4+ Th0 
and Th1, some Cd8+ T 
cells 
CD4-PE Dako MT310 mIgG1, κ ~1/20 Helper T cells, Tregs, 
monocytes, 
macrophages, 
Langerhans cells, 
dendritic cells 
CD45RA-PE Dako 4KB5 mIgG1, κ ~1/20 Naïve T lymphocytes, 
all B lymphocytes, Nk 
lymphocytes 
Ki67-FITC BD B56 mIgG1 1/10 Expressed in nucleus 
of cycling cells 
Foxp3-APC eBioscienc
e 
PCH101 mIgG1 1/10 Regulatory T cells 
Activated T cells 
CLA FITC BD Pharm HECA-452 Rat IgGM 1/10 Lymphocytes in  
the skin, small subset 
of circulating 
lymphocytes, all 
monocytes, 
granulocytes 
DC-SIGN 
APC 
BD DCN46 IgG2b 1/50 Monocytes, 
Macrophages, dendritic 
cells 
CD14 PeCy7 BD M5E2 IgG2a, κ 1/100 Monocytes, 
macrophages, dendritic 
cells 
CD11c PE BD B-ly6 IgG1, κ 1/100 NK cells, B and T 
cells, Monocytes, 
macrophages, 
Dendritic 
cells,granulocytes 
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2.8. T Lymphocyte transendothelial migration 
2.8.1. Endothelial culture 
Normal non-transformed human dermal microvascular endothelial cells (HDMEC-c) 
(PromoCell, Heidelberg, Germany) derived from young human dermis were cultured 
at 37°C in a humidified 5% CO2, in endothelial cell basal medium supplemented 
with 5% FCS (supplement pack C39220, PromoCell, Heidelberg, Germany). The 
preparation of endothelial cell cultures was carried out in collaboration with Dr 
Anna-Pia Papageorgiou, Institute of Child Health, UCL. Briefly the endothelial cells 
were stored frozen until needed. To initiate cell culture 5 ml of endothelial cell basal 
medium were added to a 25cm
2
 culture flask and this was warmed to 37°C. A frozen 
tube of endothelial cells was agitated in a 37°C waterbath until 90% thawed and then 
agitated outside the waterbath until completely thawed. Endothelial cells were 
pipetted into the culture flask at 10,000-20,000 cells/cm
2
. The medium was replaced 
the next day and every 2 to 3 days subsequently. The cell cultures were considered 
ready for splitting 24 hours after reaching 70-90% confluence. For splitting 5 ml of 
endothelial cell basal medium were added to a new 25cm
2
 culture flask and 
incubated at 37°C for at least 30 minutes. The endothelial culture flask was placed in 
a sterile hood and the medium removed taking care not to disturb the endothelial 
monolayer with the pipette. The medium was replaced with 5ml HEPES Buffered 
Saline Solution (HEPES-BSS) and washed for 30 seconds by swirling the flask. The 
HEPES-BSS was then removed and replaced with 100µl/cm
2
 (i.e. 2.5ml in 25cm
2 
flask) trypsin/EDTA solution. The flask was then examined under the microscope. 
When ~50% of cells were loose, the side of the container was tapped to release the 
rest of the cells. This procedure was performed at room temperature. When the 
endothelial cells were detached, an equal volume of Trypsin Neutralising Solution 
was added and the cell suspension transferred to a centrifuge tube. This was then 
centrifuged at 220g for 4 minutes at room temperature and the resultant clear upper 
layer was carefully removed. The cells were respuspended gently in 1.5ml medium 
and diluted to a total volume of 2ml and then counted. The cell suspension was then 
redistributed to new flasks (250,000-500,000 cells/flask) and maintained at 37°C in 
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5% CO2 and the medium replaced every 2-3 days until they reached 50% confluence 
when they were used for migration assays. The cell culture was checked for mitotic 
figures/clusters, indicating that the cells were in a proliferative state. 
2.8.2. Activation of endothelial cells for migration studies 
HDMEC monolayers were grown to confluency in 96 well plates and stimulated with 
TNF-α (100ng/ml)(110,000 U/ml) and IFN-γ (100U/ml) for 24 hours prior to 
migration assay. By FACS analysis, TNF-α and IFN-γ treated cells were >99% and 
96% positive for ICAM-1 and VCAM-1 respectively, after 24 hours of treatment. 
2.8.3. Migration experiments 
CD4
+
 T cells, isolated from young and old PBMCs by negative selection and kept 
overnight in X-vivo medium (to prevent downregulation of CLA) were added 
(20,000 cells per well) with a minimum of 6 wells per condition per experiment. To 
evaluate the level of migration, cocultures were placed on the stage of a phase-
contrast inverted microscope housed in a temperature controlled (37°C), 5% CO2 
gassed chamber (Zeiss, Herts, U.K.). For each well a 200 x 200-mm field was 
randomly chosen and recorded for 5 min spanning the 4-h time point using a camera 
linked to a time-lapse video recorder. Recordings were replayed at 160 x normal 
speed, and lymphocytes that had migrated through the monolayer were identified and 
counted. Lymphocytes on the surface of the monolayer were identified by their 
highly refractive morphology (phase-bright) and rounded or partially spread 
appearance. In contrast, cells that had migrated through the monolayer were phase-
dark and highly attenuated. Data were expressed as the percentage of total 
lymphocytes within a field that had migrated through the monolayer 
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2.9. In Vitro Cell Culture 
2.9.1. Measurement of cellular proliferation by [3H] thymidine incorporation 
For measurement of cellular proliferation by [
3
H] thymidine incorporation, PBMCs 
were added to 96 well round bottomed tissue culture plates (Falcon, Becton 
Dickinson Labware) at a concentration of 10
5 
cells/well. The cells were incubated at 
37C in a humidified 5% CO2 atmosphere for 5-6 days (5 days for PPD antigen, 6 
days for candida and VZV antigens) before adding [
3
H] thymidine (Amersham 
Biosciences UK Ltd, Chalfont St. Giles, UK). The mean of triplicate wells was 
calculated and used for the purpose of data analysis. 
2.9.2. Monocyte cell culture with TLR ligands 
PBMCs were obtained from healthy young and old subjects( n=3 young, n=3 old) as 
described. The PBMCs were suspended at 1 x10
6
/ml in RPMI +10% human serum in 
24 well flat bottomed plates and incubated at 37C in a humidified 5% CO2 
atmosphere for 18 or 72 hours TLR ligands: LPS (100ng/ml, Sigma) or Pam3CSK4 
(1μl/ml, Invitrogen) or Candida antigen (5μg/ml, Greer). Unstimulated controls were 
also used. Prior to surface staining for extracellular DC-SIGN, CD14, CD11c and 
CLA, the 24 well plate was placed on ice for 1 hour so that macrophages which are 
known to adhere to plastic in warm environments, start to detach back into solution. 
To ensure further detachment of macrophages the sides of each well were scraped 
with the tip of a Pasteur pipette and the cell suspension aspirated and prepared for 
extracellular marker staining for flowcytometry as described before. 
2.10. Cytokine assays 
Concentrations of cytokines (IL-6, IL-10, TNF, IFN-) in blister fluid and serum 
were analysed using the BD
TM 
Cytometric Bead Array (CBA) Cell Signalling Flex 
Set System and were analysed using a BD FACSArray
TM 
bioanalyser with FCAP 
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Array Software (all BD Biosciences, San Jose, California, USA). This technique 
employs the use of particles with discrete fluorescent intensities and sizes to detect 
soluble analytes and enables multiplexed quantitative analysis of multiple proteins 
from a single sample using flow cytometry. 
The assay was performed in a 96 well round bottomed plate (Falcon, Becton 
Dickinson Labware, New Jersey, USA). 50l of mixed capture beads each coated 
with a cytokine-specific antibody was mixed with 50l of mixed cytokine-specific 
PE-conjugated antibodies in addition to 50l of blister fluid, serum or dilution series 
of analyte recombinant protein. The plate was gently vortexed and then incubated at 
4 hours in the dark, at room temperature, in order for sandwich complexes to form.  
The plate was then centrifuged and the supernatant aspirated from each well. 150l 
of wash buffer was then added to each well and the plate was then inserted in to the 
BD FACSArray
TM 
bioanalyser for analysis. This machine automatically assigns an 
alpha-numeric position on a grid for each bead population using the NIR and Red 
channels. A standard curve for each analyte is created based on bead size and PE- 
fluorescence intensity for the dilution series of the recombinant protein samples. This 
enables the quantitative calculation of the concentration of the analytes from the test 
samples bound to the beads. 
All samples were analysed in one experiment in order to minimise variation in 
measured concentrations due to different experimental conditions on different days.  
In addition, blister and serum samples were stored at -70C immediately after 
collection from volunteers and were only defrosted for the purpose of analysis in 
order to minimize changes in cytokine concentration due to repeated freeze thaw 
cycles. 
2.11. Statistics 
Statistical analysis was performed using GraphPad Prism version 5.00 for Windows 
(GraphPad Software, San Diego, California, USA).  Non-parametric tests were 
predominantly utilised as the data could not be assumed to be normally distributed.  
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The Kruskall-Wallis test was used to compare three or more unpaired groups and a 
2-tailed Mann-Whitney test was used when comparing only two unpaired groups.  
The Wilcoxon matched pairs test was used when comparing two groups of matched 
data. 
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Chapter 3. Decreased clinical and cellular response to 
injected recall antigen in old skin 
3.1. Introduction 
Immunity is known to decline with age (Yoshikawa, 2000). This may explain why 
there is an age-associated increase in the frequency of skin tumours and infections 
(Diffey and Langtry, 2005) (Laube, 2004). Most studies directed at identifying 
defects in the immune system during ageing have focused on circulating leucocyte 
populations but it is not clear if the results obtained can be extrapolated to the 
behaviour of leucocytes within tissues. In this chapter we elicited cutaneous delayed 
type hypersensitivity responses to bacterial and fungal skin test antigens in young 
and old subjects. This enabled us to compare the kinetics of this memory immune 
response in the skin and to determine the correlation between local cutaneous 
immunity and peripheral blood leucocyte function in young and old subjects. 
The intra-dermal injection of recall antigens such as tuberculin purified protein 
derivative (PPD) (Orteu et al., 1998; Reed et al., 2004; Vukmanovic-Stejic et al., 
2008) or candida albicans induces a delayed type hypersensitivity reaction (DTH) in 
the skin. DTH responses against Candida or vaccine antigens (Tetanus) can be used 
clinically as a measure of overall cell mediated immunity. The Candin skin test, 
using a sterile solution produced from the culture filtrate and cells of two strains of 
Candida albicans, has been licenced for the evaluation of cellular immune responses 
in the skin in patients with HIV (Ahmed and Blose, 1983). In this chapter we 
therefore use Candin skin test injected intradermally to compare cell mediated 
immunity in young and old subjects. Our group has previously characterised the 
cutaneous response to the injection of tuberculin purified protein derivative (PPD), 
known as the Mantoux test (MT), in terms of the kinetics of CD4
+
 T cell 
accumulation in the response (Reed et al., 2004) (Orteu et al., 1998). In humans, a 
positive clinical response to the injection of PPD antigen in to the skin is typically 
characterised by erythema and swelling that peaks at 48-72 hours and resolves within 
14 days (Reed et al., 2004). This clinical response in the skin has been used as a 
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measure of systemic immunity in vivo (Turk JL., 1980). Previous studies in old 
subjects, predominantly performed on nursing home residents, have indicated an 
increase in the percentage of negative DTH reactions to the Mantoux test (MT) and 
other antigens (Castle et al., 1990; Dorken et al., 1987; Rodysill et al., 1989). 
Previous work carried out in our group has shown that subjects over 70 years have 
poor clinical responses to the injection of PPD antigen intradermally when compared 
to subjects under the age of 40. Older subjects also show reduced percentages of 
antigen specific cells for PPD when cells obtained from suction blisters raised over 
the skin test are stained for IFN-γ production in vitro (Dr Katie Lacy, unpublished 
data). Moreover in young individuals, good PBMC proliferative responses in vitro to 
PPD antigen were associated with a good clinical response to the MT. However, in 
the old group, there was dissociation between the observed absent clinical response 
in the skin and PBMC responses. In spite of good proliferative PBMC responses 
(equivalent to those seen in the young) twenty-two old individuals failed to develop a 
clinical response to the MT. This indicates that, in the old, the absent clinical skin 
response to the MT may not be reflective of global immunity to the antigen and may 
be reflective of local age- specific changes in cutaneous immunity. 
The BCG (Bacillus of Calmette and Guerin) vaccine immunisation programme in the 
UK did not start until the 1940‟s and therefore most individuals over the age of 70 
will not have routinely been vaccinated. Therefore another explanation for the 
observed differences between the young and old observed previously in our group 
(Dr Katie Lacy) could be that all individuals in the young group had been immunised 
with the BCG vaccine whereas only one individual in the old group had been 
vaccinated. Previous studies have demonstrated that the route of primary exposure to 
antigen may determine the ability of different tissues to subsequently develop 
memory responses to that antigen. PPD comprises of a complex mixture of peptides 
and carbohydrates derived from M. tuberculosis and immunity can be acquired in 
several ways; namely previous and/or latent infection with TB, BCG vaccination and 
exposure to environmental mycobacteria. The young individuals were most likely to 
have developed immunity to the PPD antigen as a result of BCG vaccination 
(administered percutaneously) whereas immunity in the old group was likely to be 
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due to previous exposure to tuberculosis or environmental mycobacteria. Of interest, 
however, one old individual in this study had been vaccinated and did not have a 
clinical response to the Mantoux test in spite of good peripheral blood response to 
the antigen. This suggests that percutaneous administration of the BCG vaccine may 
not determine subsequent ability to respond to the antigen in the skin in the old. In 
view of this possible confounding factor with regards to accurately comparing skin 
immunity in young and old subjects we subsequently decided to use candida skin test 
antigen to induce DTH responses for comparison in young and old subjects. Candida 
is a commensal on skin and mucous membranes and therefore both young and old 
subjects are equally exposed to this organism suggesting that both age groups could 
potentially mount a secondary cutaneous immune response to it on re-challenge. Old 
individuals are particularly prone to candida infections of the skin (Ronald Marks, 
1999). The most common clinical subtypes that affect the elderly include 
vulvovaginal candidiasis, intertrigo and candida paronychia (Robert A.Norman, 
2001). 
Also our group has previously shown that non-immune individuals do not mount a 
DTH response to antigen despite the fact that equal levels of antigen as well as 
trauma to the skin occurs (Orteu et al., 1998) (Reed et al., 2004). This highlights the 
importance of memory T cell recruitment for the amplification step of this response 
to take place (Reed et al., 2004). Memory T cell recruitment into the skin of young 
and old subjects will be looked at throughout the course of this chapter. 
3.2. Candida Skin testing 
3.2.1. Clinical response to the Candida skin test in young and old individuals 
A total of 40 young and 34 old individuals were tested with the Candin skin test with 
intradermal injection of Candin skin test solution into the inner aspect of the upper 
forearm. A dose of 0.02ml of the Candin skin test solution was selected for use in the 
study as this was the smallest dose/volume that could be administered accurately 
intradermally without the need for diluting the commercial preparation with an 
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associated risk of contamination of the skin test preparation. Once again, a clinical 
score was assigned for each individual tested based on erythema, diameter and 
palpability of the clinical response (Table 2-2). In both young and old groups, a peak 
in clinical response to the Candin skin test was seen at 48- 72 hours. 
 
B
Young Old
0
5
10
15 ***
Candida
C
li
n
ic
a
l 
S
c
o
re
 
Figure 3-1: Cutaneous clinical responses to the Candida skin test are 
reduced in old individuals. 
Young and old volunteers were injected intradermally with 0.02ml of Candida 
skin test antigen ((n=40 young, 34 old)) (A) A photograph of the injection site at 
day 3 following candida skin test antigen injection. (B) Induration diameter, 
erythema index and palpability of the lesion were assessed and graded at day 3 
and a clinical score assigned based on these parameters (***P<0.0001,Mann 
Whitney test). (Dr KE Lacy collected half of the data points shown in this graph) 
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A marked reduction in clinical response to antigen injection was observed in the old 
compared with the young at Day 3 (P<0.0001; Mann Whitney test) (Figure 3-1 A/B) 
and at all time points following the injection of 0.02ml of Candin skin test solution  
3.2.2. Clinical response to the Candida skin test correlated to peripheral blood 
response in young and old individuals 
The ability of old and young volunteers‟ PBMCs to proliferate in response to 
Candida antigen in vitro for 5-6 days was assessed for a range of concentrations of 
Candida antigen up to 20 g/ml. No statistical difference was found between young 
and old PBMC proliferation at all concentrations of candida antigen tested including 
the 20 g/ml concentration (Mann Whitney P=0.69).The clinical response to the skin 
test was then correlated with PBMC proliferative responses. This demonstrated that, 
as with the MT, there were significant numbers of old volunteers who failed to 
respond clinically to Candida antigen injection in spite of good peripheral blood 
responses (Figure 3-2:). This indicates that they have defective local immune 
responses to secondary antigen challenge in the skin that does not reflect a global 
loss of systemic immunity. The majority of young individuals tested had both good 
peripheral blood responses and skin responses to the Candida antigen. 
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Figure 3-2: PBMC proliferation in response to Candida antigen in vitro 
plotted against clinical scores to Candida skin test antigen. 
PBMC from old individuals proliferate well in response to Candida antigen in 
vitro despite poor clinical scores.Freshly isolated PBMC were stimulated with 
candida (n=23 young, 20 old) in vitro for 5-6 days. Proliferation was assessed by 
[3H] thymidine incorporation and plotted against the corresponding clinical 
score. (Dr KE Lacy collected half of the data points shown in this graph) 
 
3.2.3. Differences in T cell number accumulation during the candida skin test 
in young and old subjects 
We next determined whether the defective clinical response in old subjects was 
associated with decreased CD4
+
 T cell infiltration after antigen challenge since 
optimal secondary immune responses in the skin are dependent on antigen-specific 
CD4
+
 T cells. 
3.2.3.1. CD3
+
 and CD4
+
 T cell numbers  
We carried out skin punch biopsies on normal skin and at 24hrs, 3 and 7 days after 
candida skin test antigen injection in at least 4 young and 4 old volunteers at each 
timepoint tested. H&E staining in young and old skin sections at day 3 revealed 
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perivascular collections of lymphocytes which were much larger in the young skin 
sections compared to the old (Figure 3-3:A). We then performed 
immunohistochemical staining for CD3, CD4 on young and old skin sections 
obtained from 24hr, day 3 and day 7 biopsies. In the young, after the injection of 
intradermal Candin, CD3
+
 and CD4
+
 cells were seen to accumulate perivascularly 
within the dermis (Figure 3-3:). The peak of the cellular response for candida skin 
test injection in the young was at Day 3 which corresponds to the peak clinical 
response. Furthermore, there were reduced numbers of CD3+ (Figure 3-3:B) and 
CD4
+
 T lymphocytes (Figure 3-3:C) in perivascular infiltrates in old skin sections at 
all time-points studied (Figure 3-4:) indicating that the results obtained were not due 
to a shift in the kinetics of the response in old individuals. 
 
Figure 3-3: Cellular infiltrate at the site of cutaneous DTH response is 
reduced in the old. 
Young and old volunteers were injected with 0.02ml Candin skin antigen test and 
5mm punch biopsies were performed on days 1, 3 or 7 post injection (n=20 old, 
22 young with 4-7 volunteers per timepoint). (A) H&E staining of skin sections 
from young and old skin on day 3 following Candin injection showing 
perivascular infiltrates (black arrow). Scale bar=100µm. Day 3 biopsies (n=5 
young, 4 old) were stained for CD3 (B) and CD4 (C) using an indirect 
immunoperoxidase immunohistochemical technique (original magnification: 
x200). 
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Figure 3-4: CD3
+
, CD4
+ 
T cell numbers at the site of the Candida antigen 
skin test 
The number of CD3
+
, CD4
+ 
and CD8
+
T cells within perivascular infiltrates was 
determined by counting the number of positive cells within the 5 largest 
perivascular infiltrates per skin section. Mean±SEM of 4-7 individuals per time 
point is shown (*P=0.01, **P=0.007 Mann Whitney test). 
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Figure 3-5: Candida-specific T cell infiltration in the skin following the 
Candida skin test in young and old. 
The percentage of Candida specific CD4
+
 T cells in the peripheral blood and skin 
was determined in the old and young by examining for intracellular cytokine 
staining using flow cytometry. Skin blister and PBMC were stimulated with 
Candida antigen overnight in the presence of brefeldin A. Unstimulated controls 
were also performed. Live CD3+CD4+ cells were gated and at least 10,000 
CD4+T cell events were acquired. The percentage IFN-γ producing antigen 
specific CD4+ T lymphocytes in old blisters is significantly reduced compared to 
young (n=6 young, 10 old; Mann Whitney test *P=0.04). Horizontal bars 
represent the median. At all time points measured the percentage of antigen 
specific (CD4
+ 
IFN-) cells was significantly higher in the SB cell population 
compared with the blood.  
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3.2.3.2. Local in situ T cell proliferation at site of candida response in young 
and old skin 
We have previously shown that T cell proliferation is likely to occur in situ in the 
skin during the Mantoux response in humans and not only in the draining lymph 
nodes (Reed et al., 2004). We therefore hypothesised that there is reduced T cell 
proliferation in old skin during a candida immune response. We carried out indirect 
immunoperoxidase staining for Ki67, a nuclear protein expressed during cell 
replication in young and old skin sections from normal skin biopsies and different 
time-points after candida injection (n=at least 4 old and 4 young subjects per 
timepoint). We found that Ki67 expression peaks at day 7 though later time-points 
were not studied for candida skin test histology. (Figure 3-6) There is a significant 
reduction in Ki67
+
 cell numbers at day 3 in skin sections from old individuals 
(Figure 3-6 A and B). This could occur however because the total number of CD3
+
 T 
cells in the old is reduced and therefore there are obviously fewer proliferating cells. 
However when the number of Ki67
+
 cells is expressed as a percentage of total CD3
+
 
T cells quantitated from consecutively stained skin sections no significant difference 
is detected for Ki67 expression in young and old candida injected skin (Figure 
3-66C). The percentage of CD3
+
Ki67
+
 cells on day 0 could not be accurately 
assessed due to very low CD3 numbers found on histology. However it was noted 
that very few cells were positive for Ki67 expression at Day 0. 
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Figure 3-6: Kinetics of T cell proliferation during a cutaneous response to 
Candida skin test antigen in young and old. 
Young and old volunteers were injected with 0.02ml Candin skin antigen test and 
5mm punch biopsies were performed on days 1, 3 or 7 post injection (n=20 old, 
22 young with 4-7 volunteers per timepoint) Biopsies were stained using 
antibodies for Ki67 and the indirect immunoperoxidase technique.  Ki67
+
 cells 
were seen predominantly within the perivascular infiltrates.  Ki67
+
 cells within 
frames centred over the 5 largest perivascular infiltrates per section were counted 
and the mean number of Ki67
+
 cells per frame per individual was calculated.  A. 
There was a reduction in the mean number of Ki67
+
 cells in the old)compared 
with the young (Mann Whitney test *P=0.03). B. However when the Ki67
+
 cells 
are expressed as a percentage of total CD3
+
 cells counted in the same individual 
using consecutive skin sections there is no significant difference between young 
and old CD3
+
 cell proliferation rates. 
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3.2.4. Differences in numbers of candida-specific memory T cell accumulation 
in young and old 
We showed previously that large numbers of antigen-specific CD4
+
 T cells, 
identified by their ability to secrete IFN-γ after re-challenge,  accumulated and 
proliferated at the site of antigen injection (Reed et al., 2004). We found that old and 
young subjects have similar proportions of PPD and candida specific CD4
+
T 
lymphocytes in the blood however; the former had significantly lower proportions of 
Ag-specific CD4
+
 T cells in the skin (Figure 3-5:). This indicates that the inability to 
mount a clinical response to recall antigen challenge older individuals is associated 
with decreased cutaneous antigen-specific CD4
+
 T cell infiltration.  
3.2.5. Clinical response to the candida skin test correlated to numbers of T cells 
in situ 
In order to confirm our findings that low cell numbers on histology corresponded to 
poor clinical responses we performed correlation analysis between these two 
parameters. Figure 3-7 shows that there is a significant correlation for T cell number 
and clinical score in both young and old individuals (CD3: Spearman‟s correlation 
coefficient = 0.793, P=0.0007 and CD4: Spearman‟s correlation coefficient = 0 .748, 
P=0.002). Two old individuals had high clinical scores compared to the rest of the 
subjects in their age group and were found to have correspondingly higher T cell 
numbers on histology. This further supports our findings that the clinical score is 
linked to the number of T cells accumulating within the skin response for Candida 
skin test injections. 
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Figure 3-7: T cell number found on histology of Candida skin test injected 
skin correlates to the clinical score in both young and old. 
The number of CD3
+
 and CD4
+
 T cells counted perivascularly was correlated to 
clinical score(n=7 young,6 old). There was a significant correlation for T cell 
number and clinical score in both young ad old individuals (CD3: Spearman‟s  
correlation coeffieint = 0.793, P=0.0007 and CD4: Spearman‟s correlation 
coefficient = 0 .748, P=0.002). The two old individuals with high clinical scores 
had correspondingly higher T cell numbers on histology. 
3.3. Discussion 
In order to study young versus old cutaneous immune reactions our group has 
developed a skin model that allows assessment of the DTH response as it evolves in 
the skin in terms of the clinical and histological characteristics of the immune 
response. Previous studies investigating the changes to the immune system with age 
have focussed on peripheral blood samples. Our skin model has allowed us to 
determine the in vivo kinetics of T cell accumulation in young healthy skin during a 
response to the Mantoux test and candida skin test. We were then able to compare 
the findings in young skin to those seen in old subjects to determine and investigate 
crucial differences. Moreover by investigating PBMCs from young and old 
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individuals in parallel to skin we can directly compare localised skin immunity to 
that of the peripheral blood compartment. The suction blister technique in addition 
allows assessment of function and antigen specificity of the T cells in the response. 
Our results indicate that older subjects have decreased ability to mount a clinical 
response to recall antigen challenge in the skin, which is also associated with a 
decreased antigen-specific CD4
+
 T cell accumulation. However this study 
demonstrates for the first time that in the old volunteer cohort this does not equate to 
decreased immunity, as the numbers of antigen-specific T cells in peripheral blood 
and their ability to respond to antigen is not different in subjects in both age groups. 
This points to a skin specific rather than a general decline in cell-mediated immunity 
and suggests that the DTH response is not a good test for the presence of immunity 
to a particular antigen in the old. 
The DTH response to recall antigen in the skin has been used as a marker of systemic 
immunity (Takahashi et al., 2003; Almeida et al., 2001). Numerous studies have 
documented age-associated changes in different types of immune cells including T 
cells, B cells and antigen presenting cells that may result in defective immunity with 
ageing (Grubeck-Loebenstein and Wick, 2002). In particular, changes in the memory 
T cell pool with ageing which include large clones of terminally differentiated 
memory T cell which are less able to divide and persist in vivo, may result in the loss 
of immune memory (Fletcher et al., 2005). However, the equal ability of young and 
old PBMCs to proliferate in response to both PPD and candida antigens suggests that 
healthy old individuals used in this study were not significantly 
immunocompromised. It is possible that PBMC proliferation is not totally 
representative of an individuals‟ ability to respond to infection. However, previous 
studies investigating global parameters of immunity in healthy old individuals also 
indicate that the decline in immunity is modest in this population (Castle et al., 
1990). This data is further supported by the prior observation that anergic old 
individuals have been able to mount an adequate secondary immune response 
following infection with acute TB (Creditor et al., 1988). A negative skin test 
response to cutaneous challenge with antigen in the old is therefore not necessarily 
reflective of globally reduced immunity. 
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In view of the dissociation between clinical and cellular responses seen in the young 
the aim of this study was to establish whether the reduced clinical response in the 
skin in the old was truly reflective of reduced lymphocytic responses at the site of the 
response. We used Candida skin test antigen instead of the MT to ascertain that the 
differences observed in the clinical and histological response in the skin in young and 
old subjects were attributable to changes in the cutaneous immune system with age 
and not to different rates of vaccination with BCG. A reduction in lymphocyte 
numbers was seen at 1, 3 and 7 days after skin testing with Candin. Importantly, a 
positive correlation between clinical response and numbers of cells within 
perivascular infiltrates for both young and old individuals was demonstrated with 
reduced numbers of lymphocytes in all individuals who failed to develop a clinical 
response to the injection of antigen.  This data is important as it further indicates that 
the clinical DTH responses in the skin are dependent on T lymphocyte responses at 
the site. We have however only studied lymphocytic responses at a set number of 
time points. It remains possible that lymphocyte numbers peak after day 7 in the old 
due to a slower response time, although this is unlikely as there is no detectable 
clinical response in the old past day 7.  
In old subjects, reduced proliferative capacity of T lymphocytes present in the skin 
may be responsible for reduced cellular response. In particular, a lack of cellular 
proliferation at the site may be responsible for the reduced expansion of the CD4
+
 T 
lymphocyte population in the skin. Published data from human studies has indicated 
that a significant proportion of the expansion of lymphocyte numbers within the skin 
is mediated by localised T cell proliferation (Reed et al., 2004). This model is further 
supported by the results from this study that show that there is a marked increase in 
the percentage of Ki67
+
 T cells at day 3 and day 7 in the skin. Previous work in our 
group has shown no detectable increase in Ki67
+
 cells within the peripheral blood 
population during a DTH response in the skin (Dr Katie Lacy, unpublished data). 
Moreover the similar percentages of CD3
+
Ki67
+
 cells in both old and young confirm 
that the difference in T cell numbers seen is not due to decreased T cell proliferation 
in old skin. 
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In this study we have demonstrated a marked reduction in the percentage of antigen-
specific cells present in the skin during the Candin skin test in the old compared with 
the young. The Candin skin test is thought to induce Th1 type lymphocytic responses 
in the skin with the production of predominantly IFN-. It is also possible that the 
observed reduction in antigen specific cells in the old may not be due to a reduction 
in antigen-specific cells per se but rather an inherent inability of these cells to 
produce IFN-. Although no difference in IFN- production was found for peripheral 
blood CD4
+
 T lymphocytes in the young and old groups, the skin microenvironment 
in the old could render T lymphocytes refractory to restimulation with antigen and 
also affect their ability to produce IFN-. It is also possible that the old skin suction 
blister cells may have contained reduced numbers or defective antigen presenting 
cells, required for restimulation of T cells by the antigen in our in vitro model. 
Further investigation, using autologous irradiated APCs from PBMCs added to the 
skin suction blister cells, would help to exclude absent or defective antigen 
presenting cells within the skin suction blister cell population as a reason for the 
apparent reduction in antigen specific cells. 
Low percentages of antigen specific cells were identified during the course of the 
response to the Candin skin test in the young. It was not possible to use the same 
reagent as used for the skin test for in vitro work. This was thought to be attributable 
to the presence of preservative agents within the skin test that were toxic to the SB 
cells in vitro.  It is therefore possible that the agent used to test for in vitro responses 
did not contain the full range of epitopes that were present in the skin test resulting in 
an underestimation of the actual number of antigen specific cells present. Previous 
studies have indicated that intracellular cytokine staining only detects between 30 to 
90% of tetramer positive cells (Hislop et al., 2001) and it is therefore possible that 
our data represents an underestimate of the percentage of antigen specific cells 
present in the skin. Of interest, other studies have found that less than 1% of cells 
infiltrating the skin are antigen specific (Kalish and Johnson, 1990).  
Another possibility to explain the presence of reduced T cell numbers in old skin is 
that T cells in old subjects are migrating into skin in equal numbers to young initially 
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but a larger percentage of them is undergoing apoptosis early on in the response 
compared to the young. Although assessment of apoptosis rates in young and old T 
cells in situ was not performed in this study, the fact that significantly reduced 
numbers of CD4
+
 T cells are noticed as early as 24 hours post injection in the old 
subjects compared to the young, makes it unlikely that increased apoptosis rates 
account for the significantly reduced numbers of CD4
+
 T cells found in old skin. It is 
more likely that T cells are not getting into old skin and this hypothesis will be 
explored in Chapter 4. 
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Chapter 4. Impaired memory T cell-endothelial interaction 
affects transmigration into ageing skin  
4.1. Introduction 
In order for a localised immune response to develop, circulating T cells need to 
migrate to the tissue where the microbes/antigen is found. In Chapter 3 we showed 
that there are reduced CD4
+ 
T cell numbers in the skin, which is noticed as early as 
24 hours post antigen injection and lasts throughout the course of the response in old 
subjects. As circulating antigen-specific T cells are not decreased in number or 
capacity to respond to antigen in the old, we hypothesised that T lymphocytes might 
be impaired in their capacity to migrate into the skin following antigen injection. 
This chapter studies the mechanism of T cell-endothelial interactions during a 
secondary memory cutaneous immune response in vivo.  
Skin homing memory T lymphocytes express CLA which binds E-selectin expressed 
by dermal microvascular endothelium (Berg et al., 1991) and this interaction leads to 
rolling of the T cell on the endothelium. Subsequently Cd11a and VLA-4 (α4β1) on T 
lymphocytes bind ICAM-1 and VCAM-1on the endothelium respectively. 
Chemokines on endothelial surfaces signal to integrins CD11a and VLA-4 on the 
rolling lymphocyte to activate them. CCR4 is a chemokine receptor for skin homing 
of T cells as it allows binding to its agonist thymus and activation-regulated 
chemokine, TARC, secreted within inflamed skin tissue (Imai et al., 1997). We 
hypothesised that the migration process was impaired in old subjects ie either 
circulating T cells in old subjects were deficient in their expression of adhesion 
molecules and/or endothelium in old skin was defective in its expression of adhesion 
molecules. 
The endothelial cells (ECs) that line the postcapillary venules are responsible for 
local recruitment of T lymphocytes into the skin. Flowing blood quickly dislodges 
lymphocytes that touch the vessel wall. Endothelial cells that line the high 
endothelial venules in lymph nodes or Peyer‟s patches constitutively express 
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adhesion molecules which support the homing of naïve lymphocytes, whereas 
endothelial cells in the dermis permit little or no lymphocyte binding unless they are 
exposed to inflammatory mediators. The cutaneous endothelium therefore only 
solicits the entry of T lymphocytes when faced with danger signals and this is a 
homeostatic mechanism to protect skin and other organs from unnecessary 
inflammation. In this chapter we also explore the importance of endothelial 
activation in cutaneous T cell transmigration using in vitro migration assays across 
both activated and non-activated endothelium. 
4.2. Expression of skin homing receptors on CD4+ T cells is not reduced 
during ageing 
In view of the reduced number of T cells found at the site of a cutaneous immune 
response in skin from old subjects one hypothesis is that the expression of adhesion 
molecules on circulating leucocytes in old individuals was reduced. We therefore 
assessed expression of CLA, CCR4 and CD11a on the leucocyte cell surface in 
PBMCs from young and old subjects. 
4.2.1. CLA expression on T lymphocytes in peripheral blood. 
CLA expression on circulating T cells in the young and old was investigated in order 
to determine whether decreased CLA expression could be responsible for the 
observed reduced lymphocytic response in the skin. CLA
+
 lymphocytes bind to E-
selectin on inflamed skin. 
PBMCs from young and old individuals were stained for CD3, CD4 and CLA and 
analysed using flow cytometry (Figure 4-1). No significant difference was identified 
between the groups for percentage CLA expression on total CD4
+
 T lymphocytes 
(Mann Whitney p=0.054) although a small increase in the expression of CLA on the 
total CD3
+
 lymphocyte population was seen in the old (Mann Whitney: P=0.01, 
Figure 4-1).  
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Figure 4-1: Expression of CLA on circulating CD3
+
 and CD4
+
 T 
lymphocytes in the young and old.  
Expression of old peripheral blood leukocytes‟ skin homing receptor CLA not 
reduced. Immunostaining of peripheral blood mononuclear cells from old and 
young with antibodies to CLA was analysed by flow cytometry. The percentage 
CLA expression amongst CD3 and CD4 subsets was similar for young and old 
(n=9 young, 10 old, each symbol represents an individual and lines indicate the 
mean). 
4.2.2. CCR4 expression  
We next investigated CCR4 expression on skin homing (CLA
+
) and non-skin homing 
(CLA
-
) CD4
+
 T lymphocytes isolated from the peripheral blood in the young and old 
by flow cytometry (Figure 4-2). In both groups, CCR4 expression was found to be 
significantly higher on the CLA
+
 T cells (Mean old: 70.37% vs 22.45%; mean 
young: 60.65% vs 13.7% for CLA
+
 and CLA
-
 cells respectively). No difference was 
found for percentage of CD4
+
 T cells expressing CCR4 in young and old groups 
(Mann Whitney CLA
+
 cells: P=0.15, CLA- cells P=0.2) (Figure 4-2A). The level of 
expression of this chemokine receptor (MFI) is not reduced but actually increased on 
the old T cells (Figure 4-2B, Mann Whitney P=0.03), further indicating that the lack 
of infiltration into the skin is does not result from decreased chemokine receptor 
expression. 
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Figure 4-2: Expression of CCR4 on CLA
+
 and CLA
-
 CD4
+
 T lymphocytes in 
the young and old. 
Immunostaining of peripheral blood mononuclear cells from old and young with 
antibodies to CCR4 was analysed by flow cytometry. CCR4 expression was 
compared on both CLA
+
 and CLA
- 
CD4
+
 T lymphocytes isolated from the 
peripheral blood in the young and old. In both groups, CCR4 expression was 
found to be significantly higher on the CLA
+
 T cells. No difference was found 
for CCR4 expression between the young and old groups (n=15young, 9 old, each 
symbol represents an individual and lines indicate the mean). The level of 
expression of this chemokine receptor is not reduced but actually increased on 
the old T cells(MFI, Mann-Whitney P=0.03). 
4.2.3. CD11a (LFA-1) expression on peripheral blood T lymphocytes. 
After selectin mediated rolling on the endothelium, lymphocytes attach firmly to the 
endothelium through the adhesion of beta 2 integrins, including LFA-1, expressed on 
the lymphocyte cell surface and adhesion molecules such as ICAM expressed on the 
endothelium.  The expression of CD11a, a subunit of LFA-1, on both CLA+ and 
CLA- circulating peripheral blood CD4+ T lymphocytes was compared in young and 
old using flow cytometric analysis. (Figure 4-3). No difference was found for CD11a 
expression between young and old CLA positive (Mann Whitney p=0.21) and 
negative cells (Mann Whitney p=0.48) (Figure 4-3). 
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Figure 4-3: Expression of CD11a on CLA
+
 and CLA
-
  CD4
+
 T lymphocytes 
in the young and old. 
Immunostaining of peripheral blood mononuclear cells from old and young with 
antibodies to CD11a was analysed by flow cytometry. No difference was found 
for CD11a expression (MFI) between young and old CLA positive and negative 
cells (n=10 young, 9 old), each symbol represents an individual and lines 
indicate the mean) 
In conclusion the decreased migration of T cells into the skin after antigen challenge 
in old subjects is therefore not due to the decreased expression of key cell surface 
molecules on circulating CD4
+
 T cells.  
4.3. Capacity of CD4+ T cells to migrate is not reduced during ageing 
To further investigate the physical capacity of T cells from peripheral blood of old 
subjects for migration across endothelium, we used phase-contrast microscopy to 
assess the migration of these cells across primary human dermal microvascular 
endothelial cells (HDMEC) in vitro. 
4.3.1. Endothelial monolayer culture and activation and control studies using 
pre-activated T cells for migration  
The HDMEC monolayer was grown to confluence on 96 well plates as described in 
Chapter 2 Materials and Methods. It was then pre-activated for 24 hours with TNF-α 
and IFN-γ to stimulate E-selectin, ICAM-1 and VCAM-1 expression (Swerlick et al., 
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1992). Adhesion molecule expression and CD4 cell migration was minimal when 
using unactivated endothelium compared to activated endothelium (Figure 4-4a-c). 
Control assays using stimulated (IL-2 overnight exposure-5ng/ml and plate bound 
CD3-OKT3 0.5µl/ml and CD28-1µg/ml) versus unstimulated T cells were carried 
out simultaneously. CD4
+
 T cell stimulation prior to migration assay made no 
difference to % total migration rates (Figure 4-4d). 
 
Figure 4-4: CD4
+
 T cell migration across dermal microvascular endothelium 
assays. 
Activation of HDMEC is necessary for migration assays. HDMEC was grown to 
confluence in 96-well plates and endothelial monolayers were activated with 
TNF- α (110,000 U/ml) and IFN-γ (100 U/ml) for 24 hours prior to addition of T 
cells.(a) Photomicrographs of immunostaining of HDMEC monolayer for 
VCAM-1 and ICAM-1 (green) on unactivated (top panel) and activated (bottom 
panel) endothelium (Scale bar=10µm). (b) Graph showing ICAM-1 and VCAM-
1 upregulation upon HDMEC activation. (c) Bar graph showing increased total 
CD4
+
 T cell migration across stimulated HDMEC compared to unstimulated 
endothelium.(d) Bar graph showing similar levels of stimulated (IL-2 or plate-
bound CD3 and CD28 exposure overnight ) versus non-stimulated T cell 
migration across activated endothelium. 
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4.3.2. CD4+ T cell migration  
Unactivated CD4
+
 T cells from young and old subjects were incubated with activated 
HDMEC for 4 hours and video recordings of the culture wells were taken using 
phase-contrast visualisation and time-lapse microscopy. We found that CD4
+
 T cells 
from old subjects migrated more efficiently than those from young subjects across 
activated endothelium (Figure 4-5). 
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Figure 4-5: Comparison of young and old subject peripheral CD4
+
 T cell 
migration across dermal endothelial monolayer in vitro  
To evaluate the level of migration, CD4
+
 T cells isolated from young and old 
volunteers were plated onto confluent dermal endothelial monolayers for 4 hours 
at 37
o
C and 5%CO2. (n=at least 6 wells per experimental condition, n=3 young, 3 
old). The percentage total migration for old vs young CD4+T cells across 
stimulated endothelium was significantly different (Mann Whitney *P=0.02).  
Furthermore, this migration was blocked by the addition of anti-ICAM-1 and  anti-
VCAM-1 antibodies, (Figure 4-6) supporting the direct requirement for these 
molecules in the migration process (McHale et al., 1999). This confirmed that the 
defect in the accumulation of antigen-specific CD4
+
 T cells in the skin of old donors 
after antigen challenge was not due to alterations in the migration capacity of the T 
cells themselves. 
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Figure 4-6: Effect of adding blocking antibodies on CD4
+
 T lymphocyte 
migration. 
Graph showing effect of adding blocking antibodies on CD4
+
 lymphocyte 
migration to ICAM-1, VCAM-1 and E-selectin on total CD4
+
 lymphocyte 
migration across endothelial monolayers in vitro (n=3; at least 6 wells per 
experimental condition, Paired t test *P=0.04). 
4.4. Reduced expression of adhesion molecules by dermal endothelium during 
a DTH response in old subjects.  
Since we found no defect in the migratory capacity of and adhesion molecule 
expression of circulating T cells from old subjects compared to young we next 
hypothesised that the lack of T cell infiltration into the skin in these individuals was 
due to defective endothelial cell activation.  
The activation of dermal blood vessel endothelial cells induces expression of E-
selectin, ICAM-1 and VCAM-1, the ligands to CLA, LFA-1 and VLA-4 respectively 
on T cells (Berg et al., 1991; Berlin et al., 1995; Alon et al., 1995). The interaction of 
these molecules with their counter receptors is essential for the rolling, adhesion, and 
extra-vasation of the T cells from blood into the skin (von Andrian and Mackay, 
2000). Skin biopsies from day 3 post-candida skin test injections from young and old 
skin were stained for these adhesion molecules in conjunction with CD31 to 
highlight the dermal endothelial vessels (Newman, 1997). 
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4.4.1. E-selectin expression 
 
 
Figure 4-7: Dermal endothelium in old individuals shows reduced 
expression of adhesion molecule E-selectin. 
(a) Dermal endothelium in old individuals shows reduced expression of adhesion 
molecule E-selectin. Histological sections (6µm) from skin injected with candida 
(n=5 young, 6 old) at day 3 post injection were stained with antibody to CD31 to 
highlight dermal capillary loops and endothelial adhesion molecule E-selectin. 
Original magnification: x200. Double immunofluorescence staining of 
representative biopsies (young and old) shows CD31 (green) and E-selectin 
(red). Capillary loops expressing adhesion molecules appear yellow (merge). 
(b)Graph shows percentage of capillary loops expressing E-selectin at time-point 
0, 24hrs and Day 3 post candida skin injection; each symbol represents an 
individual and lines indicate the mean (* P=0.01 ** P=0.008, young vs old Mann 
Whitney test). 
E-selectin is not constitutively expressed on endothelium at Day 0 (Figure 4-7b) 
although expression was noted to increase at 24hrs post candida injection with 93% 
of dermal capillary loops expressing E-selectin in skin from young subjects. There 
was a significant reduction in the proportion of capillary loops that expressed E-
selectin in old skin at 24hrs (Figure 4-7b) and at day 3 (Mann Whitney P=0.008) 
(Figure 4-7a,b). Therefore the first crucial steps of tethering and rolling of the 
Chapter 4 
Page 92 
lymphocyte on dermal endothelium would be impaired in old skin not expressing E-
selectin post-candida injection and would explain the reduced number of T cells 
found in skin from old subjects injected with candida. 
4.4.2. VCAM-1 expression 
VCAM-1(CD106) is an endothelial adhesion molecule belonging to the 
immunoglobulin superfamily. This is absent on resting endothelial cells and its 
expression is induced by cytokines. It interacts with VLA-4, expressed by leucocytes 
to enable the steps of both tethering and rolling (although this is less efficient than 
the tethering and rolling mediated by the selectin group of adhesion molecules) and 
also arrest and firm binding of T cell to endothelium. Dermal endothelial cells from 
the site of injection in old subjects also showed significantly reduced VCAM-1 
expression at day 3 post Candida antigen injection compared to young controls 
(Mann Whitney P <0.015, Figure 4-8). 
 
Figure 4-8: Dermal endothelium in old individuals shows reduced 
expression of adhesion molecule VCAM-1. 
(a)Histological sections (6µm) from skin injected with candida (n=5 young, 6 
old) at day 3 post injection were stained with antibody to CD31 to highlight 
dermal capillary loops and endothelial adhesion molecule VCAM-1. Original 
magnification: x200.Representative staining of CD31 (green) and VCAM-1 (red) 
in young and old skin on day 3 following candida injection. (b)Graph shows 
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percentage of capillary loops expressing VCAM-1; each symbol represents an 
individual and lines indicate the mean (Mann Whitney *P=0.015, young vs old). 
4.4.3. ICAM-1 expression 
The expression of ICAM-1 was found on all dermal capillary loops throughout skin 
sections from old subjects but the intensity of staining was reduced in skin sections 
from 6 out of 6 old compared to young donors (Figure 4-9) as visualised 
independently by 2 investigators. The defective accumulation of dermal T cells 
during the response to recall antigen in the skin in old donors is therefore linked to 
the reduced expression of adhesion molecules that are essential for T cell migration 
on the endothelium of dermal vessels. 
 
Figure 4-9: Dermal endothelium in old individuals shows reduced 
expression of adhesion molecule ICAM-1. 
Histological sections (6µm) from skin injected with candida (n=5 young, 6 old) 
at day 3 post injection were stained with antibody to CD31 to highlight dermal 
capillary loops and endothelial adhesion molecule ICAM-1. Original 
magnification: x200. Double immunofluorescence staining of representative 
biopsies shows CD31 (green) and ICAM (red). 
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4.5. Endothelial activation using TNF-α and IFN-γ in young and old skin 
explant culture 
To determine if the reduction in endothelial adhesion molecule expression in the skin 
of old donors was caused by an intrinsic defect in the endothelium of these subject or 
due to a lack of activation by pro-inflammatory cytokines we obtained biopsies from 
normal young and old skin (n=3 young, 3 old) and incubated the tissue with medium 
containing TNF-α and IFN-γ or medium alone for 16 hours (Figure 4-10).  
We found that there was an increase in the intensity of E-selectin, ICAM-1 and 
VCAM-1 stains on the endothelium in the presence of TNF-α and IFN-γ in all the 
old and young subjects (as assessed independently by 2 investigators). A 
representative VCAM-1 staining profile is shown in Figure 4-10. Similar results 
were obtained for E-selectin and ICAM-1 (data not shown). This suggests old 
endothelium is able to express adhesion molecules in the presence of appropriate 
cytokines. We next investigated whether the number or surface area of capillary 
loops in the skin was reduced in the old. 
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Figure 4-10: Old endothelium can upregulate adhesion molecules in vitro. 
Young and old normal skin explants were cultured in RPMI+10% human serum 
or in RPMI+10% human serum supplemented with TNF-α (110,000 U/ml) and 
IFN-γ (100 U/ml) for 16 hours at 37ºC and 5% CO2. Histological sections from 
skin explants (n=3 young, 3 old) were stained with antibodies to CD31 and E-
selectin, ICAM-1 and VCAM-1. Representative VCAM-1 staining is shown for 
young (a,b) and old (c, d).  
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4.6. Surface area of endothelial cells in young and old dermis 
Structural changes that occur in the skin with ageing, including atrophy of the 
epidermis or dermal connective tissues might mean that the vascular network in 
elderly skin is also affected in terms of number of dermal capillary loops and total 
surface area of dermal endothelium across which T cell transmigration can occur. 
This could explain reduced transmigration of T cells into old skin during an immune 
response. Moreover the vascular endothelium is a source of numerous cytokines such 
as IL-1α and β, IL-6, IL-8, G and GM-CSF, gamma IP-10, IFN-γ, MCP-1,2, and 3, 
M-CSF, MIF, MIP-2, OSM, PDGF, and TNF-α  and reduced numbers or surface area 
of endothelial cells could also account for reduced inflammation seen in old skin. To 
explore this possibility, we counted CD31
+ 
endothelial loops in micrographs of 
young and old skin (n=4 young, 6 old). We found that there was no significant 
difference in the number of dermal endothelial loops (Figure 4-11). We then 
measured the total surface area of dermal endothelial CD31
+
 loops in young and old 
skin using a surface area measurement tool on Image J (NIH Image 6.1; 
http://rsb.info.nih.gov/nih-image). We found no significant difference in the surface 
area of young and old dermal endothelial networks. Therefore the endothelium 
shows no defect in function or surface area in old subjects compared to young. 
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Figure 4-11: Dermal CD31
+
 endothelial loop surface area and number is 
similar in young and old skin. 
(a) Graph shows numbers of CD31
+
 endothelial loops/ per micrograph (x100 
original magnification) of young and old skin at day 3 post-candida injection. 
Each symbol represents an individual and lines indicate the mean (n=4 young , 
n=6 old) (b) Graph shows total measured surface area of CD31
+
 endothelial 
loops in young and old skin section at day 3 post candida injection measured in 
mm
2
 using Image J software (micrographs x100 original magnification). Each 
symbol represents an individual and lines indicate the mean. 
4.7. Discussion 
In this chapter we have shown that old circulating memory T cells have all the 
migratory machinery required to effectively transmigrate across dermal endothelium. 
However there is much reduced expression of endothelial adhesion molecules, E-
selectin, VCAM-1 and ICAM-1 during a secondary cutaneous immune responses in 
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old subjects. We have shown that these molecules are essential for T cell 
transmigration as blocking them in in vitro migration assays leads to significantly 
reduced migration of both young and old T cells across dermal endothelial 
monolayers in vitro. The lack of endothelial activation in skin from old subjects 
therefore leads to decreased transmigration of T cells into skin in the older 
individuals. This might account for the decreased immune response of elderly skin to 
infection and skin cancer (Diffey and Langtry, 2005; Laube, 2004). 
Clark et al have recently (Clark et al., 2008) shown that in squamous cell carcinomas 
of the skin which are very common in the elderly and in immunosuppressed 
individuals, there is reduced local expression of E-selectin in blood vessels within 
and surrounding the tumour. Moreover the tumours contained few CLA
+
 T cells. 
This finding correlates with our observation of reduced expression of endothelial 
adhesion molecules in elderly individuals during the course of a secondary cutaneous 
immune response in the skin and also shows that problems with T cell migration into 
skin lead to cutaneous immunosuppression and consequent pathology. 
The density of superficial capillary loops decreases with age in association with 
atrophy of the superficial dermis, however overall blood flux has been shown to 
increase with an expansion of the parallel vasculature in the deeper dermis (Kelly et 
al., 1995; Li et al., 2006). In one study, old individuals (60-74 years) were found to 
have a 66% reduction in capillary density on the volar (photoexposed) aspect of the 
forearm compared to a young cohort (Li et al., 2006). Similar findings have been 
demonstrated in mice (Vollmar et al., 2000). In our hands however we found no 
difference in the number or surface area of dermal endothelial loops between young 
and old skin sections (Figure 4-11). We also found no difference in the number of 
perivascular infiltrates in young and old skin tissue (data not shown, Dr Katie Lacy 
thesis). Our study uses only skin tissue from the same non-photoexposed skin site in 
both young and old cohorts. The changes others have noticed between young and old 
skin vasculature density might be attributed to different anatomical sites studied for 
young and old and also failing to factor in different degrees of photoexposure for the 
individuals and sites studied (Chung et al., 2002; Toyoda et al., 2001).  
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Some authors suggest endothelial dysfunction with ageing. Ageing has been shown 
to result in a decreased expression of eNOS, the constitutive isoform of nitric oxide 
(NO) synthetase, responsible for endothelium derived NO synthesis (Matsushita et 
al., 2001). NO is thought to be a potent inhibitor of cellular adhesion, in particular 
monocytes and leukocytes, by the inhibition of the expression of adhesion molecules 
such as VCAM-1(Peng et al., 1998). A reduction in endothelial nitric oxide 
production in the old has been proposed as a possible mechanism for development of 
atherosclerosis (Matsushita et al., 2001). However, we have shown that endothelium 
in skin explants from old subjects is capable of upregulating expression of adhesion 
molecules to a similar extent as the young if exposed to TNF-α and IFN- γ in vitro . 
The concentration of TNF-α and IFN- γ used in the skin explants culture experiment 
were the same ones used to stimulate HDMEC in vitro. This is considerably higher 
than physiological concentrations of these cytokines during secondary cutaneous 
memory immune responses (see Chapter 5) and one might argue that if skin explants 
from old individuals are exposed to lower concentrations of TNF-α and IFN-γ they 
might not upregulate endothelial adhesion molecules to a similar extent as in the 
young. It is unlikely that lower doses would have caused perceptible upregulation of 
adhesion molecule expression as the in vitro concentrations of cytokines used, reflect 
careful titrations adopted in the case of HDMEC stimulation in vitro. Therefore 
because skin biopsies are thicker than HDMEC monolayers it is unlikely that lower 
rather than higher cytokine concentrations would be required. Also the situation in 
vivo is different to in vitro and one cannot extrapolate too much between the two, for 
example in vivo one finds a complex network of interacting cytokines as opposed to 
the two cytokines tested here so that one cannot acheive the in vivo settings in vitro. 
Also each 5 mm skin punch biopsy obtained from volunteers was bisected and the 
two halves placed in control/experimental solution containing cytokines and due to 
the small size of the biopsy there is no tissue left over to carry out titrations of the 
cytokine concentration in the media.  
The clinical importance of leucocyte-endothelial adhesion cascade is demonstrated 
by the leucocyte adhesion deficiency syndrome, a genetic defect either in β2 
integrins (type 1) or in selectin ligands (type 2) where neutrophils cannot stop or roll, 
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respectively. As a consequence recurrent infections, particularly of the skin, is seen 
(Etzioni et al., 1992). Blocking T cell migration into skin has also been used 
therapeutically to control skin diseases such as psoriasis, which is associated with 
increased T cell migration into the dermis and epidermis. Efaluzimab, which blocks 
CD11a from interacting with ICAM-1 is widely used in dermatological practice to 
treat psoriasis (Papp et al., 2001).It was shown to decrease numbers of epidermal and 
dermal T cells (Gottlieb et al., 2000). Similarly lack of endothelial adhesion molecule 
expression in old individuals may predispose ageing skin to decreased cutaneous 
immunosurveillance by T cells. 
Therefore we have shown that T cell migration into cutaneous secondary memory 
immune responses in old subjects is impaired due to lack of expression of endothelial 
adhesion molecules. Moreover we have shown that the old endothelium per se is not 
defective but that the defect arises due to a lack of adequate activating signals within 
the skin microenvironment in old individuals. In the next two chapters we explore 
the mechanism of this defective skin conditioning in the old. 
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Chapter 5. The innate immunity and its effects on 
secondary memory cutaneous immune 
responses in ageing skin 
5.1. Introduction 
Secondary cutaneous immune responses are antigen specific, such that if an 
individual was never exposed to candida antigen before re-challenge with the 
candida skin test, a T cell infiltrate does not develop at the site of skin injection with 
antigen. However if an individual had been exposed to candida antigen in the past 
one would expect that the presence of antigen specific cells in their circulation would 
ensure the development of a secondary cutaneous immune response upon antigen 
injection in the skin. Therefore in the traditional model of secondary immunity the 
presence of functional antigen specific cells per se would seem to be enough for the 
generation of a secondary response to that particular antigen. We have shown 
however that although the majority of old individuals retain normal functional 
activity in their candida antigen specific memory T cell compartment in the blood, 
they are unable to develop a secondary response to candida at the site of antigen 
injection in the skin. We have also shown in Chapter 4 that there is inadequate 
endothelial activation in old skin during a secondary cutaneous immune response. In 
this case, it is possible that despite the adaptive arm of the immune system in the old 
being capable of effectively responding to antigen, in the absence of pro-
inflammatory cytokine release within skin tissue, which we have shown is necessary 
for effective endothelial activation, there is no activation of the endothelium and 
memory T cells are unable to transmigrate into the site of antigen injection to 
generate an immune response. 
TNF-α is essential for endothelial activation. It has been shown to upregulate 
expression of E-selectin, ICAM-1 and VCAM-1 40-80 fold on dermal microvascular 
endothelium in vitro (Johnson et al., 2006) and this has also been demonstrated in in 
vivo models of delayed type hypersensitivity in mice (McHale et al., 1999). Both 
IFN-γ and IL-6 have also been shown to upregulate adhesion molecule expression. 
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(Swerlick et al., 1992; Wung et al., 2005). We therefore hypothesised that there 
might be reduced levels of pro-inflammatory cytokines necessary for endothelial 
activation in skin from old subjects compared to young. 
The macrophage is crucial for early pro-inflammatory cytokine production, including 
TNF-α, during a secondary memory cutaneous immune response. Macrophages 
initiate an effective immune response against microbes by recognising pathogen-
associated molecular patterns (PAMPs) through pattern-recognition receptors (PRPs) 
(Taylor et al 2005 901-944) such as TLRs. They are phagocytes and can kill most 
micro-organisms. By producing TNF-α and presenting antigens to T cells (Pozzi LA, 
2071-2081), both macrophages and DCs induce the adaptive immune response 
leading to the expansion and differentiation of lymphocytes specific for invaders. We 
hypothesised therefore that there might be a defect in the number or function of 
macrophages and dendritic cells found in skin from old subjects. 
5.2. Early inflammatory cytokine levels during cutaneous secondary memory 
immune responses 
We measured the concentration of TNF-α, IFN-γ, IL-6 and IL-10 in blister fluid 
aspirated from blisters induced at Day 3 over the site of Candin injection (n=6 young, 
n=11 old). The cytokine concentrations were calculated using the BD
TM
 Cytometric 
Bead Array (CBA) Cell Signalling Flex Set System (Figure 5-1). A significant 
reduction in the concentration of TNF-α, IFN-γ and IL-6 was found in the old 
following Candin injection compared with the young. Concentrations of IL-10 did 
not differ between young and old suggesting that the lack of inflammation in the old 
is not due to overproduction of the inhibitory cytokine IL-10. The observed 
differences in pro-inflammatory cytokine levels could also be due to the fact that old 
skin blisters more easily and therefore generates less trauma and cytokine release. 
However in parallel control experiments (performed in our group by Dr Katie Lacy), 
using saline injection in the young and old (n=3 both groups), lower levels of TNF-α 
were found in blister fluid from both old and young subjects after saline injection 
compared to injection of Candin, indicating that TNF-α production was induced by 
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the injection of antigen rather than by trauma alone. Therefore there is a true 
difference in pro-inflammatory cytokine levels in blister fluid post-candida injection 
in young and old skin. 
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Figure 5-1: Early pro-inflammatory cytokines are reduced in old skin 
blisters. 
Skin suction blisters were raised over the site of Candida antigen injection at day 
3 (n=10 old, 6 young). Levels of TNF-α, IFN-γ, IL-10 and IL-6 were measured 
in the blister fluid using cytometric bead array. The assay was kindly performed 
by Dr John Curnow, University of Birmingham. The graph shows the mean  
SEM of 6 experiments for Young and 10 experiments for old. A significant 
reduction in the level of TNF-α (Mann Whitney *P=0.01), IL-6 (Mann Whitney 
*P=0.03) and IFN-γ (Mann Whitney *P=0.01) was noted in the old group 
compared with the young. The level of IL-10 was not altered. 
5.3. Distribution of TNF-α expression in skin tissue 
In order to confirm the above findings and also to establish whether TNF-α was 
mainly being produced in the epidermis (suggesting a keratinocyte origin) or dermis 
(suggesting T lymphocyte or monocyte derived cell origin) we carried out 
immunohistochemical staining of young and old skin sections for TNF-α. Normal 
skin sections (n=3 young, 3 old), 24 hour (n=3 young, 3 old) and day 3(n=3 young, 3 
old) candida injected skin were stained using an indirect immunoperoxidase 
technique for TNF-α. There was pronounced TNF-α staining in the 24 hour and day 
3 candida young skin sections but none in the old (Figure 5-2). Moreover the 
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keratinocytes did not seem to be expressing TNF-α in that all the TNF-α staining was 
limited to the dermis. 
 
Figure 5-2: Lack of TNF- α expression in old skin compared to young. 
TNF-α producing cells present in biopsies taken on day 3 following candida 
injection were identified using an indirect immunoperoxidase technique.The 
staining signal was developed using chromogen 3-amino-9-ethylcarbazole 
(Sigma-Aldrich). The TNF-α producing cells were limited to the dermis. Insert 
shows high power magnification of TNF-α positive cells in a perivascular 
cluster. Representative photomicrographs from 1 out of 5 experiments for young 
and old at 24 hours and day 3 post-candida injection are shown. Scale bar: 
100µm. 
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5.4. Numbers of macrophages and dendritic cells in young and old skin by 
immunohistochemistry 
Previous studies have shown that skin macrophages and DCs are mainly responsible 
for TNF-α and IL-6 secretion after cutaneous challenge with recall antigens while 
IFN-γ is secreted mainly by T lymphocytes (Chu et al., 1992). We have already 
shown (Chapter 3) that numbers of T lymphocytes are reduced in old skin and this 
might explain the lack of IFN-γ. We next wanted to assess if there was a reduction in 
numbers of macrophages or DCs to explain the observed decreased levels TNF-α, 
IFN-γ and IL-6. Many of the DC and macrophage markers overlap (Zaba et al., 
2007). A recent study by Zaba et al has shown however that CD163 can be used to 
selectively stain for macrophages whilst CD11c is a good selective marker for DCs 
(Zaba et al., 2007). 
We carried out single immunohistochemical staining for CD163 in normal, 24hour 
and day 3 post-Candin injection skin sections (n=5 young, 5 old at each time point 
studied) (Figure 5-3). There were similar numbers of CD163
+
 cells in skin from 
young and old subjects at all time-points tested. There was a trend for a higher 
number of CD163
+
 cells in skin sections from old subjects compared to the young. 
Single immunohistochemical staining for CD11c in normal, 24 hour and day 3 post-
candida antigen skin test injection skin sections showed similar numbers in young 
and old skin at all time-points (Figure 5-4). 
It is interesting to observe the differences in anatomical distribution of CD163
+ 
macrophages and CD11c
+
 DCs. Macrophages were noted to be predominantly 
interstitial and present throughout the dermis at all time-points. CD11c
+
 DCs are 
found in the upper dermis in normal skin, at the junction between reticular and 
papillary dermis. At 24 hours and Day 3 post-candida skin test injection they are 
found in perivascular clusters throughout the dermis (Figure 5-4A) in a similar 
distribution to that seen for T cells (Chapter 3). This is ideal for cross-talk with 
infiltrating T cells to occur. The CD163
+ 
macrophages form an outer border of cells 
surrounding the immediate perivascular clusters of cells (Figure 5-5A). 
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Figure 5-3: Similar number of CD163
+
 macrophages in skin from young and 
old subjects. 
(a)The number of dermal CD163
+
 cells was determined by indirect 
immunoperoxidase staining of 6μm tissue sections. The staining signal was 
developed using chromagen 3-amino-9-ethylcarbazole (Sigma-Aldrich). 
Representative day 0, 24 hours and day 3 sections from young and old volunteers 
are shown. (b) Graph shows mean number of CD163
+
 macrophages per mm at all 
time points (n=5-7 per timepoint young and old, mean± SEM are plotted). Scale 
bar: 100µm. 
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Figure 5-4: Similar number of CD11c
+
 dendritic cells in skin from young 
and old subjects. 
(A)The number of dermal CD11c
+
 cells was determined by indirect 
immunoperoxidase staining of 6μm tissue sections. The staining signal was 
developed using chromogen 3-amino-9-ethylcarbazole (Sigma-Aldrich). 
Representative day 0, 24 hours and day 3 sections from young and old volunteers 
are shown. (B) Graph shows mean number of CD11c
+
 dendritic cells at all time 
points (n=5-7 per timepoint young and old, mean± SEM are plotted). 
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5.5. TNF-α expression by monocyte derived cells by immunohistochemical 
analysis of skin tissue 
Having established that there were similar numbers of macrophages and DCs in 
young and old skin we hypothesised that there might be a defect in the production of 
TNF-α by either or both of these cell types during the secondary memory cutaneous 
response to candida injection. We therefore carried out double immunofluorescence 
staining for TNF-α and CD163 or CD11c (Figure 5-5 and Figure 5-6) on skin 
sections at 24hours and day 3 post-candida injection. Grey level images of single 
stains were obtained to improve optical resolution with the naked eye. Isotype 
control staining was carried out on young skin tissue injected with candida skin test 
antigen and at the same timepoint as experimental tissue and is shown for 
comparison with TNF-α staining. The double positive cells were clearly discernible 
and were counted using the manual count function on Adobe Photoshop CS3 (San 
Jose, California) in each perivascular infiltate and were plotted as a percentage of 
total CD163
+
 cells in the infiltrate (see graph Figure 5-5b). This showed significantly 
reduced proportions of CD163
+
TNF-α+ double positive cells in the old. The isotype 
control shows some background perivascular infiltrate autofluorescence in the green 
channel, which is also the TNF-α FITC channel (Figure 5-5a, greyscale images 
bottom panel). This does not affect the interpretation of the CD163
+
TNF-α + double 
positive staining cells as these cells are found on the periphery of the main 
perivascular infiltrate (Figure 5-5a, greyscale images left panel and merge panel). 
However in the case of CD11c
+
 cells which are part of the perivascular infiltrate 
(Figure 5-6, greyscale images left panel and merge panel), it is less clear if the 
perivascular cells are producing TNF-α or if there is autofluorescence as the intensity 
of greyscale staining of these cells appears the same both for isotype (Figure 5-6, 
greyscale images, bottom panel) and experimental TNF-α staining. It is therefore not 
possible to say if the CD11c
+ 
cells in both young and old subjects are producing 
TNF-α. The images were carefully obtained using the same exposure times when 
acquiring isotype, young and old images. The results were confirmed by two 
independent investigators. Therefore CD163
+
 macrophages in situ in old skin fail to 
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express TNF-α both at early time-points (24hrs) and at the peak of the response (Day 
3) to candida antigen injected intradermally. 
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Figure 5-5: TNF-α expression is reduced in CD163
+
 macrophages in old skin 
(a)Double immunofluorescence staining of representative biopsies from day 3 
following candida injection shows  perivascular infiltrate staining for TNF 
(middle panel grey level images, tinted green in merge) and CD163 (left panel 
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grey level images and tinted red in merge). The bottom panel shows staining with 
an isotype control. Original magnification x20. (b) Graph shows mean 
percentage of CD163+ macrophages producing TNF- per perivascular infiltrate 
(n= 3 young, y old). 
 
Figure 5-6: Perivascular cell cluster autofluorescence obscures detection of 
possible TNFexpression by CD11c
+
 cells. 
Double immunofluorescence staining of representative biopsies from day 3 
following candida injection for CD11c (left panel grey level images, tinted red in 
merge) and TNF (middle panel black and grey level images white, tinted 
green in merge) CD11c
+
 DCs are located perivascularly in the dermis. 
Perivascular cells autofluoresce in the green channel as seen in the isotype 
control (bottom panel grey level images). Original magnification x20.  
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5.6. Dermal macrophages from old individuals can be induced to secrete 
TNF-α in vitro  
The lack of TNF-α secretion by macrophages in old subjects could have been due to 
lack of activating signals for these cells in the aged skin microenvironment following 
antigen injection, or to a generalised defect in macrophage activation in old 
individuals per se. To clarify this, we investigated the capacity of macrophages that 
were isolated from the skin of old and young subjects 48 hrs after injection with 
candida, to secrete TNF-α upon challenge with the TLR 1/2 ligands Pam3CSK4 and 
Candida or a TLR-4 ligand  lipopolysaccharide (LPS) in vitro. Peripheral blood 
monocytes were examined in parallel. Peripheral blood CD14
+
 monocytes and 
cutaneous macrophages from both young and old donors secreted significantly more 
TNF- in response to LPS, Pam3CSK4 and Candida compared to unstimulated 
controls in vitro (Figure 5-7a). This was also true when we stimulated peripheral 
blood monocytes with a lower concentration of LPS (5ng/ml vs 100ng/ml;Figure 
5-7b). However, in contrast to the low TNF- production of old macrophages in 
vivo, cutaneous macrophages from old and young subjects secreted similar levels of 
TNF-in response to LPS, Pam3CSK4 stimulation in vitro (Figure 5-7c). Thus once 
removed from the skin environment macrophages can synthesize TNF- suggesting 
that the cutaneous immune defect in old individuals may be reversible. 
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Figure 5-7: Macrophages 
isolated from the skin of old 
donors secrete TNF-α in 
response to TLR signals in vitro. 
Cells removed from skin suction 
blisters 48 hours after candida 
injection were stimulated with LPS 
(100ng/ml; Sigma), Pam3CSK4 
(1µg/ml), Candida 10µg/ml) or 
medium as a control for 4hrs in the 
presence of Golgi Stop and then 
stained for CD14, CD163 and 
TNF-α. PBMC were stimulated in 
parallel. (a) Graph shows 
percentage of TNF-α-secreting 
CD14
+
 cells following in vitro 
stimulation of PBMC with LPS, 
Pam3CSK4 and Candida( n=11 
young and old for LPS; n=6young, 
n=7 old for Pam3CSK4; n=7 
young, 7 old for Candida). (b) 
Graph shows percentage of CD14
+
 
cells producing TNF-α following 
in vitro stimulation of blister cells 
with LPS, Pam3CSK4 and 
Candida(n= 6 young, n=7 old for 
LPS; n=3 young and n=4 for old 
for Pam3CSK4; n=3 young, 3 old 
for Candida). (c) Graph shows 
percentage of TNF-α-secreting 
CD14+ cells following in vitro 
stimulation of PBMC with LPS 
5ng/ml or 100ng/ml. 
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5.7. Monocyte and DC transmigration into skin  
Although T cell numbers are decreased after antigen challenge, macrophages 
identified by CD163 (this study) or CD68 and CD14 (unpublished observations, Dr 
Katie Lacy PhD thesis) are present in equal numbers in young and old skin. It has 
been shown that DC-SIGN/ICAM-2 interaction mediates dendritic cell trafficking 
(Geijtenbeek et al., 2000) and DC-SIGN is strongly expressed on CD163
+
 
macrophages in both normal and inflamed skin (Zaba et al., 2007). ICAM-2 is 
constitutively expressed on endothelial cells and in contrast to E-selectin, VCAM-1 
and ICAM-1, its expression is not dependent on the presence of TNF-α. (Silverman 
et al., 2001). We hypothesised that macrophages and DCs in young and old skin 
expressed similar levels of DC-SIGN and this is the way by which these cells enter 
the skin through the endothelium. 
5.7.1. DC-SIGN expression on monocytes and DCs 
We obtained young and old skin sections from biopsies of skin injected with candida 
as before and carried out double immunofluorescence staining for CD163 or CD11c 
and DC-SIGN (Figure 5-8). DC-SIGN was equally expressed on CD163
+
 cells in 
skin from young and old subjects at day 3 post candida injection (Figure 5-8a). 
CD11c
+
 DCs co-expressed DC-SIGN to a lesser degree than the CD163
+ 
macrophages, though the pattern of staining was similar for young and old skin 
sections examined (Figure 5-8b). 
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Figure 5-8: DC-SIGN expression by CD163
+
 macrophages and CD11c
+
 
dendritic cells in skin not altered in old subjects. 
Double immunofluorescence staining of representative biopsies from day 3 
following candida injection shows merged image for (a) CD163
+ 
(red) and DC-
SIGN
+
(green) and (b) CD11c
+ 
(red) and DC-SIGN
+
(green). Co-expression of 
DC-SIGN is reduced for CD11c
+
 compared to CD163
+
 cells. Representative 
experiments of n=3 young, 3 old experiments shown) 
5.7.2. TLR activation leads to upregulation of DC-SIGN expression by 
peripheral monocytes and DCs  
Lymphocytes express CLA which binds E-selectin on the dermal endothelium and 
leads to transmigration. CLA has also been shown to be important for monocyte 
transmigration into skin. However notwithstanding reduced E-selectin expression on 
dermal microvascular endothelium in old skin we have shown similar numbers of 
macrophages and DCs in young and old skin sections. Monocytes differentiate into 
macrophages and also give rise to inflammatory DCs when transmigrating into 
tissues and following TLR activation (Krutzik et al., 2005; Auffray et al., 2009). We 
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therefore hypothesised that in view of reduced E-selectin expression in old skin, 
monocytes and monocyte-derived cells use an alternative pathway to transmigrate 
into skin and therefore upregulate DC-SIGN in preference to CLA. We obtained 
PBMC from 3 young and 3 old volunteers and carried out staining for CLA, DC-
SIGN, CD14 and CD11c directly ex-vivo and after 24 and 72 hrs of TLR stimulation 
with LPS (TLR4), Pam3CSK4 (TLR2/1) and Candida (TLR2/4). The monocytes were 
identified by their typical scatter characteristics on the forward side scatter. They 
expressed higher levels of CD14 compared to dendritic cells (Figure 5-9). 
 
Figure 5-9: TLR stimulation with LPS upregulates DC-SIGN but not CLA 
expression on circulating monocytes from young and old subjects in vitro. 
PBMC‟s were obtained from n=3 young, 3 old and activated with TLR ligands 
for 24 and 72hrs and labeled with specific antibodies. R1, monocytes gated based 
on large cell size (FSC) and high side scatter (SSC), R4, CD14 and CD11c 
double positive cells. DC-SIGN vs CLA expression (R1+R4) for young vs old 
and LPS activated vs unactivated monocytes.  
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We found a significant increase in the proportion of CD14
+
 cells expressing DC-
SIGN post 72 hrs activation with all TLR ligands tested compared to control. The 
proportion of CD14
+
CLA
+
 monocytes was not significantly different after TLR 
activation compared to control (Figure 5-10a/b). CLA expression has also been 
observed to decrease on PBMCs in culture medium and this might also partly 
account for the gradual reduction in its expression from that on blood monocytes and 
DCs directly ex-vivo (Figure 5-10, Figure 5-11 and Figure 5-12). These results 
suggest a selective upregulation of DC-SIGN as opposed to CLA upregulation after 
TLR activation and imply that monocytes are able to infiltrate skin in old subjects 
equally well because they are using the DC-SIGN-ICAM2 interaction for migration.  
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Figure 5-10: Monocytes from young and old subjects upregulate DC-SIGN 
and CLA expression similarly upon TLR stimulation 
 a)Young and old monocytes upregulate DC-SIGN after 72hrs of TLR (LPS) 
stimulation. b) TLR stimulation using TLR4 (LPS), TLR2/1(Pam3CSK4 and 
Candida) leads to significant DC-SIGN upregulation compared to medium alone 
but no significant CLA upregulation at 72hrs. Data are shown as the mean+SEM 
of 6 independent experiments. 
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Figure 5-11: Old circulating myeloid DCs show reduced upregulation of DC-
SIGN on TLR stimulation. 
PBMC‟s were obtained from n=3young, 3 old and activated with TLR ligands 
for 24 and 72hrs and labeled with specific antibodies. R1, monocytes gated based 
on large cell size (FSC) and high side scatter (SSC), R5, CD14-negative and 
CD11c positive cells. DC-SIGN vs CLA expression (R1+R5) for young vs old 
and LPS activated vs unactivated monocytes.  
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Figure 5-12: Old peripheral blood DCs show reduced capacity to upregulate 
DC-SIGN expression after 72 hours of LPS stimulation in vitro. 
Similar data was obtained with Candida and Pam3CSK4 stimulation (not 
shown). Circulating myeloid DCs show high CLA expression at 0hrs (22% mean 
in young) compared to monocytes (2% mean in young as shown in Fig. 5.10). 
5.8. Discussion 
In this chapter we have used the candida antigen skin test model to investigate the 
mechanism for reduced endothelial activation and T cell infiltration in old skin. A 
secondary immune response relies on cells of the innate immune system working in a 
direct way to contain invading microbes and in an indirect way, through cytokine 
release, to induce adaptive T cell responses. We have shown in chapter 4 that skin 
endothelium requires TNF-α and IFN-γ for activation. Using immunohistology and 
cytokine analysis of blister fluid from the candida skin model we were able to 
determine that old skin lacks expression of TNF-α and IFN-γ early on post antigen 
injection, suggesting a possible defect in innate immunity in ageing skin.  
A previous study using the mantoux test as a skin model in healthy young individuals 
showed that TNF-α is detectable at 6 hours and peaks at 72 hours post antigen 
injection. CD68
+
 cells were found to be the main cell type expressing TNF-α during 
Chapter 5 
Page 119 
the mantoux reaction (Chu et al., 1992). CD68 is expressed by both macrophages and 
DCs in healthy skin (Zaba et al., 2007). We therefore hypothesised that the lack of 
TNF-α in old skin might be caused by either a reduced number of macrophages 
and/or DCs in old skin or by defective functioning of these cells.  
Based on recent characterisation of novel phenotypic markers for cutaneous 
macrophages and DCs (Zaba et al., 2007) we used CD163 to identify macrophages 
and CD11c to distinguish DCs. Single staining for these markers on skin sections 
from normal or candida injected young and old skin showed similar numbers of both 
macrophages and dendritic cells. The discrepancy between the obviously reduced 
numbers of T cells found in old skin as opposed to the normal numbers of 
macrophages and dendritic cells is likely due to the different trafficking 
requirements. It has been shown that DC-SIGN-ICAM-2 interaction mediates 
dendritic cell trafficking (Geijtenbeek et al., 2000) and DC-SIGN is strongly 
expressed on CD163
+
 macrophages in both normal and inflamed skin (Zaba et al., 
2007) ICAM-2 is constitutively expressed on endothelial cells and in contrast to E-
selectin, VCAM-1 and ICAM-1, its expression is not dependent on the presence of 
TNF-α (Silverman et al., 2001). The DC-SIGN-ICAM-2 interaction accounts for 
41% of transendothelial migration of DCs across mouse endothelium in the steady 
state. It was also shown that blocking of CD18 (β2 integrins) had no effect on 
transendothelial migration of DCs (Wethmar et al., 2006). Therefore in the absence 
of TNF-α to upregulate the expression of selectins and integrin adhesion molecules 
on the endothelium, DCs and macrophages can still migrate into the skin, and this 
explains why similar numbers of these innate immune cells are present in young and 
old skin. Furthermore we show, using extracellular staining for DC-SIGN and CLA 
on circulating monocytes in young and old subjects that macrophages and DCs 
upregulate DC-SIGN in preference to CLA when they are stimulated with TLR 
ligands including LPS, Pam3CSK4 and Candida antigen in vitro. Therefore we have 
shown that despite an equal number of innate immune cells in young and old skin, 
there is reduced TNF-α expression in old skin during a secondary memory cutaneous 
immune response to candida injection. We therefore next investigated if there could 
be a defect in cutaneous macrophage or DC function. 
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Studies carried out in mice have shown that when alveolar macrophages from old 
mice are stimulated in vitro with LPS they are unable to upregulate the expression of 
cyto-protective enzymes such as hemeoxygenase-1 (Ito et al., 2009). Another study 
showed reduced production of TNF-α by macrophages from old mice following 
candida antigen stimulation in vitro (Murciano et al., 2006). Studies on monocytes 
from whole blood have shown reduced production of TNF-α after stimulation with 
LPS in old humans (Gon et al., 1996) and mice (Effros et al., 1991). In this study we 
sought to characterise macrophage and DC function both in vivo by looking at TNF-
α in situ expression by these cells in young and old skin sections and in vitro by 
directly activating  macrophages derived from young and old skin with TLR agonists 
and assessing TNF-α production. We found that in vivo expression of TNF-α was 
drastically reduced in CD163
+
 macrophages in skin from old subjects injected with 
candida. However once these cells were removed from the skin environment and 
stimulated with LPS, Pam3CSK4 and Candida antigen in vitro both old and young 
macrophages were able to produce TNF-α to a similar extent. 
An important unanswered question is why macrophages in the old skin are not 
triggered to secrete TNF-α. Previous studies have shown that there is an age 
associated defect in human TLR1 and 2 function that results in a significant defect in 
TNF-α secretion after ligation of these receptors (van Duin et al., 2007). Since 
candida activates TLR1 and 2, this may explain the cutaneous defect in macrophage-
derived TNF-α that we have observed. It has also been shown that there is a defect in 
TLR4 function and expression and function during ageing (Renshaw et al., 2002; van 
den Biggelaar et al., 2004) although this has not been confirmed in other studies (van 
Duin et al., 2007). However, we found that both peripheral blood monocytes and 
isolated cutaneous macrophages from donors of both age groups synthesized similar 
levels of TNF-after TLR 1/2 and TLR-4 stimulation in vitro. We conclude 
therefore that macrophages in old humans are not inherently defective in terms of 
TNF-synthesis but do not rule the possibility that other functions in these cells may 
be altered during ageing. 
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TNF-α has also been shown to upregulate expression of endothelial adhesion 
molecules on cutaneous lymphatics in mouse models and that this is an essential step 
to enable DC migration to lymph nodes (Johnson et al., 2006). This would mean that 
TNF-α is required very early on in the development of a secondary immune response 
to start the process of antigen presentation to T cells in the lymph node. 
Another factor to consider is the lack of IFN-γ in the skin of old subjects injected 
intradermally with candida. For macrophages to become activated and fully 
functional, these cells must also interact with cytokines such as IFN-γ in addition to 
TLR ligands. Previous studies have shown that IFN-γ is mainly secreted by T cells 
during DTH responses (Chu et al., 1992). The lack of IFN- γ in the skin in our 
studies may reflect the decreased infiltration of T cells into the site of antigen 
challenge. Activation by IFN-γ leads to the expression of several genes that regulate 
macrophage biology including expression of MHC Class II genes (Celada et al., 
1989; Cullell-Young et al., 2001; Gonalons et al., 1998), which are crucial for 
presenting antigens to T lymphocytes. It has been shown that mice deficient in IFN-γ  
receptor show profoundly altered responses to LPS suggesting that IFN- γ has an 
important role in making macrophages more responsive to LPS (Kamijo et al., 1993). 
It is possible that the lack of T cell signals such as IFN-γ early in the DTH response 
in old subjects may prevent the cascade of events required for its amplification. 
Alternatively, macrophages in the skin of old individuals may become modified 
through the interaction with other resident cells, such as regulatory T cells that have 
been shown to inhibit their capacity to synthesize TNF-(Tiemessen et al., 2007). 
Both of these hypotheses require further investigation. 
In conclusion we have shown for the first time a defect in a key innate immune 
pathway of the delayed type hypersensitivity response in old skin. This is the first 
study to show that lack of TNF-α production by CD163+ macrophages within old 
skin leads to impaired cutaneous secondary immune responses to antigen with 
ageing. The observation that Imiquimod, a TLR7 agonist which is applied topically 
is useful in the treatment of non-melanoma skin cancer in the elderly, and infections 
such as viral warts (Beutner et al., 1999) further suggests a possible role of the innate 
Chapter 5 
Page 122 
immune system in the mechanism of sub-optimal secondary cutaneous immunity in 
this age group. Similarly this study highlights the need for novel immunotherapeutic 
agents for preventing/treating skin cancer and infections, aimed at improving pro-
inflammatory cytokine secretion by macrophages within old skin.  
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Chapter 6. Regulatory T cells and their role in secondary 
cutaneous immune responses 
6.1. Introduction 
In the previous chapter we have shown that cutaneous CD163
+
 macrophages fail to 
express TNF-α in situ during a secondary cutaneous immune response in old 
subjects. However they are capable of TNF-α synthesis and release when exposed to 
TLR agonists in vitro. Therefore we hypothesised that a factor in the skin 
microenvironment in old subjects is contributing to altered macrophage function. We 
know that CD4
+
CD25
+
Foxp3
+
 regulatory T cells (Tregs) have suppressive effects on 
the adaptive immune system and on CD4
+
 cells in particular (Sakaguchi, 2005; 
Shevach et al., 2006). It has also recently been shown that CD4
+
CD25
+
FoxP3
+
 Tregs 
are able to directly promote the alternative activation of monocytes/macrophages 
(Tiemessen et al., 2007). We hypothesised therefore that Tregs might play a role in 
old skin immunosuppression by suppressing/altering dermal macrophage function in 
old individuals. 
Little is known about the kinetics of Treg accumulation during the cutaneous delayed 
type hypersensitivity response. Our group has previously characterised the clinical 
and histological characteristics of the CD4
+
 T cell response to the Mantoux test (MT) 
in young skin (Reed et al., 2004; Orteu et al., 1998). We demonstrated that the 
histological response to the MT is characterised by dermal perivascular infiltrates 
consisting of predominantly CD4
+
 T cells which peak in T cell number at day 7 post-
injection of the MT. We also show that the peak of antigen-specific CD4
+
 IFN-γ + T 
cells in the MT occurs at Day 7 with a median of 30% CD4
+
IFN- γ + T cells present 
in suction blisters. The peak of the clinical response occurs at day 3 post injection of 
antigen (Reed et al., 2004). Most studies on CD4
+
CD25
hi
Foxp3
+
 T cells in humans 
have been performed using peripheral blood populations and apart from a few 
notable exceptions (Ruprecht et al., 2005; van Amelsfort et al., 2004; Uhlig et al., 
2006; Miyara et al., 2006) there is very little data on the behaviour of these cells at 
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sites of immune responses in vivo. In mice vaccinated with BCG and then infected 
with Mycobacterium tuberculosis by the aerosol route, it was shown that there is an 
increase in the size of the Treg compartment in lung tissue which is in proportion to 
the increase in other T lymphocyte subsets (Jaron et al., 2008). In order to determine 
whether Tregs are involved in the alteration of function of macrophages in skin from 
old subjects it was necessary to first fully characterise their presence, function and 
numbers during a secondary memory cutaneous immune response in humans in vivo. 
6.2. Accumulation of CD4+ Foxp3+ T cells during a secondary response to 
antigen in vivo 
 
Figure 6-1: Treg gating and phenotype. 
PBMCs were stained with CD4, CD25, CD127 and Foxp3 as described. Subsets 
are defined by the expression of CD25 as CD25-, CD25
int
 and CD25
hi
. 
Expression of Foxp3 and CD127 by each subset is shown in the histograms. 
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Tregs are identified by expression of CD4, high expression of Foxp3 and CD25 and 
low expression of CD127. Figure 6-1 shows the gating strategy we used based on 
these three markers to distinguish nTregs from other CD4
+
 T cells. 
 
Figure 6-2: Human CD4
+
CD25
hi
 regulatory cells turnover rapidly in vivo. 
Freshly isolated PBMC from healthy individuals were stained for 
CD4/CD25/CD127/Foxp3 and Ki67 following the standard protocol. Regulatory 
T cells were identified as CD25
hi
, Foxp3
+
 and CD127
lo
 as in Figure 1). (A) Dot 
plots show expression of Ki67 on CD4
+
CD25
hi
, CD4
+
CD25
int
 and CD4
+
CD25
-
 
cells from a representative sample. Numbers denote the percentage of cells 
expressing Ki67, relative to the control gate set with an irrelevant antibody. FSC, 
forward scatter (B) Cumulative data showing percentage of Ki67
+
 cells in each 
subset. Each symbol represents a different individual (n=10 per group) and the 
mean percentage is shown as a horizontal line. Significance was determined by 
paired t-test 
Our group has previously shown a high level of proliferation in circulating 
CD4
+
CD25
hi
 Tregs (Vukmanovic-Stejic et al., 2006). This was confirmed using 
Ki67, a nuclear protein expressed by proliferating cells in all phases of the active cell 
cycle (Gerdes et al., 1984). PBMCs were obtained from 10 healthy young volunteers 
and stained for CD4/CD25/CD127/Foxp3 and Ki67 as described in previous 
chapters. It was found that in freshly isolated peripheral blood mononuclear 
populations, in all individuals tested, significantly higher proportions of 
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CD4
+
CD25
+
CD127
lo
FoxP3
+
 T cells expressed Ki67 than CD4
+
CD25
int
 and 
CD4
+
CD25
-
 T cell populations (mean ± SEM 22.8 ± 2.2% compared to 5 ± 0.3% and 
2.6 ± 0.2% respectively (Figure 6-2 A/B). 
 
Figure 6-3: Accumulation of CD4
+
Foxp3
+
 T cells during a secondary 
response to antigen in vivo. 
(A) Double immuno-flourescence staining of representative biopsies (days 0, 3,7 
and 14, n=5 per time point) shows CD4
+
 (green) and Foxp3
+
 (red) cells in a 
perivascular lymphocytic infiltrate (original magnification, x400). The 5 largest 
perivascular infiltrates present in the upper and mid dermis were selected for 
analysis. Cell numbers were expressed as the mean absolute number of cells 
counted within the frame. (B) Number of total CD4
+
 cells (black squares) and 
number of Foxp3
+
CD4
+
 cells (white squares) in perivascular infiltrates following 
PPD injection.  (C) Percentage of CD4
+
 cells expressing Foxp3 per perivascular 
infiltrate counted. Each symbol represents an average of 5perivascular infiltrates 
counted for each individual (n=5-7 per time point).Data are mean +/- SEM. 
We examined tissue biopsies taken throughout the course of the MT, for the 
expression of CD4 and Foxp3 and enumerated double positive cells in the 
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perivascular infiltrates. Figure 6-3A shows the expression of CD4 and Foxp3 in 
representative cellular infiltrates at day 0 (control skin), 3, 7 and 14 post PPD 
injection. Cumulative data from 5 individuals per time point is presented in Figure 
6-3B showing a significant increase in the number of CD4
+
 and CD4
+
Foxp3
+
 T cells 
on day 7 (P=0.04, one way Anova). This increase in the percentage of CD4
+
Foxp3
+
 
cells coincides with the increase in total CD4
+
 T cell numbers and also with peak 
cellular proliferation (p=0.01, one way Anova). However, when the corresponding 
increase in CD4
+
 T cell numbers is taken into account and the data expressed as the 
proportion of CD4
+
 T cells expressing Foxp3, this value remains fairly constant 
during the response (between 8-15% of CD4
+
 cells, Figure 3C). We concluded that 
both memory and Foxp3
+
 (putative regulatory) T cells therefore accumulate at the 
same relative rate after antigenic stimulation in vivo.  
6.3. Accumulation and proliferation of CD4+ T cells during a secondary 
response to antigen in vivo 
The increase in antigen-specific CD4
+
 T cells observed in the skin during the MT 
may not only result from the recruitment of T cells from the blood, but also from the 
localised proliferation of activated T cells in the skin. Evidence in mice, however, 
suggests that increase in numbers of antigen-specific T cells in non-lymphoid tissues 
is predominantly mediated by proliferation in lymphoid tissues followed by 
migration to non-lymphoid organs (Reinhardt et al., 2003; Roman et al., 2002; Ely et 
al., 2003; Harris et al., 2002; Ostler et al., 2001). 
Tissue biopsies obtained from the site of antigen injection at different times were co-
stained with Ki67 and CD4 (Figure 6-4A). The five largest perivascular infiltrates 
per section were photographed and counted, and data expressed as mean absolute cell 
number per frame. Very few proliferating cells were observed in normal skin (day 0), 
and the perivascular infiltrates were very small or absent. At day 7, the time of 
maximal CD4
+
 T cell accumulation, the number of CD4
+
 T cells expressing Ki67 is 
significantly increased (Figure 6-4B) and  >20% of CD4
+
 T cells were in cycle 
(Figure 6-4A/C).  This indicates that the increase in PPD specific CD4
+
 T cells in the 
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skin after antigenic challenge occurs in part through their extensive local 
proliferation  
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Figure 6-4: CD4
+
 T cell proliferation at the site of the MT 
(A) Double immuno-fluorescence staining of representative biopsies from day 0, 
3, 7 and 14 following MT induction. Ki67 is green, CD4 red. Original 
magnification was x400. (B) Number of total CD4
+
 cells (black squares) and 
number of Ki67
+
CD4
+ 
cells (white squares) in perivascular infiltrates following 
PPD injection. (C) Percentage of CD4
+
 cells expressing Ki67 found per 
perivascular infiltrate in each donor. Each circle represents an average of 
perivascular infiltrates counted for each individual (n=5-7 per time point, 
horizontal line indicates the mean).  
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6.4. Transient expression of Foxp3 expression induced by activation of CD4+  
T cells in vitro 
Previous studies have found that human CD4
+
CD25
-
 effector T cells can upregulate 
Foxp3 transiently, following activation (Walker et al., 2005; Allan et al., 2005; Gavin 
et al., 2006). It was possible therefore that the Foxp3 expressing CD4
+
 T cells that 
were found in the skin after antigen challenge were activated memory T cell 
populations that were induced to express this marker temporarily. To clarify this we 
first investigated the relationship between Foxp3 expression and proliferation in 
CD4
+
CD25
-
Foxp3
-
 T cells after activation in vitro (Figure 6-5). This work was 
carried out in collaboration with Dr Nicola Booth (PhD student). These cells were 
isolated from peripheral blood, labelled with CFSE and then activated with anti-
CD3/anti-CD28 coated beads. The expression of CD25, Foxp3 and Ki67 was 
determined on days 0, 3, 5 and 7. By day 3, approximately 80% of cells are CD25
+
 
and 35% of CD4
+
 cells express Foxp3. All Foxp3
+
 cells are Ki67
+
 and ~80% of the 
activated CD4
+
 T cell population had lost the CFSE label by day 3(Figure 5). Most 
cells lost Foxp3 expression (but remained CD25
+ 
and Ki67
+
) by day 7 indicating that 
the induction of Foxp3 expression in CD4
+
 T cells after activation was transient 
(Figure 6-5). 
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Figure 6-5: Memory T cells induced to express Foxp3 transiently in humans 
by stimulation. 
CD4
+
CD25
-
 (responder) T cells were isolated from PBMC using MACS and 
labeled with CFSE. Cells were stimulated with magnetic beads coated with 
antibodies to CD3 and CD28 for 7 days. Samples were removed at regular 
intervals and stained for the expression of CD25, Foxp3 and Ki67. Numbers  in 
dot plots indicate the percentage of cells in each quadrant. Dilution of the CFSE 
signal indicates proliferation of the cells. Data shown is representative of 3 
independent experiments. 
6.5. Foxp3+ T cells at the site of MT proliferate in parallel to effector T cells 
and have a regulatory T cell phenotype 
To characterize the Foxp3
+ 
T cells in the skin more extensively, we induced skin 
suction blisters at the site of the MT response on day 7 following PPD injection. This 
time point was chosen as it coincided with the peak CD4
+
 T cell infiltration and 
proliferation. Cells isolated from the blisters were stained for the co-expression of 
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Foxp3 with CD25, CD127, CD39 and CD27 as all these markers have been shown to 
identify nTregs (Ruprecht et al., 2005; Borsellino et al., 2007; Deaglio et al., 2007; 
Liu et al., 2006; Seddiki et al., 2006) (Figure 6-6, histograms right panel). Percentage 
of Foxp3
+
 cells in day 7 blisters was very similar to that observed in histology (range 
7.1 to 22.2%, mean 14.5 ± 2, n=6) (Figure 6-6, dot plot left panel). The majority of 
Foxp3 expressing CD4
+
 T cells were CD25
+
 (78.5 ± 7.5%, n=3) and expressed low 
levels of CD127 (mean and SEM, 10 ± 2.7% n=5). Furthermore these cells were 
uniformly CD27
+
, a hallmark of regulatory T cells at sites of immune activation in 
vivo (Ruprecht et al., 2005). Finally, the Foxp3 expressing T cells in skin also 
express CD39, another marker for nTregs (mean 83.6 ± 4) (Borsellino et al., 2007; 
Deaglio et al., 2007). In contrast, the CD4
+
Foxp3
-
 T cells that were found in the same 
samples were largely CD25 and CD39 negative but with high expression of CD127. 
 
Figure 6-6: Foxp3
+
 T cells isolated from the MT have a Treg phenotype. 
Blister cells were isolated on day 7 following MT induction and stained for 
Foxp3, CD127, CD25, CD27 and CD39. Representative staining (n=6) is shown. 
Dot plot indicates gating strategy. Histograms show expression of surface 
molecules on CD4
+
Foxp3
+
 and CD4
+
Foxp3
-
 subsets  as indicated. MFI and % 
positive cells are indicated as appropriate. 
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6.6. Foxp3+ T cells at the site of MT have regulatory T cell function 
Technical limitations, namely very small numbers of leucocytes collected from 
blisters precluded purification of the putative regulatory population from the skin. 
For day 7 blisters in 30 subjects that have been investigated, a mean of 295,000 cells 
were obtained (range 40-900,000 leucocytes, of which 5-50% were CD4
+
 T cells). 
Therefore the estimated mean number of CD4
+
 CD25
+
CD127
lo
 cells that are present 
is in the region of 2,000-25,000 cells that we are unable to isolate with current 
technology. However, nTregs, unlike effector cells do not secrete IL-2 and IFN- 
after recent stimulation in vitro (Pandiyan et al., 2007; Scott-Browne et al., 2007; 
Levings et al., 2001; Tiemessen et al., 2007). We therefore investigated the capacity 
of Foxp3
+
 and Foxp3
-
 CD4
+
T cells that were isolated from suction blisters to produce 
effector cytokines following re-stimulation with antigen in vitro. Cells isolated from 
day 7 blisters were stimulated with PPD for 16 hours, and stained for CD4, Foxp3, 
and IFN- or IL-2. Following re-stimulation, significantly greater numbers of 
CD4
+
Foxp3
-
 cells synthesized IFN- compared to CD4+Foxp3+ T cell population 
(n=6, for IFN- p=0.015, Wilcoxon paired test, Figure 6-7, left panel). Similar data 
was obtained for IL-2 in 4 separate donors (Figure 6-7, right panel, p=0.06). Thus 
although we were not able to assess suppressive function directly, we find that the 
CD4
+
Foxp3
+
 cells that are found in the skin after antigenic challenge are not recently 
activated effector CD4
+
 T cells and are clearly distinct, phenotypically and 
functionally from the CD4
+
Foxp3
- 
population. 
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6.7. Foxp3+ T cells at the site of MT proliferate in parallel to effector T cells  
IF
N
-
Foxp3 Foxp3
IL
-2
24% 2.9% 0.9%43.4%
 
Figure 6-7: Foxp3
+
 T cells isolated from MT showTreg function. 
Blister cells were isolated on day 7 following MT induction, stimulated with 
PPD for 15 hours in the presence of brefeldin A and stained for intracellular 
expression of cytokines and Foxp3. Percentage of Foxp3+ and Foxp3- cells 
secreting cytokine is indicated. Dot plots are representative of 4-6 independent 
experiments. 
To determine if the Foxp3
+ 
cells found in the skin represent a regulatory population 
or activated CD4
+
 T cells that express Foxp3 transiently we double stained the MT 
skin sections for Ki67 and Foxp3 expression (Figure 6-8A). In contrast to the CD4
+
 
T cells that were activated in vitro, where all Foxp3
+
 are also Ki67
+ 
(Figure 6-6, 
middle panel), in the skin only a proportion of Foxp3
+
CD4
+
 cells express Ki67 (14-
33%, at all times following PPD injection, mean 23.2%). The kinetics of Ki67 
expression in Foxp3
+
 (putative Tregs) and CD4
+
Foxp3
- 
(effector cells) are very 
similar (Figure 6-8B). 
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Figure 6-8: Foxp3
+
 T cells have a Treg phenotype and proliferate at the site 
of an immune response. 
(A) Double immunofluorescence staining of Ki67(green)and Foxp3(red) in a 
representative day 7 skin section (original magnification, x400). Arrows indicate 
cells staining positive for both Ki67 and Foxp3 (yellow). (B) Graph shows 
percentage of CD4 cells expressing Ki67 (white bars) and percentage of Foxp3+ 
cells expressing Ki67 (black bars). Graph shows mean±SD, n=5 per time point. 
Finally, to determine whether or not the cycling Foxp3
+
 cells (Ki67
+
) also exhibit a 
Treg phenotype, we compared the expression of CD127 on Foxp3
+
Ki67
+
 and 
Foxp3
+
Ki67
-
 T cells (Figure 6-9). Both cycling and non-cycling Foxp3 expressing 
populations expressed low levels of CD127 indicating that they were regulatory T 
cells (mean ± SEM: 8 ± 2.3 and 10.5 ± 3.2, n=6). In contrast, CD127 was highly 
expressed both in Foxp3
-
Ki67
+
 and Foxp3
-
Ki67
- 
populations (mean ± SEM: 55.7 ± 7 
and 80.1 ± 2, respectively n=6) highlighting the fact that CD127 expression is a good 
marker to distinguish between Tregs and non-regulatory T cells. Therefore, Foxp3
+ 
cells that accumulate during the course of MT have multiple phenotypic and 
functional characteristics of naturally occurring regulatory T cells and a significant 
proportion of these are proliferating in parallel with the corresponding effector T 
cells. 
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Figure 6-9: Proliferating Foxp3
+
 T cells in the skin express low levels of 
CD127. 
Blister cells were isolated on day 7 following MT induction and stained for CD4, 
Foxp3, CD127 and Ki67. Representative staining (n=6) is shown. (A) Dot plot 
indicates gating strategy. The percentage of cells in each quadrant is indicated. 
Histograms show expression of CD127 on CD4
+
Foxp3
+
 and CD4
+
Foxp3
- 
subsets 
divided by Ki67 expression. Numbers indicate the percentage of cells expressing 
CD127. (B) Cumulative data comparing Foxp3
+
Ki67
+
 and Foxp3
+
Ki67
-
 subsets.  
P-values were calculated using a paired t-test. Data are mean +/-SEM. 
6.8. Increased representation of CD4+Foxp3+ regulatory T cells (Tregs) in the 
skin of old humans 
Previous studies have shown that CD4
+
Foxp3
+ 
Tregs can inhibit TNF- secretion by 
macrophages (Tiemessen et al., 2007; Taams et al., 2005). We therefore investigated 
whether the decreased macrophage production of TNF- in old subjects was 
associated with increased proportions of these cells in the skin. In the data presented 
above we showed that cutaneous CD4
+
Foxp3
+
 T cells expressed typical phenotypic 
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and functional characteristics of regulatory cells (Vukmanovic-Stejic et al., 2008). 
There was a significant increase in the proportion of these cells in the skin of old 
subjects compared to the young group either before, or after injection of antigen 
(Figure 6-10 A,B).This data suggests that the over-representation of Tregs in the skin 
may explain in part the decreased TNF- secretion by cutaneous macrophages in old 
humans. 
 
Figure 6-10: Numbers of CD4
+
Foxp3
+
 Tregs are increased in the skin of old 
subjects. 
(A) Double immuno-fluorescence staining of representative biopsies from young 
and old normal skin; CD4
+
 (green) and Foxp3
+
 (red) cells in a perivascular 
lymphocytic infiltrate. CD4
+
Foxp3
+
 cells are indicated by a white arrow. (B) 
Percentage of CD4+ cells expressing Foxp3 per perivascular infiltrate counted. 
Five largest perivascular infiltrates present in the upper and mid dermis were 
selected for analysis for each subject. Each symbol represents an average of 5 
perivascular infiltrates counted for each individual (n= 5-7 subjects per time 
point, line indicates the mean). 
6.9. Discussion 
We have clearly shown that cells expressing Foxp3 in human skin during a 
secondary memory cutaneous immune response have a proliferation rate that equals 
that of nTregs in blood (~10-25% of cells are in cycle at any one time) and also 
exhibit the functional characteristics of nTregs. Overall our results indicate that the 
accumulation of Tregs closely parallels the expansion of CD4
+ 
effector T cells at the 
site of a controlled immune response. This intimate relationship between both 
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populations suggests that memory T cell proliferation is closely controlled by 
CD4
+
CD25
hi
 Tregs at the peripheral sites of immune reactivity. Moreover Tregs have 
recently been implicated in the regulation of macrophage phenotype and function and 
we applied our characterisation of nTregs in the mantoux model to the candida skin 
test model in young and old skin to ascertain if differences in nTreg numbers could 
explain the lack of TNF-α expression by macrophages in old skin as shown in 
Chapter 5. 
In humans, Foxp3 expression does not always correlate with regulatory activity as it 
is induced on recently activated CD4
+
 effector populations(Walker et al., 2005) . The 
question therefore arises as to whether the CD4
+
Foxp3
+
 T cells that we observed in 
the skin are actually Tregs or recently activated effector cells. CD4
+
Foxp3
+
 cells 
isolated from skin blisters expressed all the phenotypic hallmarks associated with 
natural regulatory T cells (CD25
hi
 CD39
hi
 CD127
lo
) irrespective of whether or not 
they were in cell cycle. In contrast Foxp3
- 
T cells were CD25
lo
, CD39
lo
 and mainly 
CD127
hi
. Furthermore, previous studies have shown that in inflamed tissues, high 
expression of CD27 can be used to distinguish regulatory T cells from activated 
CD25
+
CD4
+
 effectors (Ruprecht et al., 2005) and we found that Foxp3
+
 cells isolated 
from the skin showed uniformly high expression of CD27. Finally, CD4
+
Foxp3
+
 
cells isolated from skin blisters did not produce any cytokines associated with 
effector T cells (IL-2, IFN-), In contrast, CD4+Foxp3- population synthesized IL-2 
and IFN-following Ag-specific re-stimulation in vitro. This is in agreement with a 
widely accepted view that Foxp3
+
 regulatory T cells do not produce IL-2 or IFN- 
(Tiemessen et al., 2007; Pandiyan et al., 2007; Scott-Browne et al., 2007; Levings et 
al., 2001). Taken together these results strongly support the view that the Foxp3
+
 T 
cells that are found in the skin after secondary antigenic challenge are a regulatory T 
cell population, however we were not able to test regulatory function directly due to 
limitations in cell numbers that were obtained from suction blisters. 
The origin of the Tregs in the skin is not clear. High expression of skin homing 
receptors CLA and CCR4 on peripheral blood Foxp3
+ 
cells (Hirahara et al., 2006) 
and on Foxp3
+
 cells recovered from skin after antigenic challenge suggests that some 
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of the Tregs in the skin may be recruited from the blood (Hirahara et al., 2006; 
Chong et al., 2004). Furthermore, we and others (Clark and Kupper, 2007) have 
demonstrated that CD4
+
CD25
hi
Foxp3
+
 Tregs are present in normal skin and it is 
possible that the increase in numbers of these cells at the site of antigenic challenge 
may reflect the proliferation of skin-resident cells. A third but not mutually exclusive 
possibility is that some CD4
+
CD25
hi
Foxp3
+
 Tregs may be derived from responsive 
memory CD4
+
 T cell populations during the immune response in the skin in vivo 
(Akbar et al., 2007). 
In Chapter 5 we showed that CD163
+ 
macrophages in skin from old skin subjects 
show drastically reduced expression of TNF-α. It is interesting that the number of 
CD4
+
FoxP3
+
 Tregs is increased in old skin sections compared to young, both at 
baseline and throughout the course of the response to candida skin test, since Tregs 
have been recently implicated in the control of monocyte/macrophage phenotype 
(Tiemessen et al., 2007). Monocytes/macrophages are involved in both the initiation 
and resolution of an inflammatory immune response. The resolution phase of an 
immune response is characterised by alternatively-activated macrophages (AAMs) 
which produce mainly anti-inflammatory cytokines (Mosser and Edwards, 2008). 
The excessive presence of the latter type of macrophage could cause damage to the 
host because this could prevent an appropriate immune response leading to hampered 
cutaneous tumour and infection immunity. Treg-modulated monocytes have up-
regulated CD206 and CD163 expression, increased phagocytic activity, increased 
CCL18 and IL-1Ra production, decreased HLA-DR expression, and down-regulated 
proinflammatory cytokine/chemokine production (Tiemessen et al., 2007). Recent in 
vitro and in vivo studies have shown that macrophages in tissues can undergo 
phenotypic switches from M1 to M2 macrophages and vice versa (Lumeng et al., 
2007; Arnold et al., 2007; Porcheray et al., 2005). Therefore when entering tissues, 
monocytes/macrophages will not only be affected by the local microenvironment 
(cytokines, chemokines, growth factors, and tissue cells) but also by the presence of 
activated effector T cells and Tregs. For example, on this basis, it can be 
hypothesised that the increased presence of Tregs in skin from old subjects skews 
newly recruited monocytes towards an AAM phenotype. This would mimic the 
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situation previously described at tumour sites (Curiel et al., 2004; Woo et al., 2001) 
where the increased presence of Tregs together with the tolerogenic milieu skews 
newly recruited monocytes toward an AAM phenotype. Indeed the presence of M2-
like tumour-associated macrophages with low proinflammatory and high phagocytic 
capacity have been described in various human and mouse tumours (Sica et al., 2006; 
Van Ginderachter et al., 2006). Thus Tregs may hamper effective tumour immunity 
not only by inhibiting CD4
+
 and CD8
+ 
T cell responses but also by steering 
monocytes/macrophages toward an alternatively activated phenotype and function. 
Tregs may therefore promote the induction of AAM/macrophages, which will help to 
maintain tissue homeostasis and prevent local tissue damage but may also contribute 
to hampered antitumor immunity. This newly discovered ability of Tregs may help 
us to understand many disease processes and may also provide a novel tool to 
manipulate local immune responses. 
Squamous cell carcinomas (SCCs) of the skin are sun-induced skin cancers that are 
particularly numerous in patients on T cell immunosuppression and become more 
prevalent with increasing age. Clark et al have recently reported that approximately 
50% of the T cells infiltrating SCCs were FoxP3
+
 Tregs. The blood vessels in the 
SCC tumour itself were also found to express less E-selectin than surrounding 
unaffected skin and there were few CLA
+ 
T cells infiltrating the tumour. The authors 
concluded that the SCC was evading the immune response by downregulating E-
selectin expression thus preventing uptake of CLA
+
 immunosurveillance cells, and 
the SCC is also recruiting immunosuppressive Tregs. They also found that when 
tumours were treated with Imiquimod (a TLR7 agonist applied in topical cream 
formulation), they contained a decreased percentage of Treg cells and showed 
induction of E-selectin on tumour vessels together with recruitment of CLA
+
 CD8
+
 T 
cells, and histological evidence of tumour regression. SCCs treated in vitro with 
Imiquimod also expressed vascular E-selectin. They therefore found that the TLR7 
agonist neutralized both of these strategies, supporting its use in SCCs and other 
tumours with similar immune defects (Clark et al., 2008). We have also found 
reduced expression of E-selectin as well as increased nTreg numbers during the 
course of a secondary memory cutaneous immune response in skin from old subjects. 
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It is possible that the initial problem in old skin is Treg induced immunosuppression 
which induces an AAM phenotype which allows the SCC to develop and that the 
TLR7 agonist used in this study reverses this process by directly activating the 
suppressed macrophages in old skin. This is currently under investigation. 
In summary we have shown that regulatory T cells and effector memory T cells 
proliferate in parallel during a secondary memory cutaneous immune response in 
vivo. In the skin microenvironment from old subjects, the presence of increased 
numbers of Tregs might be skewing the monocytes present into an AAM phenotype 
thus favouring less production of TNF-α by CD163+ macrophages which leads to 
reduced endothelial activation and reduced entry of effector memory T cells into the 
dermis in old subjects. 
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Chapter 7. Summary and future directions 
There is an increased incidence of cutaneous malignancy and infection with 
advancing age in humans (Diffey and Langtry, 2005; Laube, 2004). In addition, the 
incidence and severity of contact allergic eczema is decreased with ageing (Balato et 
al., 2008; Piaserico et al., 2004). Both of these facts suggest a reduction in skin 
immunity with age. The central observation of this study is that the cutaneous DTH 
response to challenge by bacterial, fungal and viral recall antigens injected into the 
skin was defective in older humans. The cutaneous DTH response to antigen is 
widely considered to be a manifestation of memory T cell responsiveness in vivo. An 
unexpected observation of this study was that the defect in the response to cutaneous 
antigenic challenge was not in the memory T cell compartment, but in the innate 
conditioning of the skin after antigen stimulation. 
Cells of the innate immune system in the skin sense danger signals after antigen 
injection and respond appropriately with the release of pro-inflammatory mediators 
which leads to conditioning of the skin so that a memory T cell response can 
develop. This is the first study to show that lack of TNF-α production by CD163+ 
macrophages in old skin leads to impaired cutaneous secondary immune responses to 
antigen with ageing. Furthermore we show low level expression of E-selectin, 
ICAM-1 and VCAM-1 on dermal endothelium secondary to decreased TNF-α in the 
old skin environment. This in turn leads to the reduced infiltration of antigen specific 
CD4
+
 T cells that we found both on histology and in blister fluid of secondary 
cutaneous immune responses in old subjects. Hence the majority of old individuals 
are unable to respond effectively to recall antigen despite prior exposure. 
Although T cell numbers are decreased after antigen challenge, macrophages 
identified by CD163 (this study) or CD68 and CD14 (unpublished data) are present 
in equal numbers in young and old skin. This is likely due to the different trafficking 
requirements and preferential reliance on DC-SIGN/ICAM-2 interactions that 
mediate dendritic cell trafficking (Geijtenbeek et al., 2000) and is strongly expressed 
on CD163
+
 macrophages in both normal and inflamed skin (Zaba et al., 2007). We 
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have also shown that high levels of DC-SIGN are expressed on activated peripheral 
blood monocytes. ICAM-2 is constitutively expressed on endothelial cells and in 
contrast to E-selectin, VCAM-1 and ICAM-1, its expression is not dependent on the 
presence of TNF-α (Silverman et al., 2001). Activated monocytes may therefore 
enter the skin through an alternative pathway of transmigration through the 
endothelium compared to memory T cells. Furthermore, significant numbers of 
CD163
+
 macrophages are present in the skin of both young and old subjects even 
without injection of antigen therefore the recruitment of circulating myeloid cells at 
the very early stages of the response may not be a limiting step in DTH responses of 
old humans. 
The dominant role of TNF-α in regulating leucocyte migration via the activation of 
endothelial cells is supported by studies using murine models of contact 
hypersensitivity. It was shown that selectively blocking TNF-α significantly inhibited 
the up-regulation of ICAM-1 and VCAM-1 expression and the development of ear 
swelling in response to contact allergen, but blocking of IL-1α and IL-1β had no such 
effect (McHale et al., 1999). Furthermore, it was found that anti-TNF-α therapy in 
humans decreases the expression of adhesion molecules E-selectin, ICAM-1 and 
VCAM-1 in various assays, leading to reduced trafficking of leucocytes (Paleolog et 
al., 1998). This decreased endothelial activation is associated with an increase in the 
frequency of skin and soft tissue infections in anti-TNF-α treated rheumatoid arthritis 
patients compared to those receiving traditional disease-modifying anti-rheumatic 
drugs (DMARDs) (Dixon et al., 2006).  
The need for appropriate leucocyte migration for immunosurveillance and the 
prevention of disease is further underscored by the use of anti-α4β1 integrin 
monoclonal antibody (mAb) that binds to VLA-4, the main homing molecule 
involved in lymphocyte migration to inflamed brain in rodent models of multiple 
sclerosis (Engelhardt et al., 1995). This mAb is thought to work by blocking the 
ability of VLA-4 to bind to its endothelial counter-receptor, VCAM-1. In so doing it 
led to reduction of the inflammatory infiltrate in brain tissue and blocked clinical 
paralysis in various animal models of multiple sclerosis (Deloire et al., 2004; 
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Yednock et al., 1992; Theien et al., 2003). However, the use of Natalizumab, a 
humanised monoclonal antibody to α4β1 integrin, for treatment of multiple sclerosis 
led to the development of severe opportunistic brain infections (Steinman, 2005). 
Thus inhibiting leucocyte migration in humans can lead to severe pathological 
consequences. 
The initiation of an inflammatory immune response depends on the ability of local 
antigen presenting cells to recognise danger signals in response to tissue injury, 
microbial infection and other changes of homeostasis (such as tumour cells or 
contact allergens;(Matzinger, 2007). The macrophages play a critical role in this 
respect through their ability to recognise danger signals via their TLRs and other 
pattern-recognition receptors which leads to the local production of pro-
inflammatory cytokines (Gordon, 2007). This study and others have shown that the 
macrophage is the main source of TNF-α production during a DTH in the skin (Chu 
et al., 1992). We used CD163 and CD11c markers to distinguish between cutaneous 
macrophages and dermal dendritic cells respectively and found that TNF-α is 
abundantly expressed by CD163
+
 macrophages in young skin during a DTH response 
but not in old. Moreover we found no significant difference in the numbers of 
CD163
+
 macrophages in normal or antigen injected young and old skin, pointing to 
functional impairment in macrophages in old skin accounting for sub-optimal 
immunity rather than reduced recruitment or fewer resident skin macrophages.  
Although our finding of reduced TNF-α expression by cutaneous macrophages is 
clear-cut it could be argued that the lack of T cells early on in the response is also 
responsible for reduced cytokine release and endothelial activation. This question is 
difficult to establish in our human model, however a study carried out in a murine 
model of contact hypersensitivity elegantly clarifies this issue. McHale et al showed 
that if T lymphocyte migration into skin was blocked by intraperitoneal injection of 
mAb against CD11a and VLA-4 integrins at 1 hour prior to cutaneous challenge with 
oxazolone, there was no down-regulation of ICAM-1 and VCAM-1 expression at 4 
hours compared to control suggesting that initial cytokine release required for proper 
endothelial activation happened as normal despite lack of T cells infiltrating the 
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response. However similar blockade of T cell migration at 24 hours led to a 
significant downregulation of ICAM-1 and VCAM-1compared to control suggesting 
that at this later stage of the immune response T cell cytokine release is essential for 
continued expression of endothelial adhesion molecules (McHale et al., 1999). 
Therefore T cell signals are needed to maintain expression of endothelial adhesion 
molecules. 
The defect in macrophage triggering to secrete TNF-α in the skin, raises the question 
of whether there is a defect in endothelial activation during immune responses in 
other organs during ageing as the potential decrease in T cell immunosurveillance, 
may contribute to the reported increase in susceptibility of old individuals to a wide 
range of infections (Yoshikawa, 2000; Nicholson et al., 1997; Schmader, 2001).  
An important unanswered question is why macrophages in the old skin are not 
triggered to secrete TNF-α. Previous studies have shown that there is an age 
associated defect in human TLR1 and 2 function that results in a significant defect in 
TNF-α secretion after ligation of these receptors (van Duin et al., 2007). Since 
candida activates TLR1 and 2, this may explain the cutaneous defect in macrophage-
derived TNF-α that we have observed. It has also been shown that there is a defect in 
TLR4 function and expression and function during ageing (Renshaw et al., 2002; van 
den Biggelaar et al., 2004) although this has not been confirmed in other studies (van 
Duin and Shaw, 2007). However, we found that both peripheral blood monocytes 
and isolated cutaneous macrophages from donors of both age groups synthesized 
similar levels of TNF-after TLR 1/2 and TLR-4 stimulation in vitro. We conclude 
therefore that cutaneous macrophages in old humans are not inherently defective in 
terms of TNF-synthesis but do not rule the possibility that other functions in these 
cells may be altered during ageing. This is currently under investigation. 
In addition to the need for TLR signalling for macrophage activation, these cells 
must also interact with cytokines such as IFN- to become fully functional. Previous 
studies have shown that IFN- is mainly secreted by T cells during DTH responses 
(Chu et al., 1992). The lack of IFN-  in the skin in our studies may reflect the 
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decreased infiltration of T cells into the site of antigen challenge. Activation by IFN-
 leads to the expression of several genes that regulate macrophage biology including 
expression of MHC Class II genes (Celada and Maki, 1991; Cullell-Young et al., 
2001; Gonalons et al., 1998), which are crucial for presenting antigens to T 
lymphocytes. It is possible that the lack of T cell signals such as IFN- early in the 
DTH response in old subjects may prevent the cascade of events required for its 
amplification. 
An alternative possibility is that macrophages in the skin of old individuals may be 
inhibited functionally in situ. It has been shown that human CD4
+
Foxp3
+ 
 Tregs are 
potent inhibitor of macrophage activation and TNF-secretion by these cells 
(Tiemessen et al., 2007; Taams et al., 2005). In addition, in a previous study we 
showed that there is a significant increase in functional circulating Tregs in old 
individuals (Vukmanovic-Stejic et al., 2006) which is in agreement with the 
observation that functional Tregs accumulate in tissues of aged mice (Lages et al., 
2008). We now show that there are significantly higher proportions of CD4
+
Foxp3
+
 
T cells in the skin of old volunteers either before or 7 days after injection of candida 
antigens. Although circumstantial, this suggests that the accumulation of Tregs in the 
skin may be one possible mechanism for the observed decrease of TNF- secretion 
by cutaneous macrophages in old individuals. This is currently under investigation. 
The innate immune system has evolved to allow humans to live together with 
commensal microorganisms whilst at the same time keeping the growth of microbes 
under tight control. However the activation of the innate immune system has side-
effects ie tissue damage to the host caused by inflammation. The reduced activation 
of the innate immune system in old skin could be an attempt to protect against a state 
of chronic inflammation that would result if the immune system was targeting debris 
that accumulates with age in the skin, in a similar way to increasing debris deposited 
in the blood vessel wall (atherosclerosis leading to heart attacks and strokes) and 
retina (lipofuscin pigments leading to age related macular degeneration) with age 
(Richards et al., 2007). This implies that tuning down but not turning off innate 
surveillance may delay the ageing of tissues and prevent or attenuate inflammatory 
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disorders. It is clear that a balance must be achieved within the local innate immune 
system in specific organs such as the skin in the old between too much inflammation 
and too little protection against infection. We postulate that this imbalance in certain 
old individuals may lead to the increased frequency of infections and cutaneous 
tumours that are found in this age group. 
There are various examples in the body where an attenuation of the immune response 
is desirable and are worth examining as they could parallel our observations in 
ageing skin immunity; the gut immune system can distinguish between harmless 
commensal microorganisms and dangerous pathogens, and attenuates its response to 
the former to avoid dangerous chronic inflammation. Dendritic cells (DCs) are 
crucial to intestinal immune regulation because of their roles in inducing protective 
immunity against pathogens while maintaining tolerance to commensal bacteria. The 
mechanisms that maintain this hyporesponsiveness are just beginning to be 
understood. It has been shown that DCs migrating from the rat intestine in lymph are 
hyporesponsive to LPS stimulation, thus possibly preventing harmful immune 
responses being induced to commensal flora. Furthermore it seems like 
hyporesponsiveness might only be restiricted to LPS and not to other molecular 
associated molecular patterns (MAMP) (Cerovic et al., 2009). In fact these DCs were 
able to react to all TLR ligands they were subjected to in vitro apart from TLR4. 
Therefore the gut innate immune system or the local gut microenvironment in 
healthy young individuals is able to finetune itself so as to respond to certain 
bacterial elements only and thus prevent chronic longterm inflammation. In a similar 
way the skin microenvironment might place a selective block on reponses of the skin 
innate immune system to prevent chronic inflammation. 
The DTH response to recall antigen in the skin has been used as a marker of systemic 
immunity (Takahashi et al., 2003; Almeida et al., 2001). Our results indicate that 
older subjects have decreased ability to mount a clinical response to recall antigen 
challenge in the skin, which is also associated with a decreased antigen-specific 
CD4
+
 T cell accumulation. However this study demonstrates for the first time that in 
the old volunteer cohort this does not equate to decreased immunity, as the numbers 
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of antigen-specific T cells in peripheral blood and their ability to respond to antigen 
is not different in subjects in both age groups. This points to a skin specific rather 
than a general decline in cell-mediated immunity. This has particular relevance in the 
context of Mantoux skin testing in the elderly. In the developed world tuberculosis is 
more prevalent in the elderly population than other age groups. The Mantoux test is 
used widely to assess for both immunity to and potential infection with tuberculosis. 
However our study clearly demonstrates that mantoux skin testing in the elderly is 
not ideal for assessing presence of immunity to tuberculosis in the old. 
The clinical relevance of our findings of a suppressed innate immune system locally 
within the skin of old subjects is highlighted by the observation that Imiquimod, a 
TLR7 agonist which is applied topically is useful in the treatment of non-melanoma 
skin cancer in the elderly, and infections such as viral warts (Beutner et al., 1999). 
This study links lack of macrophage-derived TNF-α in response to antigen challenge 
with ineffective cutaneous immunity in the old population. Given the shift towards 
an ageing population and the high prevalence of non-melanoma skin cancer in this 
age-group, we propose that new strategies aimed at inducing macrophage-derived 
TNF-α should be considered both for prevention and early therapeutic intervention in 
non-melanoma skin cancers and cutaneous infections in old individuals. 
 
References 
Page 148 
Reference List 
Ackermann,R.J. and Monroe,P.W. (1996). Bacteremic urinary tract infection in older 
people. J. Am. Geriatr. Soc. 44, 927-933. 
Ahmed,A.R. and Blose,D.A. (1983). Delayed-type hypersensitivity skin testing. A 
review. Arch. Dermatol. 119, 934-945. 
Ahmed,R. and Gray,D. (1996). Immunological memory and protective immunity: 
understanding their relation. Science 272, 54-60. 
Akbar,A.N. and Fletcher,J.M. (2005). Memory T cell homeostasis and senescence 
during aging. Curr. Opin. Immunol. 17, 480-485. 
Akbar,A.N., Lord,J.M., and Salmon,M. (2000). IFN-alpha and IFN-beta: a link 
between immune memory and chronic inflammation. Immunol. Today 21, 337-342. 
Akbar,A.N., Terry,L., Timms,A., Beverley,P.C., and Janossy,G. (1988). Loss of 
CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immunol. 
140, 2171-2178. 
Akbar,A.N., Vukmanovic-Stejic,M., Taams,L.S., and Macallan,D.C. (2007). The 
dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat. 
Rev. Immunol. 7, 231-237. 
Akira,S. and Takeda,K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 
499-511. 
Albanesi,C., Cavani,A., and Girolomoni,G. (1998). Interferon-gamma-stimulated 
human keratinocytes express the genes necessary for the production of peptide-
loaded MHC class II molecules. J. Invest Dermatol. 110, 138-142. 
References 
Page 149 
Allan,S.E., Passerini,L., Bacchetta,R., Crellin,N., Dai,M., Orban,P.C., Ziegler,S.F., 
Roncarolo,M.G., and Levings,M.K. (2005). The role of 2 FOXP3 isoforms in the 
generation of human CD4+ Tregs. J. Clin. Invest. 115, 3276-3284. 
Almanzar,G., Schwaiger,S., Jenewein,B., Keller,M., Herndler-Brandstetter,D., 
Wurzner,R., Schonitzer,D., and Grubeck-Loebenstein,B. (2005). Long-term 
cytomegalovirus infection leads to significant changes in the composition of the 
CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine 
production profile in elderly persons. J. Virol. 79, 3675-3683. 
Almeida,L.M., Barbieri,M.A., Da Paixao,A.C., and Cuevas,L.E. (2001). Use of 
purified protein derivative to assess the risk of infection in children in close contact 
with adults with tuberculosis in a population with high Calmette-Guerin bacillus 
coverage. Pediatr. Infect. Dis. J. 20, 1061-1065. 
Alon,R., Kassner,P.D., Carr,M.W., Finger,E.B., Hemler,M.E., and Springer,T.A. 
(1995). The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J 
Cell Biol. 128, 1243-1253. 
Amyes,E., Hatton,C., Montamat-Sicotte,D., Gudgeon,N., Rickinson,A.B., 
McMichael,A.J., and Callan,M.F. (2003). Characterization of the CD4+ T cell 
response to Epstein-Barr virus during primary and persistent infection. J. Exp. Med. 
198, 903-911. 
Angel,C.E., George,E., Brooks,A.E., Ostrovsky,L.L., Brown,T.L., and Dunbar,P.R. 
(2006). Cutting edge: CD1a+ antigen-presenting cells in human dermis respond 
rapidly to CCR7 ligands. J. Immunol. 176, 5730-5734. 
Arnold,L., Henry,A., Poron,F., Baba-Amer,Y., van Rooijen,N., Plonquet,A., 
Gherardi,R.K., and Chazaud,B. (2007). Inflammatory monocytes recruited after 
skeletal muscle injury switch into antiinflammatory macrophages to support 
myogenesis. J. Exp. Med. 204, 1057-1069. 
References 
Page 150 
Aspinall,R. (1999). Does the immune system of a mouse age faster than the immune 
system of a human? Bioessays 21, 519-524. 
Auffray,C., Fogg,D., Garfa,M., Elain,G., Join-Lambert,O., Kayal,S., Sarnacki,S., 
Cumano,A., Lauvau,G., and Geissmann,F. (2007). Monitoring of blood vessels and 
tissues by a population of monocytes with patrolling behavior. Science 317, 666-670. 
Auffray,C., Sieweke,M.H., and Geissmann,F. (2009). Blood monocytes: 
development, heterogeneity, and relationship with dendritic cells. Annu. Rev. 
Immunol. 27, 669-692. 
Balato,A., Balato,N., Di Costanzo,L., and Ayala,F. (2008). Contact sensitization of 
older patients in an academic department in Naples, Italy. Dermatitis 19, 209-212. 
Banchereau,J., Briere,F., Caux,C., Davoust,J., Lebecque,S., Liu,Y.J., Pulendran,B., 
and Palucka,K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 
767-811. 
Banchereau,J. and Steinman,R.M. (1998). Dendritic cells and the control of 
immunity. Nature 392, 245-252. 
Barker,J.N., Mitra,R.S., Griffiths,C.E., Dixit,V.M., and Nickoloff,B.J. (1991). 
Keratinocytes as initiators of inflammation. Lancet 337, 211-214. 
Barker,W.H. and Mullooly,J.P. (1980). Impact of epidemic type A influenza in a 
defined adult population. Am. J. Epidemiol. 112, 798-811. 
Belichenko,P.V., Fedorov,A.A., and Dahlstrom,A.B. (1996). Quantitative analysis of 
immunofluorescence and lipofuscin distribution in human cortical areas by dual-
channel confocal laser scanning microscopy. J. Neurosci. Methods 69, 155-161. 
References 
Page 151 
Bell,E.B., Hayes,S., McDonagh,M., Bunce,C., Yang,C., and Sparshott,S.M. (2001). 
Both CD45R(low) and CD45R(high) "revertant" CD4 memory T cells provide help 
for memory B cells. Eur. J. Immunol. 31, 1685-1695. 
Bennett,C.L., van Rijn,E., Jung,S., Inaba,K., Steinman,R.M., Kapsenberg,M.L., and 
Clausen,B.E. (2005). Inducible ablation of mouse Langerhans cells diminishes but 
fails to abrogate contact hypersensitivity. J. Cell Biol. 169, 569-576. 
Berard,M. and Tough,D.F. (2002). Qualitative differences between naive and 
memory T cells. Immunology 106, 127-138. 
Berg,E.L., Yoshino,T., Rott,L.S., Robinson,M.K., Warnock,R.A., Kishimoto,T.K., 
Picker,L.J., and Butcher,E.C. (1991). The cutaneous lymphocyte antigen is a skin 
lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte 
adhesion molecule 1. J. Exp. Med. 174, 1461-1466. 
Berlin,C., Bargatze,R.F., Campbell,J.J., von Andrian,U.H., Szabo,M.C., 
Hasslen,S.R., Nelson,R.D., Berg,E.L., Erlandsen,S.L., and Butcher,E.C. (1995). 
alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. 
Cell 80, 413-422. 
Berneburg,M., Plettenberg,H., and Krutmann,J. (2000). Photoaging of human skin. 
Photodermatol. Photoimmunol. Photomed. 16, 239-244. 
Bettelli,E., Oukka,M., and Kuchroo,V.K. (2007). T(H)-17 cells in the circle of 
immunity and autoimmunity. Nat. Immunol. 8, 345-350. 
Beutler,B., Tkacenko,V., Milsark,I., Krochin,N., and Cerami,A. (1986). Effect of 
gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of 
the lpsd (endotoxin resistance) phenotype. J. Exp. Med. 164, 1791-1796. 
References 
Page 152 
Beutner,K.R., Geisse,J.K., Helman,D., Fox,T.L., Ginkel,A., and Owens,M.L. (1999). 
Therapeutic response of basal cell carcinoma to the immune response modifier 
imiquimod 5% cream. J. Am. Acad. Dermatol. 41, 1002-1007. 
Birbeck,M.S., Breathnach,A.S., and Everall,J.D. (1961). An electron microscope 
study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J. 
Invest. Derm. 37, 51-64. 
Bird,J.J., Brown,D.R., Mullen,A.C., Moskowitz,N.H., Mahowald,M.A., Sider,J.R., 
Gajewski,T.F., Wang,C.R., and Reiner,S.L. (1998). Helper T cell differentiation is 
controlled by the cell cycle. Immunity. 9, 229-237. 
Blattman,J.N., Antia,R., Sourdive,D.J., Wang,X., Kaech,S.M., Murali-Krishna,K., 
Altman,J.D., and Ahmed,R. (2002). Estimating the precursor frequency of naive 
antigen-specific CD8 T cells. J. Exp. Med. 195, 657-664. 
Bolte,S. and Cordelieres,F.P. (2006). A guided tour into subcellular colocalization 
analysis in light microscopy. J. Microsc. 224, 213-232. 
Borsellino,G., Kleinewietfeld,M., Di Mitri,D., Sternjak,A., Diamantini,A., 
Giometto,R., Hopner,S., Centonze,D., Bernardi,G., Dell'Acqua,M.L., Rossini,P.M., 
Battistini,L., Rotzschke,O., and Falk,K. (2007). Expression of ectonucleotidase 
CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune 
suppression. Blood 110, 1225-1232. 
Bos Jan D (2004). Skin Immune System: Cutaneous Immunology & Clinical 
Immunodermatology. Informa Healthcare). 
BOUGHTON,B. and SPECTOR,W.G. (1963). Histology of the tuberculin reaction in 
guinea-pigs. J. Pathol. Bacteriol. 85, 371-381. 
References 
Page 153 
Buechler,C., Ritter,M., Orso,E., Langmann,T., Klucken,J., and Schmitz,G. (2000). 
Regulation of scavenger receptor CD163 expression in human monocytes and 
macrophages by pro- and antiinflammatory stimuli. J. Leukoc. Biol. 67, 97-103. 
Bursch,L.S., Wang,L., Igyarto,B., Kissenpfennig,A., Malissen,B., Kaplan,D.H., and 
Hogquist,K.A. (2007). Identification of a novel population of Langerin+ dendritic 
cells. J. Exp. Med. 204, 3147-3156. 
Butcher,E.C. and Picker,L.J. (1996). Lymphocyte homing and homeostasis. Science 
272, 60-66. 
Butcher,E.C., Williams,M., Youngman,K., Rott,L., and Briskin,M. (1999). 
Lymphocyte trafficking and regional immunity. Adv. Immunol. 72, 209-253. 
Campbell,D.J. and Butcher,E.C. (2002). Rapid acquisition of tissue-specific homing 
phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J 
Exp. Med. 195, 135-141. 
Campbell,D.J., Kim,C.H., and Butcher,E.C. (2003). Chemokines in the systemic 
organization of immunity. Immunol. Rev. 195, 58-71. 
Candi,E., Schmidt,R., and Melino,G. (2005). The cornified envelope: a model of cell 
death in the skin. Nat. Rev. Mol. Cell Biol. 6, 328-340. 
Carter,S.B. (1965). Principles of cell motility: the direction of cell movement and 
cancer invasion. Nature 208, 1183-1187. 
Castle,S.C. (2000). Clinical relevance of age-related immune dysfunction. Clin. 
Infect. Dis. 31, 578-585. 
Castle,S.C., Norman,D.C., Perls,T.T., Chang,M.P., Yoshikawa,T.T., and 
Makinodan,T. (1990). Analysis of cutaneous delayed-type hypersensitivity reaction 
References 
Page 154 
and T cell proliferative response in elderly nursing home patients: an approach to 
identifying immunodeficient patients. Gerontology 36, 217-229. 
Celada,A., Klemsz,M.J., and Maki,R.A. (1989). Interferon-gamma activates multiple 
pathways to regulate the expression of the genes for major histocompatibility class II 
I-A beta, tumor necrosis factor and complement component C3 in mouse 
macrophages. Eur. J. Immunol. 19, 1103-1109. 
Celada,A. and Maki,R.A. (1991). IFN-gamma induces the expression of the genes 
for MHC class II I-A beta and tumor necrosis factor through a protein kinase C-
independent pathway. J. Immunol. 146, 114-120. 
Cella,M., Facchetti,F., Lanzavecchia,A., and Colonna,M. (2000). Plasmacytoid 
dendritic cells activated by influenza virus and CD40L drive a potent TH1 
polarization. Nat. Immunol. 1, 305-310. 
Cerovic,V., Jenkins,C.D., Barnes,A.G., Milling,S.W., MacPherson,G.G., and 
Klavinskis,L.S. (2009). Hyporesponsiveness of intestinal dendritic cells to TLR 
stimulation is limited to TLR4. J. Immunol. 182, 2405-2415. 
Chalasani,G., Dai,Z., Konieczny,B.T., Baddoura,F.K., and Lakkis,F.G. (2002). 
Recall and propagation of allospecific memory T cells independent of secondary 
lymphoid organs. Proc. Natl. Acad. Sci. U. S. A 99, 6175-6180. 
Charbonneau,H., Tonks,N.K., Walsh,K.A., and Fischer,E.H. (1988). The leukocyte 
common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. 
Proc. Natl. Acad. Sci. U. S. A 85, 7182-7186. 
Chattopadhyay,B. and Al Zahawi,M. (1983). Septicaemia and its unacceptably high 
mortality in the elderly. J. Infect. 7, 134-138. 
Chong,B.F., Murphy,J.E., Kupper,T.S., and Fuhlbrigge,R.C. (2004). E-selectin, 
thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion 
References 
Page 155 
molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a 
cutaneous immunosurveillance system. J. Immunol. 172, 1575-1581. 
Chu,C.Q., Field,M., Andrew,E., Haskard,D., Feldmann,M., and Maini,R.N. (1992). 
Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity 
in man. Clin. Exp. Immunol. 90, 522-529. 
Chung,J.H., Yano,K., Lee,M.K., Youn,C.S., Seo,J.Y., Kim,K.H., Cho,K.H., 
Eun,H.C., and Detmar,M. (2002). Differential effects of photoaging vs intrinsic 
aging on the vascularization of human skin. Arch. Dermatol. 138, 1437-1442. 
Clark,R.A. (2010). Skin-Resident T Cells: The Ups and Downs of On Site Immunity. 
J. Invest Dermatol. 130, 362-370. 
Clark,R.A., Chong,B., Mirchandani,N., Brinster,N.K., Yamanaka,K., Dowgiert,R.K., 
and Kupper,T.S. (2006). The vast majority of CLA+ T cells are resident in normal 
skin. J. Immunol. 176, 4431-4439. 
Clark,R.A., Huang,S.J., Murphy,G.F., Mollet,I.G., Hijnen,D., Muthukuru,M., 
Schanbacher,C.F., Edwards,V., Miller,D.M., Kim,J.E., Lambert,J., and Kupper,T.S. 
(2008). Human squamous cell carcinomas evade the immune response by down-
regulation of vascular E-selectin and recruitment of regulatory T cells. J. Exp. Med. 
205, 2221-2234. 
Clark,R.A. and Kupper,T.S. (2007). IL-15 and dermal fibroblasts induce 
proliferation of natural regulatory T cells isolated from human skin. Blood 109, 194-
202. 
Colonna,M., Trinchieri,G., and Liu,Y.J. (2004). Plasmacytoid dendritic cells in 
immunity. Nat. Immunol. 5, 1219-1226. 
References 
Page 156 
Creditor,M.C., Smith,E.C., Gallai,J.B., Baumann,M., and Nelson,K.E. (1988). 
Tuberculosis, tuberculin reactivity, and delayed cutaneous hypersensitivity in nursing 
home residents. J. Gerontol. 43, M97-100. 
Croft,M. (2003). Co-stimulatory members of the TNFR family: keys to effective T-
cell immunity? Nat. Rev. Immunol. 3, 609-620. 
Crowle,A.J. (1975). Delayed hypersensitivity in the mouse. Adv. Immunol. 20, 197-
264. 
Cullell-Young,M., Barrachina,M., Lopez-Lopez,C., Gonalons,E., Lloberas,J., 
Soler,C., and Celada,A. (2001). From transcription to cell surface expression, the 
induction of MHC class II I-A alpha by interferon-gamma in macrophages is 
regulated at different levels. Immunogenetics 53, 136-144. 
Curiel,T.J., Coukos,G., Zou,L., Alvarez,X., Cheng,P., Mottram,P., Evdemon-
Hogan,M., Conejo-Garcia,J.R., Zhang,L., Burow,M., Zhu,Y., Wei,S., Kryczek,I., 
Daniel,B., Gordon,A., Myers,L., Lackner,A., Disis,M.L., Knutson,K.L., Chen,L., and 
Zou,W. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma 
fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942-949. 
De Panfilis,G., Manara,G.C., Ferrari,C., and Torresani,C. (1988). Simultaneous 
colloidal gold immunoelectronmicroscopy labeling of CD1a, HLA-DR, and CD4 
surface antigens of human epidermal Langerhans cells. J. Invest Dermatol. 91, 547-
552. 
Deaglio,S., Dwyer,K.M., Gao,W., Friedman,D., Usheva,A., Erat,A., Chen,J.F., 
Enjyoji,K., Linden,J., Oukka,M., Kuchroo,V.K., Strom,T.B., and Robson,S.C. 
(2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory 
T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265. 
Deloire,M.S., Touil,T., Brochet,B., Dousset,V., Caille,J.M., and Petry,K.G. (2004). 
Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not 
References 
Page 157 
completely compromised by suppressed T-cell invasion: in vivo magnetic resonance 
imaging illustration in effective anti-VLA-4 antibody treatment. Mult. Scler. 10, 540-
548. 
Diehl,S. and Rincon,M. (2002). The two faces of IL-6 on Th1/Th2 differentiation. 
Mol. Immunol. 39, 531-536. 
Diffey,B.L. and Langtry,J.A. (2005). Skin cancer incidence and the ageing 
population. Br. J. Dermatol. 153, 679-680. 
Dixon,W.G., Watson,K., Lunt,M., Hyrich,K.L., Silman,A.J., and Symmons,D.P. 
(2006). Rates of serious infection, including site-specific and bacterial intracellular 
infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor 
therapy: results from the British Society for Rheumatology Biologics Register. 
Arthritis Rheum. 54, 2368-2376. 
Dorken,E., Grzybowski,S., and Allen,E.A. (1987). Significance of the tuberculin test 
in the elderly. Chest 92, 237-240. 
Dubois,B., Massacrier,C., Vanbervliet,B., Fayette,J., Briere,F., Banchereau,J., and 
Caux,C. (1998). Critical role of IL-12 in dendritic cell-induced differentiation of 
naive B lymphocytes. J. Immunol. 161, 2223-2231. 
Dudda,J.C., Perdue,N., Bachtanian,E., and Campbell,D.J. (2008). Foxp3+ regulatory 
T cells maintain immune homeostasis in the skin. J. Exp. Med. 205, 1559-1565. 
Dunne,P.J., Belaramani,L., Fletcher,J.M., Fernandez,d.M., Lawrenz,M., 
Soares,M.V., Rustin,M.H., Lam,E.W., Salmon,M., and Akbar,A.N. (2005). 
Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific 
CD8+ T cells during persistent infection. Blood 106, 558-565. 
Dunne,P.J., Faint,J.M., Gudgeon,N.H., Fletcher,J.M., Plunkett,F.J., Soares,M.V., 
Hislop,A.D., Annels,N.E., Rickinson,A.B., Salmon,M., and Akbar,A.N. (2002). 
References 
Page 158 
Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-
resistant memory cells that retain replicative potential. Blood 100, 933-940. 
Edwards,J.P., Zhang,X., Frauwirth,K.A., and Mosser,D.M. (2006). Biochemical and 
functional characterization of three activated macrophage populations. J. Leukoc. 
Biol. 80, 1298-1307. 
Effros,R.B., Cai,Z., and Linton,P.J. (2003). CD8 T cells and aging. Crit Rev. 
Immunol. 23, 45-64. 
Effros,R.B., Svoboda,K., and Walford,R.L. (1991). Influence of age and caloric 
restriction on macrophage IL-6 and TNF production. Lymphokine Cytokine Res. 10, 
347-351. 
El Domyati,M., Attia,S., Saleh,F., Brown,D., Birk,D.E., Gasparro,F., Ahmad,H., and 
Uitto,J. (2002). Intrinsic aging vs. photoaging: a comparative histopathological, 
immunohistochemical, and ultrastructural study of skin. Exp. Dermatol. 11, 398-405. 
Elbe,A., Foster,C.A., and Stingl,G. (1996). T-cell receptor alpha beta and gamma 
delta T cells in rat and human skin--are they equivalent? Semin. Immunol. 8, 341-
349. 
Ely,K.H., Cauley,L.S., Roberts,A.D., Brennan,J.W., Cookenham,T., and 
Woodland,D.L. (2003). Nonspecific recruitment of memory CD8+ T cells to the lung 
airways during respiratory virus infections. J. Immunol. 170, 1423-1429. 
Engelhardt,B., Conley,F.K., Kilshaw,P.J., and Butcher,E.C. (1995). Lymphocytes 
infiltrating the CNS during inflammation display a distinctive phenotype and bind to 
VCAM-1 but not to MAdCAM-1. Int. Immunol 7, 481-491. 
Engwerda,C.R., Handwerger,B.S., and Fox,B.S. (1994). Aged T cells are 
hyporesponsive to costimulation mediated by CD28. J. Immunol. 152, 3740-3747. 
References 
Page 159 
Etzioni,A., Frydman,M., Pollack,S., Avidor,I., Phillips,M.L., Paulson,J.C., and 
Gershoni-Baruch,R. (1992). Brief report: recurrent severe infections caused by a 
novel leukocyte adhesion deficiency. N. Engl. J. Med. 327, 1789-1792. 
Faint,J.M., Annels,N.E., Curnow,S.J., Shields,P., Pilling,D., Hislop,A.D., Wu,L., 
Akbar,A.N., Buckley,C.D., Moss,P.A., Adams,D.H., Rickinson,A.B., and Salmon,M. 
(2001). Memory T cells constitute a subset of the human CD8+CD45RA+ pool with 
distinct phenotypic and migratory characteristics. J. Immunol. 167, 212-220. 
Fithian,E., Kung,P., Goldstein,G., Rubenfeld,M., Fenoglio,C., and Edelson,R. 
(1981). Reactivity of Langerhans cells with hybridoma antibody. Proc. Natl. Acad. 
Sci. U. S. A 78, 2541-2544. 
Fletcher,J.M., Vukmanovic-Stejic,M., Dunne,P.J., Birch,K.E., Cook,J.E., 
Jackson,S.E., Salmon,M., Rustin,M.H., and Akbar,A.N. (2005). Cytomegalovirus-
specific CD4+ T cells in healthy carriers are continuously driven to replicative 
exhaustion. J. Immunol. 175, 8218-8225. 
Fogg,D.K., Sibon,C., Miled,C., Jung,S., Aucouturier,P., Littman,D.R., Cumano,A., 
and Geissmann,F. (2006). A clonogenic bone marrow progenitor specific for 
macrophages and dendritic cells. Science 311, 83-87. 
Frenette,P.S., Mayadas,T.N., Rayburn,H., Hynes,R.O., and Wagner,D.D. (1996). 
Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and 
E-selectins. Cell 84, 563-574. 
Gavin,M.A., Torgerson,T.R., Houston,E., deRoos,P., Ho,W.Y., Stray-Pedersen,A., 
Ocheltree,E.L., Greenberg,P.D., Ochs,H.D., and Rudensky,A.Y. (2006). Single-cell 
analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without 
regulatory T cell development. PNAS 103, 6659-6664. 
References 
Page 160 
Geijtenbeek,T.B., Krooshoop,D.J., Bleijs,D.A., van Vliet,S.J., van Duijnhoven,G.C., 
Grabovsky,V., Alon,R., Figdor,C.G., and van Kooyk,Y. (2000). DC-SIGN-ICAM-2 
interaction mediates dendritic cell trafficking. Nat. Immunol. 1, 353-357. 
Geissmann,F., Jung,S., and Littman,D.R. (2003). Blood monocytes consist of two 
principal subsets with distinct migratory properties. Immunity. 19, 71-82. 
Geppert,T.D. and Lipsky,P.E. (1989). Antigen presentation at the inflammatory site. 
Crit Rev. Immunol. 9, 313-362. 
Gerdes,J., Lemke,H., Baisch,H., Wacker,H.H., Schwab,U., and Stein,H. (1984). Cell 
cycle analysis of a cell proliferation-associated human nuclear antigen defined by the 
monoclonal antibody Ki-67. J. Immunol. 133, 1710-1715. 
Gibbs,J.H., Ferguson,J., Brown,R.A., Kenicer,K.J., Potts,R.C., Coghill,G., and 
Swanson,B.J. (1984). Histometric study of the localisation of lymphocyte subsets 
and accessory cells in human Mantoux reactions. J. Clin. Pathol. 37, 1227-1234. 
Gilliet,M., Cao,W., and Liu,Y.J. (2008). Plasmacytoid dendritic cells: sensing 
nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-
606. 
Ginhoux,F., Tacke,F., Angeli,V., Bogunovic,M., Loubeau,M., Dai,X.M., 
Stanley,E.R., Randolph,G.J., and Merad,M. (2006). Langerhans cells arise from 
monocytes in vivo. Nat. Immunol. 7, 265-273. 
Goerdt,S. and Orfanos,C.E. (1999). Other functions, other genes: alternative 
activation of antigen-presenting cells. Immunity. 10, 137-142. 
Gon,Y., Hashimoto,S., Hayashi,S., Koura,T., Matsumoto,K., and Horie,T. (1996). 
Lower serum concentrations of cytokines in elderly patients with pneumonia and the 
impaired production of cytokines by peripheral blood monocytes in the elderly. Clin. 
Exp. Immunol. 106, 120-126. 
References 
Page 161 
Gonalons,E., Barrachina,M., Garcia-Sanz,J.A., and Celada,A. (1998). Translational 
control of MHC class II I-A molecules by IFN-gamma. J. Immunol. 161, 1837-1843. 
Gordon,S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-
35. 
Gordon,S. (2007). The macrophage: past, present and future. Eur. J. Immunol. 37 
Suppl 1, S9-17. 
Gorse,G.J., Thrupp,L.D., Nudleman,K.L., Wyle,F.A., Hawkins,B., and Cesario,T.C. 
(1984). Bacterial meningitis in the elderly. Arch. Intern. Med. 144, 1603-1607. 
Gottlieb,A., Krueger,J.G., Bright,R., Ling,M., Lebwohl,M., Kang,S., Feldman,S., 
Spellman,M., Wittkowski,K., Ochs,H.D., Jardieu,P., Bauer,R., White,M., 
Dedrick,R., and Garovoy,M. (2000). Effects of administration of a single dose of a 
humanized monoclonal antibody to CD11a on the immunobiology and clinical 
activity of psoriasis. J. Am. Acad. Dermatol. 42, 428-435. 
Grabbe,S., Steinbrink,K., Steinert,M., Luger,T.A., and Schwarz,T. (1995). Removal 
of the majority of epidermal Langerhans cells by topical or systemic steroid 
application enhances the effector phase of murine contact hypersensitivity. J. 
Immunol. 155, 4207-4217. 
Grabbe,S., Varga,G., Beissert,S., Steinert,M., Pendl,G., Seeliger,S., Bloch,W., 
Peters,T., Schwarz,T., Sunderkotter,C., and Scharffetter-Kochanek,K. (2002). Beta2 
integrins are required for skin homing of primed T cells but not for priming naive T 
cells. J. Clin. Invest 109, 183-192. 
Greening,J.E., Tree,T.I.M., Kotowicz,K.T., van Halteren,A.G., Roep,B.O., 
Klein,N.J., and Peakman,M. (2003). Processing and Presentation of the Islet 
Autoantigen GAD by Vascular Endothelial Cells Promotes Transmigration of 
Autoreactive T-Cells. Diabetes 52, 717-725. 
References 
Page 162 
Groves,R.W., Allen,M.H., Ross,E.L., Barker,J.N., and MacDonald,D.M. (1995). 
Tumour necrosis factor alpha is pro-inflammatory in normal human skin and 
modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132, 345-352. 
Grubeck-Loebenstein,B. and Wick,G. (2002). The aging of the immune system. Adv. 
Immunol. 80, 243-284. 
Harrington,L.E., Hatton,R.D., Mangan,P.R., Turner,H., Murphy,T.L., Murphy,K.M., 
and Weaver,C.T. (2005). Interleukin 17-producing CD4+ effector T cells develop via 
a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-
1132. 
Harris,N.L., Watt,V., Ronchese,F., and Le Gros,G. (2002). Differential T cell 
function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195, 317-
326. 
Hayashi,F., Smith,K.D., Ozinsky,A., Hawn,T.R., Yi,E.C., Goodlett,D.R., Eng,J.K., 
Akira,S., Underhill,D.M., and Aderem,A. (2001). The innate immune response to 
bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103. 
Haynes,B.F., Markert,M.L., Sempowski,G.D., Patel,D.D., and Hale,L.P. (2000). The 
role of the thymus in immune reconstitution in aging, bone marrow transplantation, 
and HIV-1 infection. Annu. Rev. Immunol. 18, 529-560. 
Hermiston,M.L., Xu,Z., and Weiss,A. (2003). CD45: a critical regulator of signaling 
thresholds in immune cells. Annu. Rev. Immunol. 21, 107-137. 
Hirahara,K., Liu,L., Clark,R.A., Yamanaka,K., Fuhlbrigge,R.C., and Kupper,T.S. 
(2006). The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory 
T cells bear functional skin-homing receptors. J. Immunol. 177, 4488-4494. 
Hislop,A.D., Gudgeon,N.H., Callan,M.F., Fazou,C., Hasegawa,H., Salmon,M., and 
Rickinson,A.B. (2001). EBV-specific CD8+ T cell memory: relationships between 
References 
Page 163 
epitope specificity, cell phenotype, and immediate effector function. J. Immunol. 
167, 2019-2029. 
Hogan,R.J., Zhong,W., Usherwood,E.J., Cookenham,T., Roberts,A.D., and 
Woodland,D.L. (2001). Protection from respiratory virus infections can be mediated 
by antigen-specific CD4(+) T cells that persist in the lungs. J. Exp. Med. 193, 981-
986. 
Holmes,N. (2006). CD45: all is not yet crystal clear. Immunology 117, 145-155. 
Hori,S., Nomura,T., and Sakaguchi,S. (2003). Control of regulatory T cell 
development by the transcription factor Foxp3. Science 299, 1057-1061. 
Horn,F., Henze,C., and Heidrich,K. (2000). Interleukin-6 signal transduction and 
lymphocyte function. Immunobiology 202, 151-167. 
Hu,H., Huston,G., Duso,D., Lepak,N., Roman,E., and Swain,S.L. (2001). CD4(+) T 
cell effectors can become memory cells with high efficiency and without further 
division. Nat. Immunol. 2, 705-710. 
Imai,T., Baba,M., Nishimura,M., Kakizaki,M., Takagi,S., and Yoshie,O. (1997). The 
T cell-directed CC chemokine TARC is a highly specific biological ligand for CC 
chemokine receptor 4. J. Biol. Chem. 272, 15036-15042. 
Ito,Y., Betsuyaku,T., Moriyama,C., Nasuhara,Y., and Nishimura,M. (2009). Aging 
affects lipopolysaccharide-induced upregulation of heme oxygenase-1 in the lungs 
and alveolar macrophages. Biogerontology. 10, 173-180. 
Jamieson,B.D., Douek,D.C., Killian,S., Hultin,L.E., Scripture-Adams,D.D., 
Giorgi,J.V., Marelli,D., Koup,R.A., and Zack,J.A. (1999). Generation of functional 
thymocytes in the human adult. Immunity. 10, 569-575. 
References 
Page 164 
Janeway CA,T.P.W.M.S.M. (2009). Immunobiology:The Immune System in Health 
and Disease. 5
th
 Edition. Churchill Livingstone.2001. 
Jaron,B., Maranghi,E., Leclerc,C., and Majlessi,L. (2008). Effect of attenuation of 
Treg during BCG immunization on anti-mycobacterial Th1 responses and protection 
against Mycobacterium tuberculosis. PLoS. One. 3, e2833. 
Jarrossay,D., Napolitani,G., Colonna,M., Sallusto,F., and Lanzavecchia,A. (2001). 
Specialization and complementarity in microbial molecule recognition by human 
myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393. 
Jenkins,G. (2002). Molecular mechanisms of skin ageing. Mech. Ageing Dev. 123, 
801-810. 
Jenkins,M.K., Khoruts,A., Ingulli,E., Mueller,D.L., McSorley,S.J., Reinhardt,R.L., 
Itano,A., and Pape,K.A. (2001). In vivo activation of antigen-specific CD4 T cells. 
Annu. Rev. Immunol. 19, 23-45. 
John,B. and Hunter,C.A. (2008). Immunology. Neutrophil soldiers or Trojan Horses? 
Science 321, 917-918. 
Johnson,L.A., Clasper,S., Holt,A.P., Lalor,P.F., Baban,D., and Jackson,D.G. (2006). 
An inflammation-induced mechanism for leukocyte transmigration across lymphatic 
vessel endothelium. J. Exp. Med. 203, 2763-2777. 
Johnson-Huang,L.M., McNutt,N.S., Krueger,J.G., and Lowes,M.A. (2009). 
Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin 
diseases. J. Clin. Immunol. 29, 247-256. 
Jones,C.M., Cose,S.C., McNally,J.M., Jennings,S.R., Heath,W.R., and Carbone,F.R. 
(2000). Diminished secondary CTL response in draining lymph nodes on cutaneous 
challenge with herpes simplex virus. J. Gen. Virol. 81, 407-414. 
References 
Page 165 
Kalinin,A.E., Kajava,A.V., and Steinert,P.M. (2002). Epithelial barrier function: 
assembly and structural features of the cornified cell envelope. Bioessays 24, 789-
800. 
Kalish,R.S. and Johnson,K.L. (1990). Enrichment and function of urushiol (poison 
ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J. 
Immunol. 145, 3706-3713. 
Kamijo,R., Le,J., Shapiro,D., Havell,E.A., Huang,S., Aguet,M., Bosland,M., and 
Vilcek,J. (1993). Mice that lack the interferon-gamma receptor have profoundly 
altered responses to infection with Bacillus Calmette-Guerin and subsequent 
challenge with lipopolysaccharide. J. Exp. Med. 178, 1435-1440. 
Kaplan,D.H., Jenison,M.C., Saeland,S., Shlomchik,W.D., and Shlomchik,M.J. 
(2005). Epidermal langerhans cell-deficient mice develop enhanced contact 
hypersensitivity. Immunity. 23, 611-620. 
Katou,F., Ohtani,H., Saaristo,A., Nagura,H., and Motegi,K. (2000). Immunological 
activation of dermal Langerhans cells in contact with lymphocytes in a model of 
human inflamed skin. Am. J. Pathol. 156, 519-527. 
Kelley,V.E., Fiers,W., and Strom,T.B. (1984). Cloned human interferon-gamma, but 
not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal 
monocytes and myeloid leukemic cell lines. J. Immunol. 132, 240-245. 
Kelly,R.I., Pearse,R., Bull,R.H., Leveque,J.L., de Rigal,J., and Mortimer,P.S. (1995). 
The effects of aging on the cutaneous microvasculature. J. Am. Acad. Dermatol. 33, 
749-756. 
Kiistala,U. (1968). Suction blister device for separation of viable epidermis from 
dermis. J. Invest Dermatol. 50, 129-137. 
References 
Page 166 
King,C., Tangye,S.G., and Mackay,C.R. (2008). T follicular helper (TFH) cells in 
normal and dysregulated immune responses. Annu. Rev. Immunol. 26, 741-766. 
Kipling,D. and Cooke,H.J. (1990). Hypervariable ultra-long telomeres in mice. 
Nature 347, 400-402. 
Kissenpfennig,A., Henri,S., Dubois,B., Laplace-Builhe,C., Perrin,P., Romani,N., 
Tripp,C.H., Douillard,P., Leserman,L., Kaiserlian,D., Saeland,S., Davoust,J., and 
Malissen,B. (2005). Dynamics and function of Langerhans cells in vivo: dermal 
dendritic cells colonize lymph node areas distinct from slower migrating Langerhans 
cells. Immunity. 22, 643-654. 
Klonowski,K.D., Williams,K.J., Marzo,A.L., Blair,D.A., Lingenheld,E.G., and 
Lefrancois,L. (2004). Dynamics of blood-borne CD8 memory T cell migration in 
vivo. Immunity. 20, 551-562. 
Krutzik,S.R., Tan,B., Li,H., Ochoa,M.T., Liu,P.T., Sharfstein,S.E., Graeber,T.G., 
Sieling,P.A., Liu,Y.J., Rea,T.H., Bloom,B.R., and Modlin,R.L. (2005). TLR 
activation triggers the rapid differentiation of monocytes into macrophages and 
dendritic cells. Nat. Med. 11, 653-660. 
Kung,C., Pingel,J.T., Heikinheimo,M., Klemola,T., Varkila,K., Yoo,L.I., 
Vuopala,K., Poyhonen,M., Uhari,M., Rogers,M., Speck,S.H., Chatila,T., and 
Thomas,M.L. (2000). Mutations in the tyrosine phosphatase CD45 gene in a child 
with severe combined immunodeficiency disease. Nat. Med. 6, 343-345. 
Kupper,T.S. and Fuhlbrigge,R.C. (2004). Immune surveillance in the skin: 
mechanisms and clinical consequences. Nat. Rev. Immunol. 4, 211-222. 
LaCroix,A.Z., Lipson,S., Miles,T.P., and White,L. (1989). Prospective study of 
pneumonia hospitalizations and mortality of U.S. older people: the role of chronic 
conditions, health behaviors, and nutritional status. Public Health Rep. 104, 350-360. 
References 
Page 167 
Lages,C.S., Suffia,I., Velilla,P.A., Huang,B., Warshaw,G., Hildeman,D.A., 
Belkaid,Y., and Chougnet,C. (2008). Functional regulatory T cells accumulate in 
aged hosts and promote chronic infectious disease reactivation. J Immunol 181, 
1835-1848. 
Laube,S. (2004). Skin infections and ageing. Ageing Res. Rev. 3, 69-89. 
Levings,M.K., Sangregorio,R., and Roncarolo,M.G. (2001). Human cd25(+)cd4(+) t 
regulatory cells suppress naive and memory T cell proliferation and can be expanded 
in vitro without loss of function. J. Exp. Med. 193, 1295-1302. 
Ley,K., Laudanna,C., Cybulsky,M.I., and Nourshargh,S. (2007). Getting to the site 
of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 
678-689. 
Leyden,J.J. (1990). Clinical features of ageing skin. Br. J. Dermatol. 122 Suppl 35, 1-
3. 
Li,L., Mac-Mary,S., Sainthillier,J.M., Nouveau,S., de Lacharriere,O., and 
Humbert,P. (2006). Age-related changes of the cutaneous microcirculation in vivo. 
Gerontology 52, 142-153. 
Ligthart,G.J., Corberand,J.X., Fournier,C., Galanaud,P., Hijmans,W., Kennes,B., 
Muller-Hermelink,H.K., and Steinmann,G.G. (1984). Admission criteria for 
immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 
28, 47-55. 
Linton,P.J. and Dorshkind,K. (2004). Age-related changes in lymphocyte 
development and function. Nat. Immunol. 5, 133-139. 
Linton,P.J., Haynes,L., Klinman,N.R., and Swain,S.L. (1996). Antigen-independent 
changes in naive CD4 T cells with aging. J. Exp. Med. 184, 1891-1900. 
References 
Page 168 
Liu,K., Waskow,C., Liu,X., Yao,K., Hoh,J., and Nussenzweig,M. (2007). Origin of 
dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8, 578-583. 
Liu,W., Putnam,A.L., Xu-Yu,Z., Szot,G.L., Lee,M.R., Zhu,S., Gottlieb,P.A., 
Kapranov,P., Gingeras,T.R., Fazekas de St,G.B., Clayberger,C., Soper,D.M., 
Ziegler,S.F., and Bluestone,J.A. (2006). CD127 expression inversely correlates with 
FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701-
1711. 
Lloberas,J. and Celada,A. (2002). Effect of aging on macrophage function. Exp. 
Gerontol. 37, 1325-1331. 
Lowes,M.A., Chamian,F., Abello,M.V., Fuentes-Duculan,J., Lin,S.L., Nussbaum,R., 
Novitskaya,I., Carbonaro,H., Cardinale,I., Kikuchi,T., Gilleaudeau,P., Sullivan-
Whalen,M., Wittkowski,K.M., Papp,K., Garovoy,M., Dummer,W., Steinman,R.M., 
and Krueger,J.G. (2005). Increase in TNF-alpha and inducible nitric oxide synthase-
expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). 
Proc. Natl. Acad. Sci. U. S. A 102, 19057-19062. 
Lu,B., Rutledge,B.J., Gu,L., Fiorillo,J., Lukacs,N.W., Kunkel,S.L., North,R., 
Gerard,C., and Rollins,B.J. (1998). Abnormalities in monocyte recruitment and 
cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. 
Med. 187, 601-608. 
Lumeng,C.N., Bodzin,J.L., and Saltiel,A.R. (2007). Obesity induces a phenotypic 
switch in adipose tissue macrophage polarization. J. Clin. Invest 117, 175-184. 
Lutz,W., Sanderson,W., and Scherbov,S. (1997). Doubling of world population 
unlikely. Nature 387, 803-805. 
Mackay,C.R., Marston,W.L., and Dudler,L. (1990). Naive and memory T cells show 
distinct pathways of lymphocyte recirculation. J. Exp. Med. 171, 801-817. 
References 
Page 169 
Mallon,E., Powell,S., Mortimer,P., and Ryan,T.J. (1997). Evidence for altered cell-
mediated immunity in postmastectomy lymphoedema. Br. J. Dermatol. 137, 928-933. 
Masopust,D., Vezys,V., Marzo,A.L., and Lefrancois,L. (2001). Preferential 
localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-
2417. 
Massberg,S., Schaerli,P., Knezevic-Maramica,I., Kollnberger,M., Tubo,N., 
Moseman,E.A., Huff,I.V., Junt,T., Wagers,A.J., Mazo,I.B., and von Andrian,U.H. 
(2007). Immunosurveillance by hematopoietic progenitor cells trafficking through 
blood, lymph, and peripheral tissues. Cell 131, 994-1008. 
Mathers,A.R. and Larregina,A.T. (2006). Professional antigen-presenting cells of the 
skin. Immunol. Res. 36, 127-136. 
Matsushita,H., Chang,E., Glassford,A.J., Cooke,J.P., Chiu,C.P., and Tsao,P.S. 
(2001). eNOS activity is reduced in senescent human endothelial cells: Preservation 
by hTERT immortalization. Circ. Res. 89, 793-798. 
Matzinger,P. (2002). An innate sense of danger. Ann. N. Y. Acad. Sci. 961, 341-342. 
Matzinger,P. (2007). Friendly and dangerous signals: is the tissue in control? Nat. 
Immunol. 8, 11-13. 
McHale,J.F., Harari,O.A., Marshall,D., and Haskard,D.O. (1999). Vascular 
endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact 
hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J. Immunol. 
162, 1648-1655. 
McLellan,A.D., Heiser,A., Sorg,R.V., Fearnley,D.B., and Hart,D.N. (1998). Dermal 
dendritic cells associated with T lymphocytes in normal human skin display an 
activated phenotype. J. Invest Dermatol. 111, 841-849. 
References 
Page 170 
Medzhitov,R., Preston-Hurlburt,P., and Janeway,C.A., Jr. (1997). A human 
homologue of the Drosophila Toll protein signals activation of adaptive immunity. 
Nature 388, 394-397. 
Merad,M., Manz,M.G., Karsunky,H., Wagers,A., Peters,W., Charo,I., 
Weissman,I.L., Cyster,J.G., and Engleman,E.G. (2002). Langerhans cells renew in 
the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135-1141. 
Mestas,J. and Hughes,C.C. (2004). Of mice and not men: differences between mouse 
and human immunology. J. Immunol. 172, 2731-2738. 
Ming,W.J., Bersani,L., and Mantovani,A. (1987). Tumor necrosis factor is 
chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138, 
1469-1474. 
Miyara,M., Amoura,Z., Parizot,C., Badoual,C., Dorgham,K., Trad,S., 
Kambouchner,M., Valeyre,D., Chapelon-Abric,C., Debre,P., Piette,J.C., and 
Gorochov,G. (2006). The immune paradox of sarcoidosis and regulatory T cells. J. 
Exp. Med. 203, 359-370. 
Mizukawa,Y., Yamazaki,Y., Teraki,Y., Hayakawa,J., Hayakawa,K., Nuriya,H., 
Kohara,M., and Shiohara,T. (2002). Direct evidence for interferon-gamma 
production by effector-memory-type intraepidermal T cells residing at an effector 
site of immunopathology in fixed drug eruption. Am. J. Pathol. 161, 1337-1347. 
Mizumoto,N. and Takashima,A. (2004). CD1a and langerin: acting as more than 
Langerhans cell markers. J. Clin. Invest 113, 658-660. 
Moon,J.J., Chu,H.H., Pepper,M., McSorley,S.J., Jameson,S.C., Kedl,R.M., and 
Jenkins,M.K. (2007). Naive CD4(+) T cell frequency varies for different epitopes 
and predicts repertoire diversity and response magnitude. Immunity. 27, 203-213. 
References 
Page 171 
Mosser,D.M. and Edwards,J.P. (2008). Exploring the full spectrum of macrophage 
activation. Nat. Rev. Immunol. 8, 958-969. 
Murasko,D.M., Bernstein,E.D., Gardner,E.M., Gross,P., Munk,G., Dran,S., and 
Abrutyn,E. (2002). Role of humoral and cell-mediated immunity in protection from 
influenza disease after immunization of healthy elderly. Exp. Gerontol. 37, 427-439. 
Murciano,C., Villamon,E., Yanez,A., O'Connor,J.E., Gozalbo,D., and Gil,M.L. 
(2006). Impaired immune response to Candida albicans in aged mice. J. Med. 
Microbiol. 55, 1649-1656. 
Murphy,K.M. and Reiner,S.L. (2002). The lineage decisions of helper T cells. Nat. 
Rev. Immunol. 2, 933-944. 
Mustelin,T., Rahmouni,S., Bottini,N., and Alonso,A. (2003). Role of protein tyrosine 
phosphatases in T cell activation. Immunol. Rev. 191, 139-147. 
Nedwin,G.E., Svedersky,L.P., Bringman,T.S., Palladino,M.A., Jr., and Goeddel,D.V. 
(1985). Effect of interleukin 2, interferon-gamma, and mitogens on the production of 
tumor necrosis factors alpha and beta. J. Immunol. 135, 2492-2497. 
Nestle,F.O., Conrad,C., Tun-Kyi,A., Homey,B., Gombert,M., Boyman,O., Burg,G., 
Liu,Y.J., and Gilliet,M. (2005). Plasmacytoid predendritic cells initiate psoriasis 
through interferon-alpha production. J. Exp. Med. 202, 135-143. 
Nestle,F.O., Filgueira,L., Nickoloff,B.J., and Burg,G. (1998). Human dermal 
dendritic cells process and present soluble protein antigens. J. Invest Dermatol. 110, 
762-766. 
Nestle,F.O. and Nickoloff,B.J. (2007). Deepening our understanding of immune 
sentinels in the skin. J. Clin. Invest 117, 2382-2385. 
Newman,P.J. (1997). The biology of PECAM-1. J Clin. Invest 99, 3-8. 
References 
Page 172 
Nicholson,K.G., Kent,J., Hammersley,V., and Cancio,E. (1997). Acute viral 
infections of upper respiratory tract in elderly people living in the community: 
comparative, prospective, population based study of disease burden. BMJ 315, 1060-
1064. 
Orteu,C.H., Poulter,L.W., Rustin,M.H., Sabin,C.A., Salmon,M., and Akbar,A.N. 
(1998). The role of apoptosis in the resolution of T cell-mediated cutaneous 
inflammation. J. Immunol. 161, 1619-1629. 
Ostler,T., Hussell,T., Surh,C.D., Openshaw,P., and Ehl,S. (2001). Long-term 
persistence and reactivation of T cell memory in the lung of mice infected with 
respiratory syncytial virus. Eur. J. Immunol. 31, 2574-2582. 
Ouyang,Q., Wagner,W.M., Zheng,W., Wikby,A., Remarque,E.J., and Pawelec,G. 
(2004). Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp. 
Gerontol. 39, 607-613. 
Paleolog,E.M., Young,S., Stark,A.C., McCloskey,R.V., Feldmann,M., and 
Maini,R.N. (1998). Modulation of angiogenic vascular endothelial growth factor by 
tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis 
Rheum. 41, 1258-1265. 
Palm,N.W. and Medzhitov,R. (2007). Antifungal defense turns 17. Nat. Immunol. 8, 
549-551. 
Pandiyan,P., Zheng,L., Ishihara,S., Reed,J., and Lenardo,M.J. (2007). 
CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated 
apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353-1362. 
Papp,K., Bissonnette,R., Krueger,J.G., Carey,W., Gratton,D., Gulliver,W.P., Lui,H., 
Lynde,C.W., Magee,A., Minier,D., Ouellet,J.P., Patel,P., Shapiro,J., Shear,N.H., 
Kramer,S., Walicke,P., Bauer,R., Dedrick,R.L., Kim,S.S., White,M., and 
References 
Page 173 
Garovoy,M.R. (2001). The treatment of moderate to severe psoriasis with a new anti-
CD11a monoclonal antibody. J. Am. Acad. Dermatol. 45, 665-674. 
Passlick,B., Flieger,D., and Ziegler-Heitbrock,H.W. (1989). Identification and 
characterization of a novel monocyte subpopulation in human peripheral blood. 
Blood 74, 2527-2534. 
Pawelec,G., Derhovanessian,E., Larbi,A., Strindhall,J., and Wikby,A. (2009). 
Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 19, 47-56. 
Pawelec,G., Effros,R.B., Caruso,C., Remarque,E., Barnett,Y., and Solana,R. (1999). 
T cells and aging (update february 1999). Front Biosci. 4, D216-D269. 
Pawelec,G., Solana,R., Remarque,E., and Mariani,E. (1998). Impact of aging on 
innate immunity. J. Leukoc. Biol. 64, 703-712. 
Peng,H.B., Spiecker,M., and Liao,J.K. (1998). Inducible nitric oxide: an 
autoregulatory feedback inhibitor of vascular inflammation. J. Immunol. 161, 1970-
1976. 
Peters,N.C., Egen,J.G., Secundino,N., Debrabant,A., Kimblin,N., Kamhawi,S., 
Lawyer,P., Fay,M.P., Germain,R.N., and Sacks,D. (2008). In vivo imaging reveals 
an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 
321, 970-974. 
Piaserico,S., Larese,F., Recchia,G.P., Corradin,M.T., Scardigli,F., Gennaro,F., 
Carriere,C., Semenzato,A., Brandolisio,L., Peserico,A., and Fortina,A.B. (2004). 
Allergic contact sensitivity in elderly patients. Aging Clin. Exp. Res. 16, 221-225. 
Picker,L.J., Kishimoto,T.K., Smith,C.W., Warnock,R.A., and Butcher,E.C. (1991). 
ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 349, 796-799. 
References 
Page 174 
Platt,J.L., Grant,B.W., Eddy,A.A., and Michael,A.F. (1983). Immune cell 
populations in cutaneous delayed-type hypersensitivity. J. Exp. Med. 158, 1227-
1242. 
Plowden,J., Renshaw-Hoelscher,M., Engleman,C., Katz,J., and Sambhara,S. (2004). 
Innate immunity in aging: impact on macrophage function. Aging Cell 3, 161-167. 
Plunkett,F.J., Franzese,O., Belaramani,L.L., Fletcher,J.M., Gilmour,K.C., Sharifi,R., 
Khan,N., Hislop,A.D., Cara,A., Salmon,M., Gaspar,H.B., Rustin,M.H., Webster,D., 
and Akbar,A.N. (2005). The impact of telomere erosion on memory CD8+ T cells in 
patients with X-linked lymphoproliferative syndrome. Mech. Ageing Dev. 126, 855-
865. 
Pober,J.S., Kluger,M.S., and Schechner,J.S. (2001). Human endothelial cell 
presentation of antigen and the homing of memory/effector T cells to skin. Ann. N. 
Y. Acad. Sci. 941, 12-25. 
Poltorak,A., He,X., Smirnova,I., Liu,M.Y., Van Huffel,C., Du,X., Birdwell,D., 
Alejos,E., Silva,M., Galanos,C., Freudenberg,M., Ricciardi-Castagnoli,P., Layton,B., 
and Beutler,B. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr 
mice: mutations in Tlr4 gene. Science 282, 2085-2088. 
Porcheray,F., Viaud,S., Rimaniol,A.C., Leone,C., Samah,B., Dereuddre-Bosquet,N., 
Dormont,D., and Gras,G. (2005). Macrophage activation switching: an asset for the 
resolution of inflammation. Clin. Exp. Immunol. 142, 481-489. 
Poulter,L.W., Seymour,G.J., Duke,O., Janossy,G., and Panayi,G. (1982). 
Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol. 
74, 358-369. 
Rabe,J.H., Mamelak,A.J., McElgunn,P.J., Morison,W.L., and Sauder,D.N. (2006). 
Photoaging: mechanisms and repair. J. Am. Acad. Dermatol. 55, 1-19. 
References 
Page 175 
Randolph,G.J., Inaba,K., Robbiani,D.F., Steinman,R.M., and Muller,W.A. (1999). 
Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. 
Immunity. 11, 753-761. 
Reed,J.R., Vukmanovic-Stejic,M., Fletcher,J.M., Soares,M.V., Cook,J.E., 
Orteu,C.H., Jackson,S.E., Birch,K.E., Foster,G.R., Salmon,M., Beverley,P.C., 
Rustin,M.H., and Akbar,A.N. (2004). Telomere erosion in memory T cells induced 
by telomerase inhibition at the site of antigenic challenge in vivo. J. Exp. Med. 199, 
1433-1443. 
Reinhardt,R.L., Bullard,D.C., Weaver,C.T., and Jenkins,M.K. (2003). Preferential 
accumulation of antigen-specific effector CD4 T cells at an antigen injection site 
involves CD62E-dependent migration but not local proliferation. J. Exp. Med. 197, 
751-762. 
Reinhardt,R.L., Khoruts,A., Merica,R., Zell,T., and Jenkins,M.K. (2001). Visualizing 
the generation of memory CD4 T cells in the whole body. Nature 410, 101-105. 
Reiss,Y., Proudfoot,A.E., Power,C.A., Campbell,J.J., and Butcher,E.C. (2001). CC 
chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting 
chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194, 
1541-1547. 
Renshaw,M., Rockwell,J., Engleman,C., Gewirtz,A., Katz,J., and Sambhara,S. 
(2002). Cutting edge: impaired Toll-like receptor expression and function in aging. J. 
Immunol. 169, 4697-4701. 
Richards,A., Kavanagh,D., and Atkinson,J.P. (2007). Inherited complement 
regulatory protein deficiency predisposes to human disease in acute injury and 
chronic inflammatory statesthe examples of vascular damage in atypical hemolytic 
uremic syndrome and debris accumulation in age-related macular degeneration. Adv. 
Immunol. 96, 141-177. 
References 
Page 176 
Robert A.Norman (2001). Geriatric Dermatology. The Parthenon Publishing Group 
Inc.). 
Rodysill,K.J., Hansen,L., and O'Leary,J.J. (1989). Cutaneous-delayed 
hypersensitivity in nursing home and geriatric clinic patients. Implications for the 
tuberculin test. J. Am. Geriatr. Soc. 37, 435-443. 
Roman,E., Miller,E., Harmsen,A., Wiley,J., Von Andrian,U.H., Huston,G., and 
Swain,S.L. (2002). CD4 effector T cell subsets in the response to influenza: 
heterogeneity, migration, and function. J. Exp. Med. 196, 957-968. 
Romero,P., Zippelius,A., Kurth,I., Pittet,M.J., Touvrey,C., Iancu,E.M., Corthesy,P., 
Devevre,E., Speiser,D.E., and Rufer,N. (2007). Four functionally distinct populations 
of human effector-memory CD8+ T lymphocytes. J. Immunol. 178, 4112-4119. 
Ronald Marks (1999). Skin disease in old age. Martin Dunitz Ltd). 
Rossi,D. and Zlotnik,A. (2000). The biology of chemokines and their receptors. 
Annu. Rev. Immunol. 18, 217-242. 
Rowe,J.W. and Kahn,R.L. (2000). Successful aging and disease prevention. Adv. 
Ren Replace. Ther. 7, 70-77. 
Roychowdhury,S. and Svensson,C.K. (2005). Mechanisms of drug-induced delayed-
type hypersensitivity reactions in the skin. AAPS. J. 7, E834-E846. 
Rudolph,M.G., Stanfield,R.L., and Wilson,I.A. (2006). How TCRs bind MHCs, 
peptides, and coreceptors. Annu. Rev. Immunol. 24, 419-466. 
Ruprecht,C.R., Gattorno,M., Ferlito,F., Gregorio,A., Martini,A., Lanzavecchia,A., 
and Sallusto,F. (2005). Coexpression of CD25 and CD27 identifies FoxP3+ 
regulatory T cells in inflamed synovia. J. Exp. Med. 201, 1793-1803. 
References 
Page 177 
Rustemeyer,T., de Groot,J., von Blomberg,B.M., Bruynzeel,D.P., Frosch,P.J., and 
Scheper,R.J. (2002). Assessment of contact allergen cross-reactivity by retesting. 
Exp. Dermatol. 11, 257-265. 
Sadaoka,K., Okamoto,S., Gomi,Y., Tanimoto,T., Ishikawa,T., Yoshikawa,T., 
Asano,Y., Yamanishi,K., and Mori,Y. (2008). Measurement of varicella-zoster virus 
(VZV)-specific cell-mediated immunity: comparison between VZV skin test and 
interferon-gamma enzyme-linked immunospot assay. J. Infect. Dis. 198, 1327-1333. 
Sakaguchi,S. (2004). Naturally arising CD4+ regulatory t cells for immunologic self-
tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-
562. 
Sakaguchi,S. (2005). Naturally arising Foxp3-expressing CD25+CD4+ regulatory T 
cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352. 
Sallusto,F., Geginat,J., and Lanzavecchia,A. (2004). Central memory and effector 
memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 
22, 745-763. 
Sallusto,F., Lenig,D., Forster,R., Lipp,M., and Lanzavecchia,A. (1999). Two subsets 
of memory T lymphocytes with distinct homing potentials and effector functions. 
Nature 401, 708-712. 
Salmon,M., Pilling,D., Borthwick,N.J., Viner,N., Janossy,G., Bacon,P.A., and 
Akbar,A.N. (1994). The progressive differentiation of primed T cells is associated 
with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24, 892-899. 
Sasmono,R.T., Oceandy,D., Pollard,J.W., Tong,W., Pavli,P., Wainwright,B.J., 
Ostrowski,M.C., Himes,S.R., and Hume,D.A. (2003). A macrophage colony-
stimulating factor receptor-green fluorescent protein transgene is expressed 
throughout the mononuclear phagocyte system of the mouse. Blood 101, 1155-1163. 
References 
Page 178 
Schaerli, P., Ebert, L., Willimann,K., Blaser, A., Roos, RS., Loetscher,P., Moser, 
B.(2004).A skin-selective homing mechanism for human immune surveillance T 
cells. J.Exp. Med. 199, 1265-1275 
Schmader,K. (2001). Herpes zoster in older adults. Clin. Infect. Dis. 32, 1481-1486. 
Schroder,J.M. (1995). Cytokine networks in the skin. J. Invest Dermatol. 105, 20S-
24S. 
Schwandner,R., Dziarski,R., Wesche,H., Rothe,M., and Kirschning,C.J. (1999). 
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like 
receptor 2. J. Biol. Chem. 274, 17406-17409. 
Scott-Browne,J.P., Shafiani,S., Tucker-Heard,G., Ishida-Tsubota,K., Fontenot,J.D., 
Rudensky,A.Y., Bevan,M.J., and Urdahl,K.B. (2007). Expansion and function of 
Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204, 2159-
2169. 
Seddiki,N., Santner-Nanan,B., Martinson,J., Zaunders,J., Sasson,S., Landay,A., 
Solomon,M., Selby,W., Alexander,S.I., Nanan,R., Kelleher,A., and Fazekas de 
St,G.B. (2006). Expression of interleukin (IL)-2 and IL-7 receptors discriminates 
between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700. 
Serbina,N.V., Jia,T., Hohl,T.M., and Pamer,E.G. (2008). Monocyte-mediated 
defense against microbial pathogens. Annu. Rev. Immunol. 26, 421-452. 
Serbina,N.V., Salazar-Mather,T.P., Biron,C.A., Kuziel,W.A., and Pamer,E.G. 
(2003). TNF/iNOS-producing dendritic cells mediate innate immune defense against 
bacterial infection. Immunity. 19, 59-70. 
Shevach,E.M., DiPaolo,R.A., Andersson,J., Zhao,D.M., Stephens,G.L., and 
Thornton,A.M. (2006). The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ 
regulatory T cells. Immunol. Rev. 212, 60-73. 
References 
Page 179 
Shortman,K. and Liu,Y.J. (2002). Mouse and human dendritic cell subtypes. Nat. 
Rev. Immunol. 2, 151-161. 
Shortman,K. and Naik,S.H. (2007). Steady-state and inflammatory dendritic-cell 
development. Nat. Rev. Immunol. 7, 19-30. 
Sica,A., Schioppa,T., Mantovani,A., and Allavena,P. (2006). Tumour-associated 
macrophages are a distinct M2 polarised population promoting tumour progression: 
potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727. 
Siegal,F.P., Kadowaki,N., Shodell,M., Fitzgerald-Bocarsly,P.A., Shah,K., Ho,S., 
Antonenko,S., and Liu,Y.J. (1999). The nature of the principal type 1 interferon-
producing cells in human blood. Science 284, 1835-1837. 
Silverman,M.D., Zamora,D.O., Pan,Y., Texeira,P.V., Planck,S.R., and 
Rosenbaum,J.T. (2001). Cell adhesion molecule expression in cultured human iris 
endothelial cells. Invest Ophthalmol. Vis. Sci. 42, 2861-2866. 
Sprecher,E., Becker,Y., Kraal,G., Hall,E., Harrison,D., and Shultz,L.D. (1990). 
Effect of aging on epidermal dendritic cell populations in C57BL/6J mice. J. Invest 
Dermatol. 94, 247-253. 
Sprenger,M.J., Mulder,P.G., Beyer,W.E., Van Strik,R., and Masurel,N. (1993). 
Impact of influenza on mortality in relation to age and underlying disease, 1967-
1989. Int. J. Epidemiol. 22, 334-340. 
Sprent,J. and Surh,C.D. (2002). T cell memory. Annu. Rev. Immunol. 20, 551-579. 
Stein,M., Keshav,S., Harris,N., and Gordon,S. (1992). Interleukin 4 potently 
enhances murine macrophage mannose receptor activity: a marker of alternative 
immunologic macrophage activation. J. Exp. Med. 176, 287-292. 
References 
Page 180 
Steinman,L. (2005). Blocking adhesion molecules as therapy for multiple sclerosis: 
natalizumab. Nat. Rev. Drug Discov. 4, 510-518. 
Stockinger,B., Bourgeois,C., and Kassiotis,G. (2006). CD4+ memory T cells: 
functional differentiation and homeostasis. Immunol. Rev. 211, 39-48. 
Stoitzner,P., Pfaller,K., Stossel,H., and Romani,N. (2002). A close-up view of 
migrating Langerhans cells in the skin. J. Invest Dermatol. 118, 117-125. 
Sunderkotter,C., Nikolic,T., Dillon,M.J., van Rooijen,N., Stehling,M., Drevets,D.A., 
and Leenen,P.J. (2004). Subpopulations of mouse blood monocytes differ in 
maturation stage and inflammatory response. J. Immunol. 172, 4410-4417. 
Swerlick,R.A., Lee,K.H., Li,L.J., Sepp,N.T., Caughman,S.W., and Lawley,T.J. 
(1992). Regulation of vascular cell adhesion molecule 1 on human dermal 
microvascular endothelial cells. J. Immunol. 149, 698-705. 
Taams,L.S., van Amelsfort,J.M., Tiemessen,M.M., Jacobs,K.M., de Jong,E.C., 
Akbar,A.N., Bijlsma,J.W., and Lafeber,F.P. (2005). Modulation of 
monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. 
Immunol. 66, 222-230. 
Takahashi,M., Okada,S., Miyagawa,H., Amo,K., Yoshikawa,K., Asada,H., 
Kamiya,H., Torigoe,S., Asano,Y., Ozaki,T., Terada,K., Muraki,R., Higa,K., 
Iwasaki,H., Akiyama,M., Takamizawa,A., Shiraki,K., Yanagi,K., and Yamanishi,K. 
(2003). Enhancement of immunity against VZV by giving live varicella vaccine to 
the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 
21, 3845-3853. 
Theien,B.E., Vanderlugt,C.L., Nickerson-Nutter,C., Cornebise,M., Scott,D.M., 
Perper,S.J., Whalley,E.T., and Miller,S.D. (2003). Differential effects of treatment 
with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE. 
Blood 102, 4464-4471. 
References 
Page 181 
Tiemessen,M.M., Jagger,A.L., Evans,H.G., van Herwijnen,M.J., John,S., and 
Taams,L.S. (2007). CD4+CD25+Foxp3+ regulatory T cells induce alternative 
activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. U. S. A 104, 
19446-19451. 
Tissot,F., Zanetti,G., Francioli,P., Zellweger,J.P., and Zysset,F. (2005). Influence of 
bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what 
size? Clin. Infect. Dis. 40, 211-217. 
Toyoda,M., Nakamura,M., Luo,Y., and Morohashi,M. (2001). Ultrastructural 
characterization of microvasculature in photoaging. J. Dermatol. Sci. 27 Suppl 1, 
S32-S41. 
Tracey,K.J. and Cerami,A. (1994). Tumor necrosis factor: a pleiotropic cytokine and 
therapeutic target. Annu. Rev. Med. 45, 491-503. 
Trowbridge,I.S. and Thomas,M.L. (1994). CD45: an emerging role as a protein 
tyrosine phosphatase required for lymphocyte activation and development. Annu. 
Rev. Immunol. 12, 85-116. 
Turk JL. In: Delayed hypersensitivity, 3rd Edition edn. Amsterdam: Elsevier.  1980.  
Amsterdam: Elsevier.  
Uhlig,H.H., Coombes,J., Mottet,C., Izcue,A., Thompson,C., Fanger,A., 
Tannapfel,A., Fontenot,J.D., Ramsdell,F., and Powrie,F. (2006). Characterization of 
Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. 
J. Immunol. 177, 5852-5860. 
Uyemura,K., Castle,S.C., and Makinodan,T. (2002). The frail elderly: role of 
dendritic cells in the susceptibility of infection. Mech. Ageing Dev. 123, 955-962. 
Valladeau,J., Ravel,O., Dezutter-Dambuyant,C., Moore,K., Kleijmeer,M., Liu,Y., 
Duvert-Frances,V., Vincent,C., Schmitt,D., Davoust,J., Caux,C., Lebecque,S., and 
References 
Page 182 
Saeland,S. (2000). Langerin, a novel C-type lectin specific to Langerhans cells, is an 
endocytic receptor that induces the formation of Birbeck granules. Immunity. 12, 71-
81. 
van Amelsfort,J.M., Jacobs,K.M., Bijlsma,J.W., Lafeber,F.P., and Taams,L.S. 
(2004). CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the 
presence, phenotype, and function between peripheral blood and synovial fluid. 
Arthritis Rheum. 50, 2775-2785. 
van den Biggelaar,A.H., Huizinga,T.W., de Craen,A.J., Gussekloo,J., Heijmans,B.T., 
Frolich,M., and Westendorp,R.G. (2004). Impaired innate immunity predicts frailty 
in old age. The Leiden 85-plus study. Exp. Gerontol. 39, 1407-1414. 
van Duin,D., Mohanty,S., Thomas,V., Ginter,S., Montgomery,R.R., Fikrig,E., 
Allore,H.G., Medzhitov,R., and Shaw,A.C. (2007). Age-associated defect in human 
TLR-1/2 function. J. Immunol. 178, 970-975. 
van Duin,D. and Shaw,A.C. (2007). Toll-like receptors in older adults. J Am. Geriatr. 
Soc. 55, 1438-1444. 
van Furth,R. and Cohn,Z.A. (1968). The origin and kinetics of mononuclear 
phagocytes. J. Exp. Med. 128, 415-435. 
Van Ginderachter,J.A., Movahedi,K., Hassanzadeh,G.G., Meerschaut,S., Beschin,A., 
Raes,G., and De Baetselier,P. (2006). Classical and alternative activation of 
mononuclear phagocytes: picking the best of both worlds for tumor promotion. 
Immunobiology 211, 487-501. 
van Strien,G.A. and Korstanje,M.J. (1994). Site variations in patch test responses on 
the back. Contact Dermatitis 31, 95-96. 
References 
Page 183 
Varol,C., Landsman,L., Fogg,D.K., Greenshtein,L., Gildor,B., Margalit,R., 
Kalchenko,V., Geissmann,F., and Jung,S. (2007). Monocytes give rise to mucosal, 
but not splenic, conventional dendritic cells. J. Exp. Med. 204, 171-180. 
Veiga-Fernandes,H., Walter,U., Bourgeois,C., McLean,A., and Rocha,B. (2000). 
Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat. 
Immunol. 1, 47-53. 
Vermeer,B.J., Reman,F.C., and van Gent,C.M. (1979). The determination of lipids 
and proteins in suction blister fluid. J. Invest Dermatol. 73, 303-305. 
Vollmar,B., Morgenthaler,M., Amon,M., and Menger,M.D. (2000). Skin 
microvascular adaptations during maturation and aging of hairless mice. Am. J. 
Physiol Heart Circ. Physiol 279, H1591-H1599. 
von Andrian,U.H. and Mackay,C.R. (2000). T-cell function and migration. Two 
sides of the same coin. N. Engl. J. Med. 343, 1020-1034. 
Vora,M., Yssel,H., de Vries,J.E., and Karasek,M.A. (1994). Antigen presentation by 
human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-
gamma and IL-10. J. Immunol. 152, 5734-5741. 
Vukmanovic-Stejic,M., Agius,E., Booth,N., Dunne,P.J., Lacy,K.E., Reed,J.R., 
Sobande,T.O., Kissane,S., Salmon,M., Rustin,M.H., and Akbar,A.N. (2008). The 
kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-
specific memory response in vivo. J. Clin. Invest 118, 3639-3650. 
Vukmanovic-Stejic,M., Zhang,Y., Cook,J.E., Fletcher,J.M., McQuaid,A., 
Masters,J.E., Rustin,M.H., Taams,L.S., Beverley,P.C., Macallan,D.C., and 
Akbar,A.N. (2006). Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by 
rapid turnover of memory populations in vivo. J. Clin. Invest 116, 2423-2433. 
References 
Page 184 
Walker,M.R., Carson,B.D., Nepom,G.T., Ziegler,S.F., and Buckner,J.H. (2005). De 
novo generation of antigen-specific CD4+CD25+ regulatory T cells from human 
CD4+. Proc. Natl. Acad. Sci. U. S. A 102, 4103-4108. 
Wammanda,R.D., Gambo,M.J., and Abdulkadir,I. (2006). The mantoux test: should 
we change the site? Trop. Doct. 36, 40. 
Waskow,C., Liu,K., Darrasse-Jeze,G., Guermonprez,P., Ginhoux,F., Merad,M., 
Shengelia,T., Yao,K., and Nussenzweig,M. (2008). The receptor tyrosine kinase Flt3 
is required for dendritic cell development in peripheral lymphoid tissues. Nat. 
Immunol. 9, 676-683. 
Watts,T.H. (2005). TNF/TNFR family members in costimulation of T cell responses. 
Annu. Rev. Immunol. 23, 23-68. 
Watts,T.H. and DeBenedette,M.A. (1999). T cell co-stimulatory molecules other 
than CD28. Curr. Opin. Immunol. 11, 286-293. 
Wethmar,K., Helmus,Y., Luhn,K., Jones,C., Laskowska,A., Varga,G., Grabbe,S., 
Lyck,R., Engelhardt,B., Bixel,M.G., Butz,S., Loser,K., Beissert,S., Ipe,U., 
Vestweber,D., and Wild,M.K. (2006). Migration of immature mouse DC across 
resting endothelium is mediated by ICAM-2 but independent of beta2-integrins and 
murine DC-SIGN homologues. Eur. J. Immunol. 36, 2781-2794. 
Wick,G. and Grubeck-Loebenstein,B. (1997). The aging immune system: Primary 
and secondary alterations of immune reactivity in the elderly. Experimental 
Gerontology 32, 401-413. 
Wikby,A., Johansson,B., Olsson,J., Lofgren,S., Nilsson,B.O., and Ferguson,F. 
(2002). Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an 
association with cytomegalovirus seropositivity in the elderly: the Swedish NONA 
immune study. Exp. Gerontol. 37, 445-453. 
References 
Page 185 
Willis,C.M., Young,E., Brandon,D.R., and Wilkinson,J.D. (1986). 
Immunopathological and ultrastructural findings in human allergic and irritant 
contact dermatitis. Br. J. Dermatol. 115, 305-316. 
Wills,M.R., Carmichael,A.J., Weekes,M.P., Mynard,K., Okecha,G., Hicks,R., and 
Sissons,J.G. (1999). Human virus-specific CD8+ CTL clones revert from 
CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both 
naive and memory cells. J. Immunol. 162, 7080-7087. 
Wittmann,M. and Werfel,T. (2006). Interaction of keratinocytes with infiltrating 
lymphocytes in allergic eczematous skin diseases. Curr. Opin. Allergy Clin. 
Immunol. 6, 329-334. 
Wolff,K. and Winkelmann,R.K. (1967). Ultrastructural localization of nucleoside 
triphosphatase in Langerhans cells. J. Invest Dermatol. 48, 50-54. 
Wolpe,S.D., Davatelis,G., Sherry,B., Beutler,B., Hesse,D.G., Nguyen,H.T., 
Moldawer,L.L., Nathan,C.F., Lowry,S.F., and Cerami,A. (1988). Macrophages 
secrete a novel heparin-binding protein with inflammatory and neutrophil 
chemokinetic properties. J. Exp. Med. 167, 570-581. 
Woo,E.Y., Chu,C.S., Goletz,T.J., Schlienger,K., Yeh,H., Coukos,G., Rubin,S.C., 
Kaiser,L.R., and June,C.H. (2001). Regulatory CD4(+)CD25(+) T cells in tumors 
from patients with early-stage non-small cell lung cancer and late-stage ovarian 
cancer. Cancer Res. 61, 4766-4772. 
Wung,B.S., Ni,C.W., and Wang,D.L. (2005). ICAM-1 induction by TNFalpha and 
IL-6 is mediated by distinct pathways via Rac in endothelial cells. J. Biomed. Sci. 12, 
91-101. 
Yan,H.C., Delisser,H.M., Pilewski,J.M., Barone,K.M., Szklut,P.J., Chang,X.J., 
Ahern,T.J., Langer-Safer,P., and Albelda,S.M. (1994). Leukocyte recruitment into 
References 
Page 186 
human skin transplanted onto severe combined immunodeficient mice induced by 
TNF-alpha is dependent on E-selectin. J. Immunol. 152, 3053-3063. 
Yednock,T.A., Cannon,C., Fritz,L.C., Sanchez-Madrid,F., Steinman,L., and Karin,N. 
(1992). Prevention of experimental autoimmune encephalomyelitis by antibodies 
against alpha 4 beta 1 integrin. Nature 356, 63-66. 
Yoshikawa,T.T. (1997). Perspective: aging and infectious diseases: past, present, and 
future. J. Infect. Dis. 176, 1053-1057. 
Yoshikawa,T.T. (2000). Epidemiology and unique aspects of aging and infectious 
diseases. Clin. Infect. Dis. 30, 931-933. 
Zaba,L.C., Fuentes-Duculan,J., Steinman,R.M., Krueger,J.G., and Lowes,M.A. 
(2007). Normal human dermis contains distinct populations of CD11c+BDCA-1+ 
dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest 117, 2517-2525. 
Zaba,L.C., Krueger,J.G., and Lowes,M.A. (2009). Resident and "inflammatory" 
dendritic cells in human skin. J. Invest Dermatol. 129, 302-308. 
References 
Page 187 
Published papers 
